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Abstract
This thesis describes the design, synthesis and application of artificial
metalloenzymes for transition metal catalysed reactions not performed by natural
enzymes. Unique cysteine containing protein templates were covalently modified with
transition metal ligand complexes that generate catalytic activity, which allows for the
use of virtually any protein template. SCP-2L was selected as template for the linear
hydrophobic tunnel that traverses the protein, which has high affinity for linear
aliphatic molecules.
The use of catalysts based on this protein to induce increased activity in the biphasic
hydroformylation of linear α-olefins is investigated in this work. For this purpose, 
unique cysteine containing mutants of SCP-2L were modified with phosphine ligands
by application of a novel bioconjugation procedure. Application of rhodium adducts
of the phosphine modified protein constructs led to up to a 100 fold increase of the
turn over numbers was measured compared to a Rh/TPPTS model system which is
used in industry. Furthermore, good selectivity towards the linear product was
observed. If it can be confirmed that the found catalytic results truly are the result of
substrate encapsulation by the protein scaffold, this system represents the first
rationally designed artificial metalloenzyme which exploits the shape selectivity of
the protein scaffold to direct the outcome of a catalytic reaction.
In addition, a study was performed for the development of enantioselective artificial
metalloenzymes. Nitrogen ligands were covalently introduced in SCP-2L and the
obtained conjugates were applied in the copper catalysed Diels-Alder and Michael
addition reaction. A promising 25% ee was found for the Diels-Alder reaction
between azachalcone and cyclopentadiene using one of the created constructs.
Further development of these catalyst systems with the use of both synthetic (e.g.
optimisation of ligand structure) and biomolecular tools (e.g. optimisation of protein
environment) for optimisation can lead to very efficient and enantioselective
conversions in the future.
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ALBP = Adipocyte lipid binding protein
CD = Circular dichroism
CDI = 1,1’-carbonyldiimidazole







DNA = Deoxyribonucleic acids
DTNB = 5,5′-dithio-bis(2-nitrobenzoic acid (Ellman’s reagent) 
DTT = Dithiothreitol
EDC = N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide
EDTA = Ethylenediaminetetraacetic acid
ee = Enantiomeric excess
EPR = Electron paramagnetic resonance
ES(+) = Electron spray ionization (positive mode)
HEPES = 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HOBT = Hydroxybenzotriazole
HPLC = High-performance liquid chromatography
HSA = Human serum albumin
iBCF = Isobutylchloroformate
ICP = Inductively coupled plasma
IPA = Isopropanol
IPTG = Isopropyl-1-thio-β-D-galactopyranoside 
KPi = Potassium phosphate (buffer)
LCMS = Liquid chromatography-mass spectrometry
MES = 2-(N-morpholino)ethanesulfonic acid
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NMR = Nuclear magnetic resonance
Orn = Ornithine
PB = Production broth (see section 2.5.3 for contents)
pdb = protein data bank (file code)
PYP = Photoactive yellow protein
Pyr-C12 = 12-pyrene dodecanoic acid
RNA = Ribonucleic acids
TCEP = Tris(2-carboxyethyl)phosphine
TEV = Tobacco etch virus
TFA = Trifluoroacetic acid
THF = Tetrahydrofuran
TLC = Thin layer chromatography
TMS = Trimethyl silane
TNB = 5-thio-2-nitrobenzoic acid
TON = Turnover number
TPP = Triphenylphosphine
TPPDS = Triphenylphosphine disulfonate
TPPMS = Triphenylphosphine monosulfate
TPPTS = Triphenylphosphine trisulfonate
Tris = Tris(hydroxymethyl)aminomethane
SCP2 = Sterol carrier protein 2
SCP-2L = Sterol carrier protein 2-like
UV = Ultraviolet
Watergate = Water suppression by gradient tailored excitation
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Protein mutant coding:
[Name of the protein] [Original amino acid][Location][Newly introduced amino acid]
For example name SCP-2L V83C indicates that the valine (V) at position 83 in SCP-
2L is replaced by a cysteine (C) to obtain the named mutant protein.
Compound codes:
A# = Aldehydes for modification to hydride modified proteins other than phosphines
B# = Branched hydroformylation products
C# = Carboxylic acid containing phosphine ligands
E# = Additional compounds
H# = Rhodium complexes involved in the catalytic hydroformylation
I# = Intermediate products in the synthesis towards ligand for protein modification
K# = “Click” phosphines
L# = Linear hydroformylation products
M# = Maleimide containing compounds for selective bioconjugation to free cysteines
N# = Nitrogen ligands
P# = Phosphino aldehydes
S# = DNA-binding ligands
T# = Tetrazoles
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Chapter 1. Introduction to bioinspired catalysis 





Many bioinspired transition metal catalysts have been developed over  recent years. In 
this chapter the progress in the design and application of ligand-systems based on 
peptides and DNA and the development of artificial metalloenzymes are reviewed, 
with a particular emphasis on the combination of phosphine-ligands with the powerful 
molecular recognition and shape selectivity of biomolecules. The various approaches 
for the assembly of these catalytic systems will be highlighted, and the possibilities 
that the use of the building blocks of Nature provide for catalyst optimisation 
strategies are discussed. Additionally, an outlook is given on the artificial 
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1.2 Introduction 
Advancing the understanding of catalytic systems has proven very fruitful for the 
development of effective homogeneous catalysts. For instance, the growing insight in 
organometallic chemistry employing phosphorous donor ligands is facilitating the 
design of systems with optimised electronic and steric ligand parameters to create 
very effective transition metal catalysts for industrial chemical reactions.[1] Integrating 
the rational ligand design process with combinatorial catalyst optimisation techniques 
has proven a powerful strategy.[2] Nevertheless, despite these developments, efficient 
transition metal catalysts are still lacking for various chemical conversions with 
demanding selectivity and reactivity problems.  
Enzymes often outperform synthetic catalysts by employing highly efficient substrate 
recognition and orientation, stabilisation of reactive intermediates and other second 
sphere interactions which are still not fully understood. Studies of synthetic mimics of 
enzyme active sites have indicated that second sphere substrate interactions are very 
important for the catalytic proficiency of enzymes.[3] 
Enzymes are increasingly applied in industrial scale synthetic processes.[4] Such 
processes are very effective, but natural enzymes are not available for many important 
chemical conversions performed in industry, creating the demand for the development 
of synthetic catalysts that rival the performance of natural enzymes. Increasing insight 
in the mode of action of enzymes and the advances in computational modelling 
techniques have led to the de novo design of artificial enzymes with unnatural 
catalytic activities.[5] Alternatively, much effort has been made to develop synthetic 
catalysts that mimic the characteristics of enzymes. For example shape selective 
heterogeneous catalysts have been developed by controlling the pore size in zeolites, 
leading to increased selectivity for C1 oxidation of n–alkanes.[6] Another approach is 
the use of transition metal complexes with resins containing hydrogen bonding groups 
to mimic enzyme structures.[7] In homogeneous catalysis sophisticated modular ligand 
systems have been designed using bioinspired supramolecular interactions[8] or by 
introducing bulky organic scaffolds like cyclodextrins or calixarenes for substrate 
encapsulation.[9] In addition, ligand systems with specific hydrogen bonding 
interactions have been designed to enforce steric interactions or to favourably 
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A field that aims to combine the best features of natural and “man-made” catalysts is 
the design of transition metal catalyst systems based on the building blocks of 
Nature.[11] This approach makes use of ligand-functionalised peptide chains, DNA, 
RNA and proteins, seeking to create enzyme-like transition metal catalysts for 
reactions not found in Nature such as allylic substitution, olefin hydrogenation, 
hydroformylation, metathesis and cycloadditions. A synergy is envisioned between 
rational ligand design and the molecular recognition properties of biomolecules, 
providing catalytic systems which can overcome selectivity issues for demanding 
substrates and avoid the need for protecting groups. In addition to the potential of the 
chirality of these natural building blocks in asymmetric reactions,[11c, 12] second sphere 
ligand-substrate interactions may lead to the induction of enzyme-like regio-, chemo-, 
enantio- and substrate selectivities.[13]  
An additional advantage of this approach is the role separation between the metal 
centre, which typically dominates the chemical activity, and the biomolecular 
environment, which is used to induce selectivity in the reaction (Figure 1). This 
division of functionalities greatly simplifies the application of modular combinatorial 
synthesis approaches.  
 
Figure 1. Schematic representation of the separation of roles found in bioinspired 
transition metal catalysts. 
 
This introduction highlights various bioinspired approaches towards transition metal 
catalyst systems and their applications. In line with the research presented in this 
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Also the new opportunities for catalyst development these systems provide, using 
traditional synthetic tools combined with combinatorial assembly and/or advanced 
biomolecular methods will be discussed as well as future prospects of these systems 
for solving challenging reactivity and selectivity problems encountered in 
homogeneous catalysis 
 
1.3 Peptide based catalysts 
1.3.1 Peptide based ligands for transition metal catalysis 
Nature has always been an important source of inspiration for synthetic chemists. This 
also applies to ligand design in homogeneous catalysis. For example amino acids 
constitute an easily accessible chiral pool and can be used directly as ligands in 
transition metal catalysed chemical conversions[14] or be used as source for the 
synthesis of chiral ligand scaffolds.[15] This section will provide an overview of 
catalyst systems containing amino acid building blocks to create protein like 
structures for well-known transition metal catalysed reactions.  
Hayashi already reported in 1982 the modification of a diphosphine moiety with 
leucine to obtain a chiral diphosphine ligand which was used in the palladium 
catalysed asymmetric allylation of 2-acetylcyclohexanone (Scheme 1).[16] The 
observed 52% enantiomeric excess (ee) was ascribed to the second-sphere interaction 
of the leucine part of the ligand with the sodium enolate intermediate.  
 
Scheme 1. Amino acid modified diphosphine ligand for palladium catalysed 
asymmetric allylation.[16] 
 
This represents one of many examples where the modification of phosphine ligands 
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transition metal catalysed reactions.[11c] Another example of the potential of amino 
acid functionalised phosphines is the use as water soluble ligands.[17] 
 
1.3.2 Oligopeptide modified phosphine ligands 
For the purpose of connecting phosphine ligands to longer peptide structures, either 
phosphine containing peptide building blocks or selective strategies for the 
modification of peptides with phosphines are required. Several phosphine containing 
peptide building blocks have been reported which have not been incorporated into 
larger peptidic structures.[18] Hoveyda et al. reported the synthesis of a small library of 
dipeptides containing a diphenylphosphine-modified valine with either glycine or 
phenylalanine as the second amino acid.[19] These ligands were successfully applied in 
the copper catalysed conjugate addition of dialkyl zinc reagents to various 
electrophiles. High enantioselectivities (>90%) were typically obtained and in general 
single amino acid variants outperformed dipeptide structures.  
 
Scheme 2. Diphosphines assembled by hydrogen bonding between amino acid 
substituents for a) rhodium catalysed asymmetric hydrogenation[21] and b) rhodium 
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Breit and co-workers created a similar class of phosphine ligands based on small 
peptide chains consisting of D- and L-valine units with a terminal phosphine or 
phosphite moiety.[20] These systems were applied in copper catalysed conjugate 
additions achieving selectivities similar to those reported by Hoveyda. Breit also 
demonstrated that these phosphine ligands can form diphosphine ligands via 
homodimeric self-assembly of the peptides into helical structures via hydrogen 
bonding and π-stacking (Scheme 2a).[21] These assemblies were applied in the 
rhodium catalysed hydrogenation of protected amino acid precursors and 
dimethylitaconate reaching over 95% ee for each substrate used. This concept was 
extended to β–turn mimics using assembled hetero combinations of peptide modified 
phosphines containing glycine and alanine in addition to the valine residues (Scheme 
2b).[22] These systems were applied in the rhodium catalysed hydroformylation of 
styrene, in which high branched selectivity (>85%) was obtained with nearly all 
combinations.[23] The ee observed using these catalysts was low (<38%). 
The application of longer oligopeptides was pioneered by Gilbertson et al. who 
synthesised various phosphine modified amino acids which were introduced at 
different positions in synthetic oligopeptides containing β–turn and helical 
structures.[24] For this purpose several sulfur-protected phosphine containing alanine 
derivatives compatible with solid phase peptide synthesis were developed (Scheme 
3a).[25] In addition a phosphine-sulfide functionalised proline as alternative phosphine-
peptide building blocks (Scheme 3b) and a procedure to introduce phosphine moieties 
into aromatic amino acids after peptide synthesis were reported (Scheme 3c).[26] 
Several phosphine containing oligopeptides with a helical motif were synthesised. 
This small library was evaluated on solid support as ligands for the rhodium catalysed 
hydrogenation of amino acid precursors reaching up to 18% ee (Scheme 3d).[27] In 
addition to helical motifs, phosphine-peptides containing a proline-β-turn were 
prepared both on solid support and in solution and applied as ligands in the palladium 
catalysed asymmetric allylic substitution of 3-acetoxycyclopentene with dimethyl 
malonate (Scheme 3e).[28] The product was obtained in up to 95% ee in solution and 
88% ee on solid support. Interestingly, low ee was obtained when oligopeptides 
lacking the β-turn structure were used, showing this motif is essential for the 
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Scheme 3. Phosphine containing amino acid residues synthesised by the group of 
Gilbertson based on a) valine[25] b) proline and c) phenylalanine.[26] These units were 
applied in d) helical structures for rhodium catalysed asymmetric hydrogenation[27] 
and e) proline-β-turn motifs for palladium catalysed allylic substitution.[28] 
 
Inspired by the research of Gilbertson and co-workers, several other groups have 
created resin supported phosphine containing oligopeptides. Wills et al. reported the 
functionalisation of free amino groups of supported oligopeptides with para-
diphenylphosphino benzoic acid (Scheme 4a).[29] The thus obtained ligands were 
tested in palladium catalysed allylic substitution of diphenylallyl acetate but no ee was 
observed. Meldal et al. reported the phosphinomethylation of primary and secondary 
amino groups of resin bound oligopeptides to create diphosphine and P,S ligand 
systems (Scheme 4b-d).[30] These systems were employed in the palladium catalysed 
allylic substitution of diphenylallyl acetate obtaining up to 21% ee for the P,P systems 
and up to 60% ee for the P,S systems. Similar systems containing N-heterocyclic 
carbene ligands were successfully applied in palladium catalysed Sonogashira and 
Suzuki cross coupling reactions.[31] The group of Landis created a series of resin 
supported 3,4-diazaphospholanes modified with amino acids (Scheme 4e), resulting in 
a β-turn like structure.[32] High selectivity was obtained when a small library of these 
supported phosphines was employed in the palladium catalysed allylic substitution of 
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Scheme 4. Resin bound phosphine ligands by a) Wills et al.[29] b-d) Meldal et al.[30] e) 
Landis et al. (AA = Amino acid).[32] 
 
The previous examples show that the ligand systems using well-defined hydrogen 
bonding motifs gave generally higher selectivities compared to those with random 
chains, highlighting the importance of ligands with a well-defined three dimensional 
structure. Lammertsma et al. reported bisphosphine analogues of Gramicidin S, a 
cyclic decapeptide containing a rigid structure enforced by two β-turns.[33] These 
peptides were synthesised on solid support by replacement of two ornithines with 
phosphine containing amino acids. X-ray crystal structures of two of these cyclic 
peptides containing sulfur protected phosphines show that the phosphine amino acids 
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Scheme 5. Bisphosphine modified Gramicidin S a) crystal structures of two of the 
structures synthesised by Lammertsma et al. containing sulfur protected phosphines[33] 
Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission b) 
Structures applied in palladium catalysed asymmetric allylic substitution and rhodium 
catalysed asymmetric hydrogenation.[34] 
 
Similar systems were prepared by modification of the two ornithine (Orn) amino acids 
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complexes of these cyclic peptides were characterised and used as hydrogenation 
catalysts, resulting in moderate enantioselectivities (up to 52% R) using the meta 
substituted cyclic peptide. Interestingly the opposite enantiomers were obtained in low 
ee when the para substituted cyclic peptide was used. Low ee’s (<15%) were obtained 
in the palladium catalysed allylic substitution of diphenylallyl acetate. 
 
1.3.3 Other oligopeptide design strategies  
Another approach is to mimic protein structures using peptide containing dendrimers. 
Arya et al. reported an amino acid based dendrimer containing several free amines, 
anchored on a solid support (Scheme 6).[35]  
 
Scheme 6. Amino acid based dendrimer diphosphine rhodium catalysts for 
hydroformylation (Displayed b selectivities are shown for R = Ph over up to five 
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These amines were reacted with diphenylphosphinomethanol to create multiple 
diphosphine sites on the dendrimer. The created phosphine containing dendrimers 
were used in rhodium catalysed hydroformylation of a variety of olefins. Good 
conversions and branched selectivities were obtained. Rhodium leaching was 
significantly reduced by positioning the phosphine ligands at different sites in the 
dendrimer interior, which allowed for several recycling cycles in hydroformylation.[36] 
In the above sections several methods for mimicking enzymes using short synthetic 
peptides have been described. Larger peptide structures can also be obtained using 
solid-phase peptide synthesis. Roelfes et al. utilised this to introduce a copper binding 
site in a short (31 amino acids) peptide based on bovine pancreatic polypeptide 
(Scheme 7).[37] This polypeptide was synthesised on solid support with strategically 
placed histidine and unnatural 3- and 4-pyridylalanine amino acids to create artificial 
copper binding sites. The resulting copper adducts showed good enantioselectivities in 
Diels-Alder reactions and Michael additions of 83% and 86% ee respectively. 
 
Scheme 7. Dinitrogen copper catalyst for asymmetric Diels-Alder reactions based on 
modified bovine pancreatic polypeptide (bpp).[37] 
 
1.4 Artificial metallo DNAzymes 
1.4.1 Introduction 
Oligonucleotides are another attractive class of biopolymers for catalyst 
development.[38] Not only does the sugar-phosphate backbone provide a source of 
chirality, oligonucleotides have been found to exhibit molecular recognition 
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(DNA- and RNAzymes)[39] Moreover, the well-known base-pairing rules allow for the 
rational engineering of their secondary and tertiary structure, affording fascinating 
prospects in nanotechnology.[40] These features make oligonucleotides well-suited for 
engineering sophisticated catalysts.[39c-f] Developments in the synthesis of hybrid 
transition metal containing DNA catalysts can be divided in two main approaches: 
supramolecular assembly and covalent anchoring. 
 
1.4.2 Supramolecular assembly 
Roelfes pioneered this field with the development of copper dinitrogen complexes that 
bind to the DNA double helix by intercalation and/or groove binding. (Scheme 8).[41] 
Assembled systems of various nitrogen copper complexes and commercially available 
salmon testes and calf thymus DNA served as catalysts for asymmetric Diels-
Alder,[42] Michael addition,[43] and Friedel-Crafts alkylation[44] reactions. Using 
azachalcone or α,β-unsaturated 2-acyl imidazoles as substrate high ee’s (>80%) were 
reported for these reactions. Remarkably, all reactions were performed in water and a 
later study showed that the additions of small amounts of organic solvents can be 
beneficial to the reaction up to a level where the DNA starts to precipitate.[45] Using 
different synthetic oligonucleotide strands it was shown that the enantioselectivity of 
the Diels-Alder reaction is sequence dependent.[46] S1 (n = 2 R = 3,5-
dimethoxybenzene) provided high enantioselectivity with alternating guanidine-
cytosine (G-C) sequences, whereas S2 gave high enantioselectivity when using short 
guanidine sequences (GGG, Scheme 8). Interestingly, high selectivity was still 
obtained with salmon testes and calf thymus DNA, although these sources contain an 
enormous number of different binding sites. These results indicated that the most 
selective catalytic species are also the most active. The same system was applied by 
the group of Roelfes in the copper catalysed hydrolytic kinetic resolution of 
pyridyloxiranes[47] and by Toru and co-workers in copper catalysed electrophilic 
fluorination reactions.[48] In a very recent study, the first non-enzymatic 
enantioselective and diastereospecific syn hydration of α,β-unsaturated ketones was 
achieved using this system (Scheme 8).[49] This hydration reaction has no equivalent 
in conventional chiral transition metal catalysis and thus clearly demonstrates the 
potential of bio-inspired approaches to provide transition metal catalysts with 
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Scheme 8. A selection of DNA-binding ligands used by the group of Roelfes with 
DNA in copper catalysed asymmetric reactions.[42-46, 49] 
 
1.4.3 Covalent modification 
The alternative approach to obtain artificial metallo-DNAzymes is by covalent 
anchoring of catalytically active transition metal complexes to DNA. This strategy 
fixes the location of the transition metal catalysts which allows for a more specific 
design of the ligand environment. The covalent attachment of ligands is however 
more challenging compared to supramolecular anchoring as synthetic modification of 
the DNA is required. Due to incompatibility between DNA synthesis conditions and 
ligand synthesis, transition metal binding ligands are generally introduced after DNA 
synthesis and purification to an incorporated unnatural nucleotide.  
The group of Roelfes introduced a bipyridine copper system covalently into DNA.[50] 
They used an amine linker at a terminal position of an oligonucleotide which was 
modified by amide bond formation with a carboxylic acid modified bipyridine 
(Scheme 9). The resulting oligonucleotide was then hybridised to a longer 
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assemblies were used as ligands in copper catalysed Diels-Alder reaction between 
azachalcone and cyclopentadiene. The conversion and enantioselectivity were found 
to be dependent on the oligonucleotide sequences used. Catalyst containing 
oligonucleotide 1 with a complementary strand gave 22% ee, which could be 
improved to 93% ee by addition of a second oligonucleotide and optimisation of the 
base sequences.  
Jakobsen et al. reported the application of a polyaza-crown ether-containing DNA in 
the copper catalysed Diels-Alder reaction of azachalcone and cyclopentadiene,[51] but 
the obtained enantioselectivities were low (<10% ee). Bipyridine copper and salen-
nickel complexes have also been introduced into RNA for sequence specific DNA 
cleavage.[52] 
 
Scheme 9. Terminal bipyridine modified oligonucleotide used in combination with 
several complementary oligonucleotide templates for the copper catalysed asymmetric 
Diels-Alder reaction.[50] 
 
The group of Jäschke synthesised several diene modified oligonucleotides of 19 bases 
via modification of an introduced 4-triazolyldeoxyuridine (Scheme 10).[53] These 
modified oligonucleotides were tested in iridium catalysed allylic amination of phenyl 
allyl acetate. Several complementary DNA and RNA strands were used including 
some that form loops in either the complementary or the ligand containing strand. 
Both the ee of the substrate and the product were recorded as the conversion was 
found to be around 45% for all systems. Ee’s were found up to 27% and interestingly 
it appeared that the configuration of the major enantiomer was dependent on the 
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catalyst performance outlined in the examples above holds great promise for 
combinatorial screening and catalyst optimisation as the sequence of the 
complementary strand can easily be varied using automated DNA synthesis. 
 
Scheme 10. Diene modified oligonucleotide applied with complementary strands in 
iridium catalysed asymmetric allylic amination.[53] 
 
1.4.4 Phosphine modified DNA 
Kamer et al. reported the synthesis of phosphine modified nucleotides based on 5-
iodouridine, which were applied in palladium catalysed allylic amination of 
diphenylallyl acetate (Scheme 11a).[54] A significant influence of the solvent was 
found on the enantioselectivity, with ee changing from 80% (S) in tetrahydrofuran 
(THF) to 16% (R) in a 50:50 mixture of acetonitrile and THF for R1 = R2 = H. For R1 
= R2 = Ac the ee switched from 8% (S) in THF to 23% (R) in dichloromethane. 
Disappointingly, a trimer containing the phosphine modified nucleotide gave lower 
enantioselectivities (<12% ee). Functionalisation of longer DNA strands proved 
troublesome due to reduced rates of the palladium catalysed cross coupling step 
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Scheme 11. Phosphine modified mono and trinucleotides used in palladium catalysed 
asymmetric allylic amination a) mononucleotide inserted in trinucleotides[54] b) 
mononucleotide inserted into 15 base long oligonucleotides.[55] 
 
Jäschke and co-workers disclosed the successful modification of longer DNA strands 
with mono- and diphosphines by introduction of a free amine in DNA strands 
followed by modification via amide bond formation with carboxylic acids containing 
phosphines.[56] Kamer et al. used a similar strategy to obtain phosphine modified 
oligonucleotides (Scheme 11b).[55] Several phosphine modified 15 base long 
oligonucleotides were synthesised and a palladium complex was reported. Initial 
catalysis experiments using the phosphine modified mononucleotides resulted in full 
substrate conversion for the palladium catalysed substitution of diphenyl acetate, but 
no ee. This was attributed to the large distance between the phosphine moiety and the 
chiral backbone in these nucleotides. Catalysis using either of the above phosphine 
modified oligonucleotides systems developed by Kamer or Jäschke has not been 
reported so far. 
These new synthetic strategies for the introduction of phosphine ligands into 
nucleotides allow for many more opportunities for metallo DNAzyme applications. In 
combination with all the possibilities for molecular recognition and 3-dimensional 
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1.5 Artificial metalloenzymes 
1.5.1 Introduction 
In spite of the pioneering work by Kaiser and Whitesides already published in the late 
seventies, research on artificial metalloenzymes has flourished only in the last 
decade.[57] Many strategies can be found in literature for incorporation of catalytic 
transition metal centres into protein structures, each with their distinct features and 
(dis)advantages.[58] These strategies can be divided into two main categories: non-
covalent anchoring and covalent modification. The non covalent anchoring approach 
can be divided into two subcategories: dative anchoring, employing the affinity of a 
protein for a transition metal, and supramolecular anchoring, using high-affinity 
protein substrate interactions. For both subcategories a high complexation constant is 
a prerequisite to ensure precise and stable localisation of the transition metal centre in 
the macromolecule. This condition is also a direct advantage compared to the covalent 
approach as catalyst assembly is in principle easily achieved by mixing the 
components. Applications of artificial metallo enzymes falling into these categories 
will be discussed to give an overview of the achievements so far in this exciting field 
of bioinspired catalysis. 
 
1.5.2 Dative anchoring 
The dative approach for the creation of artificial metalloenzymes involves direct 
coordination of transition metals to protein hosts in defined cavities or on the outer 
sphere. In this way a suitable transition metal centre for the desired catalytic reaction 
can be introduced.[59] Kaiser et al. were the first to report on this approach by 
replacing zinc in the active site of carboxypeptidase A (CPA) with copper, creating an 
oxidation catalyst for ascorbic acid.[57b] However, as proteins can have multiple sites 
for metal binding, selective creation of catalysts with a defined transition metal centre 
can be problematic.[60] 
The groups of Kazlauskas[61] and Soumillion[62] simultaneously reported the 
replacement of the zinc atom in the active site of carbonic anhydrases with 
manganese, leading to an artificial metalloenzyme for asymmetric epoxidation 
reactions. Similar enantioselectivities were reported (up to 67% ee) for the 
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application of site directed mutagenesis to identify several key amino acid residues, 
which control the enantioselectivity in these reactions.  
 
Scheme 12. Application of dative artificial metalloenzymes in a) manganese 
asymmetric epoxidation[61-62] b) rhodium catalysed hydrogenation[59] c) 
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More recently, the group of Kazlauskas also introduced rhodium in carbonic 
anhydrases to create a stilbene hydrogenation catalyst with high selectivity for the cis 
substrate (Scheme 12b).[59] The significant amount of trans-stilbene formed by 
isomerisation due to surface bound rhodium was reduced by removal of surface lysine 
and histidine residues using a combination of site directed mutagenesis and chemical 
modification. The same procedure resulted in a catalyst that gave surprisingly high 
linear selectivity in the hydroformylation of styrene (Scheme 12c).[63] More examples 
of oxidation,[65] hydrogenation[66] and hydroformylation[67] catalysis using dative 
systems have been reported. 
Reetz recently reported the creation of an artificial copper binding site in the synthase 
subunit of imidazole glycerol phosphate synthase from Thermotoga maritima (tHisF) 
(Scheme 12d).[64] The introduced motif consisted of two histidine and one aspartic 
acid residue located at a strategic position in order to bind a copper atom. The system 
was applied in the copper catalysed Diels-Alder reaction between azachalcone and 
cyclopentadiene leading to 35% ee with improved activity compared to the native 
protein. The removal of several native histidines, which could act as alternative 
copper binding sites, led to an increase of the enantioselectivity up to 46%.  
These examples of artificial metalloenzymes using dative protein-transition metal 
interactions illustrate how such systems can lead to catalysts showing interesting 
enantio and chemoselectivity for non-native reactions. Engineering of the protein 
sequences using mutagenesis techniques proved to be a useful catalyst optimisation 
tool. 
 
1.5.3 Supramolecular anchoring using biotin-avidin technology 
Wilson and Whitesides reported already in 1978 the formation of an artificial 
metalloenzyme using a rhodium-diphosphine complex modified with biotin in 
combination with avidin (Scheme 13).[57a] The interaction between avidin and biotin is 
one of the strongest protein-substrate interactions known (Ka = 1015 M-1) and is 
considered to be irreversible. This supramolecular assembly was applied in 
asymmetric hydrogenation of the prochiral amino acid precursor N-acetamidoacrylic 
acid, affording full conversion to the product with an ee of 41% (S) (Scheme 13a). 
This seminal work by Whitesides inspired several groups to further exploit the 
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catalyst optimisation. Several studies were published in which the system was 
changed synthetically by varying the linker using different aliphatic and aromatic 
inserts and changing the diphosphine motif.[68]  
 
Scheme 13. a) Schematic representation of the biotin-(strept)avidin based artificial 
metalloenzymes and application in hydrogenation of prochiral amino acid 
precursors[57a, 68-71] b) ruthenium catalysed transfer hydrogenation[72] c) palladium 
catalysed allylic substitution[77] d) manganese catalysed sulfoxidation.[78] 
 
The power of this system was demonstrated using complementary biochemical tools 
for optimising the protein scaffold alongside these synthetic chemical modifications. 
Ward et al. found that changing the protein host to streptavidin improved the system 
drastically, which was explained by the deeper binding pocket and less cationic 










No rights for online publication of this chapter were obtained.  
 
 
For content, please refer to the publication of this chapter as 
review article in Chemistry, A - European Journal: 
P. J. Deuss, R. Den Heeten, W. Laan, P. C. J. Kamer, Chem.—
Eur. J. 2011, 17, 4680  
 
Chapter 1. Introduction to bioinspired catalysis  
 
Artificial Metalloenzymes; Modified Proteins as Tuneable Transition Metal Catalysts 28
acetamidoacrylic acid and N-acetamidocinnamic acid with over 90% ee (R). Using a 
small library of different linkers and catalytic rhodium centres in combination with a 
selected set of mutants of streptavidin, the selectivity could be inverted to 57% ee (S) 
for N-acetamidoacrylic acid.[68c] Further optimisation using saturation mutagenesis at 
the site of the mutation in the most promising mutant scaffold resulted in over 60% ee 
(S) in the hydrogenation of N-acetamidoacrylic acid and over 80% (S) for N-
acetamidocinnamic acid.[69] This could be further enhanced for both substrates to up 
to 95% ee (S) and a threefold rate increase using a combination of enantiopure amino 
acid linkers and saturation mutagenesis.[70] These so called second generation hybrid 
catalysts also showed improved organic solvent tolerance, which is important as 
substrate solubility in pure water is one of the main limitations of using protein 
structures as macromolecular catalyst scaffolds. Reetz et al. used directed evolution as 
a Darwinian approach for catalyst optimisation.[71] By applying several rounds of 
“evolution” and saturation mutagenesis the enantioselectivity provided by Whitesides’ 
catalytic system could either be improved from 23% ee (R) to 65% ee (R) or inverted 
to 7% ee (S) for the hydrogenation of N-acetamideacrylic acid. 
The group of Ward successfully extended this approach to other transition metal 
catalysed reactions. Using biotin modified with different amino-sulfonamide 
ruthenium η6-arenes Ward performed asymmetric transfer hydrogenation of prochiral 
ketones, achieving up to 94% ee (R) using acetophenone as substrate (Scheme 
13b).[72a, 72b] Aromatic and aliphatic ketones were hydrogenated with good 
enantioselectivity, provided that the ketone contained two substituents that varied 
sufficiently in bulk size.[72c] Using an X-ray crystal structure obtained of one of these 
hybrid catalysts, the system was further improved using designed evolution.[73] 
Systems using either benzene or p-cymene as arene could both be converted into R 
and S selective 4-phenyl-2-butanone transfer hydrogenation catalysts. After further 
optimisation using mutagenesis p-methylbenzophenone could be hydrogenated with 
98% ee (R).[74] A d6 piano stool ruthenium complex used in hybrid transfer 
hydrogenation catalysts was also found to afford metalloenzymes which catalyse 
alcohol oxidation using tert-butylhydroperoxide as oxidant.[75] Rhodium and iridium 
analogues were also created but were found to be significantly less active.  
More recently, Ward et al. evaluated the previously established set of phosphine 
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acetate (Scheme 13c).[76] Also in this catalytic system over 90% ee (R) and 80% ee (S) 
could be achieved by the introduction of a variety of linkers and mutations. The 
biotin-streptavidin system was also used by the group of Ward for the sulfoxidation of 
thioanisoles using biotin modified with different manganese salen complexes (Scheme 
13d).[77] These systems only gave low enantioselectivities (<15% ee). 
 
1.5.4 Other Supramolecular Assembled Artificial Metalloenzymes 
Additional supramolecular anchoring methodologies have been applied using 
different protein-substrate/cofactor interactions, mostly for asymmetric oxidation 
reactions.[78] One successful example of such a system was reported by Gross et al. 
who used iron and manganese containing corroles anchored to human serum albumin 
(HSA) as artificial metalloenzymes (Scheme 14a).[79] Up to 74% ee was obtained for 
the oxidation of several aryl methyl sulfides using these complexes.[80] 
 
Scheme 14. Artificial metalloenzymes obtained by a) the combination of manganese 
corroles and HSA[79-80] and b) chromium salphen used in asymmetric sulfoxidation of 
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Aided by computational methods, the group of Watanabe rationally designed active 
site mutants of myoglobin for reconstitution with chromium salphen complexes 
(Scheme 14b).[81] The sulfoxidation of thioanisole using the obtained catalysts led to 
inversion of the enantioselectivity from 4.6% ee (R) for the wild type protein to 13% 
ee (S) for the most successful mutant. The system was further improved by a 
combination of mutant design and the introduction of manganese instead of chromium 
to create catalysts that gave selectivities ranging from 33% ee (S) to 27% ee (R).[82]  
Supramolecular assembled systems have also been applied in Diels-Alder reactions. 
Reetz and co-workers applied copper phthalocyanine complexes in combination with 
different serum albumins (Scheme 14c).[83] Enantioselectivities ranging from 85% to 
95% and endo-selectivities ranging from 91% to 95% were found. In addition to 
interactions between the ligands and the proteins, catalyst anchoring in the above 
systems is likely to involve the coordination of at least one amino acid to the 
transition metal, and therefore several of these systems have also been categorised as 
dative artificial metalloenzymes.[58b] 
The biotin-avidin and other above mentioned supramolecular assembled systems 
clearly demonstrate how artificial metalloenzymes can benefit from optimisation 
opportunities which are unprecedented in either traditional transition metal catalysis 
or enzyme catalysis alone. These catalyst systems can be tuned for specific reactions 
and substrates by using combinations of both synthetic organic and biomolecular 
techniques. 
 
1.5.5 Supramolecular anchoring using antibody complexes 
The non-covalently assembled artificial metalloenzymes discussed above employ 
protein binding of artificial cofactors which resembles naturally occurring substrate-
protein interactions. Supramolecular protein-catalyst interactions can also be 
engineered by raising monoclonal antibodies against a transition metal complex of 
interest. Keinan et al. created monoclonal antibodies using an α-naphtoxy tin 
porphyrin as transition state mimic for the sulfoxidation of thioanisole.[84] Obtained 
antibody SN37.4 in combination with a ruthenium porphyrin catalysed the 
sulfoxidation of thioanisole and analogues to give the product in up to 43% ee (S) 
(Scheme 15a). To make up for the lack of coordinating amino acids like histidine and 
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containing a histidine, was developed by the group of Mahy (Scheme 15b).[85] Using 
this heme in combination with antibody 3A3 improved the rates for the oxidation of 
thioanisole and the obtained selectivity was 45% ee (R).[86] More recently, Mahy 
covalently attached a porphyrin to estradiol which in combination with estradiol 
antibody 7A3 catalysed the oxidation of 2,2’-azino-bis(3-ethylbenzothiazoline-6-
sulfonate (Scheme 15c).[87] This complex did show activity for asymmetric oxidation 
of thioanisole but only low ee of 11% (R) was found.[88] 
 
 
Scheme 15. Antibody based artificial metalloenzymes used for the sulfoxidation of 
thioanisole using a) a ruthenium porphyrin by Kenin et al.[84] b) MP8[85-86] and c) an 
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Harada and co-workers demonstrated that this approach can be extended to phosphine 
transition metal complexes by raising monoclonal antibodies against the complex 
shown in Scheme 16.[89] Several obtained antibodies combined with the diphosphine 
rhodium complex were tested for hydrogenation of amino acid precursors. One 
combination showed 98% ee (S) in the hydrogenation of N-acetamidoacrylic acid and 
also gave the best product yield (23%). 
 
Scheme 16. Rhodium diphosphine antibody system used by Harada et al. for the 
hydrogenation of amino acid precursors.[89] 
 
1.5.6 Covalent modification 
A variety of strategies are available for site selective covalent modification of proteins 
for the creation of artificial metalloenzymes.[90] Several reported methods rely on 
specific reactivity of certain amino acids residues in a specific protein environment[91] 
or on changing the reactivity of such residues.[92] However, these methods share the 
disadvantage of supramolecular systems that these only allow for the use of select 
protein structures. A more flexible method is the bioconjugation to cysteine which is 
very common in biochemistry. Because of the relatively low abundance of this amino 
acid (1.7%), proteins containing a unique cysteine can typically be easily obtained. 
Kaiser et al. were the first to create an artificial enzyme via covalent modification of 
an amino acid by alkylation of the cysteine 25 in papain (Scheme 17a) with 
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much future work for the creation of artificial metalloenzymes using the same 
covalent attachment procedure.[91e, 94]  
 
 
Scheme 17. a) Cartoon of papain showing cysteine 25 (arrow) b) Modification with a 
bulky phosphite by De Vries et al.[95] c) and with an arene ruthenium phenantroline 
complex by the group of Salmain.[96] 
 
De Vries and co-workers attached a phosphite cofactor to papain (Scheme 17b).[95] 
After rhodium complexation this modified protein was used for hydrogenation of N-
acetamidoacrylic acid methyl ester showing full conversion but no ee. Recently 
Salmain and co-workers attached an η6-arene ruthenium phenantroline complex to 
papain (Scheme 17c).[96] The obtained artificial metalloenzyme showed a significant 
rate enhancement in the Diels-Alder reaction between cyclopentadiene and acrolein, 
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Scheme 18. Dual anchoring of a manganese salen complex in myoglobin by Lu et 
al..[97] 
 
Both Reetz and De Vries have suggested that papain is an unsuitable protein host for 
application in asymmetric catalysis due to large conformational flexibility. The 
importance of conformational rigidity was also identified by the group of Lu when 
they improved their myoglobin manganese salen catalyst system by using an 
intriguing dual anchoring strategy (Scheme 18).[97] This artificial metalloenzyme 
showed increased activity and improved ee of 51% (S) compared to 21% (S) found for 
the single-point anchored system. It thus appears that structural rigidity is an 
important factor in artificial metalloenzyme performance, likely by reducing the 
number of accessible structures of the catalytic species by conformational dynamics 
of the modified proteins and/or increasing the functional interactions between the host 
and the metal-complex. 
Distefano et al. clearly showed that application of a site-specific covalent 
modification strategy makes it possible to rationally choose a suitable protein host 
based on specific structural and/or functional characteristics. The adipocyte lipid 
binding protein (ALBP) was specifically selected as host protein for its ability to truly 
encapsulate catalysts in its 600 Å3 cavity, and its capacity to sequester a variety of 
apolar substrates.[98] The unique cysteine at position 117 was modified by alkylation 
using 5–iodoacetamide–1,10–phenantroline, a cofactor previously linked by the same 
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conjugates were created and used in aryl amide hydrolysis and selective ester 
hydrolysis via kinetic resolution, achieving up to 86% ee (L-specific, Scheme 19a).  
 
Scheme 19. ALBP modification with a phenantroline ligand by the group of Distefano 
a) Cartoon representation of the crystal structure obtained of this ALBP-
phenantroline[100] b) Copper adduct applied as catalyst for amide hydrolysis and 
enantioselective ester hydrolysis[98, 101] c) Modification of ALBP with a phenantroline 
ruthenium arene complex by Kamer et al..[102] 
 
X-ray crystallography provided structures of the modified protein and fluorescence 
studies confirmed copper complexation.[100] The selectivity of the ester hydrolysis 
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proteins of intestinal fatty acid binding protein (IFABP) with varying position of the 
cysteine as protein scaffold.[101] Kamer et al. used ALBP for modification with an η6-
p-cymene ruthenium phenantroline complex via a maleimide linker (Scheme 19b).[102] 
The same cofactor was also coupled to photoactive yellow protein (PYP). Application 
of these complexes in the transfer hydrogenation of acetophenone afforded only trace 
amounts of product. 
 
1.5.7 Bioconjugation of phosphine ligands 
Whereas the supramolecular anchoring of diphosphine based catalysts has evolved 
over three decades into one of the most successful approaches in artificial 
metalloenzyme development to date, the covalent site-specific modification of 
proteins with phosphines has only recently been achieved. The attachment of a 
diphosphine to the active site serine of a lipase via a phosphonate-inhibitor was 
reported by Reetz but the linkage proved hydrolytically unstable.[91e] The strong 
nucleophilic character of phosphines makes cysteine-selective bioconjugation of such 
ligands a non-trivial task since most common electrophiles used for cysteine 
modification (e.g. iodoacetamides, maleimides) will undergo reaction with the 
phosphine. Protected phosphines (e.g. by sulfur or BH3 protection) can be introduced, 
however deprotection methods were found incompatible or ineffective for the 
obtained conjugates.[103] 
Recently our group reported the modification of the native cysteine of PYP using 1,1'-
carbonyldiimidazole (CDI) activated carboxylic acid derivatives of mono- and 
diphosphines (Scheme 20a).[104] The similar anchoring of palladium complexes 
afforded metalloenzymes active as allylic amination catalysts. Several rhodium 
complexes were also created using the same conjugation strategy, affording an active 
catalyst for the hydrogenation of dimethyl itaconate using a coupled diphosphine 
ligand (Scheme 20b).[102] Unfortunately no ee was found in allylic substitution and 
only up to 6% ee in the hydrogenation of dimethylitaconate. The denaturation of the 
protein due to the presence of organic co-solvents, required to obtain reproducible 
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Scheme 20. Phosphine modified PYP reported by Kamer et al. applied in a) palladium 
catalysed allylic amination[104] b) rhodium catalysed hydrogenation.[102] 
 
1.5.8 Genetic encoding of transition metal binding ligands 
Recent developments in biochemistry demonstrated the introduction of additional 
amino acids beyond the natural 20 in eukaryotic and prokaryotic in systems.[106] This 
technique allows site selective introduction of transition metal binding ligands in 
virtually any protein structure without challenging chemical modification. Schultz and 
co-workers demonstrated the effectiveness of such a system by introducing bipyridine 
substituted alanine in DNA binding catabolite activator protein (CAP).[107] The 
resulting artificial metalloenzyme containing copper as active metal was used as a 
sequence selective DNA cleavage catalyst (Figure 2). Such systems show much 
promise for future application as artificial metalloenzymes, although development and 
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Figure 2. Selective DNA cleavage catalyst obtained by the introduction of two 
bipyridine containing unnatural amino acids into CAP and conjugation to copper.[107] 
 
1.5.9 Optimisation techniques for artificial metalloenzymes 
The various approaches outlined above illustrate how artificial metalloenzymes 
provide unique opportunities for catalyst optimisation. In addition to traditional 
synthetic tools for optimisation of the various components of the metal-complex, the 
spacer linking the catalyst to the protein and the structure of the protein scaffold can 
be optimised; a strategy for which the term “chemogenetic” approach has been coined 
by Distefano.[108] 
Structural variants of protein scaffold can nowadays easily be generated using 
advanced mutagenesis strategies. Whereas most of the systems to date have only been 
subjected to limited mutagenesis to tune their performance, the studies of Ward and 
Reetz on the avidin-biotin system highlight the potential of evolving systems by the 
combinatorial screening of large numbers of mutant proteins.[109] 
Directed evolution is a very powerful tool for the optimisation of the properties of 
proteins, which is increasingly applied to improve enzyme performance and protein 
properties.[110] This approach uses repeating cycles of random mutagenesis followed 
by screening for the best hits in a Darwinian fashion. 
This methodology has been successfully applied to tailor the structure of the protein 
scaffold in artificial metalloenzymes based on the rhodium diphosphine modified 
biotin–streptavidin system by the group of Reetz (Figure 3).[71] To reduce the 
screening effort, Reetz et al. applied a method for mutagenesis named Combinatorial 
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acids is subject to saturation mutagenesis.[112] Although successful, the procedure was 
reported to be labor-intensive.  
 
Figure 3. Directed evolution of artificial metalloenzymes.[94] 
 
Ward et al. have implemented an alternative strategy, whereby “evolution” of the 
enzyme is achieved via chemogenetic optimisation guided by rational design, an 
approach which they called “designed evolution”.[113] In contrast to directed 
evolution, in this process the mutagenesis in every optimisation cycle is steered by 
design choices based on structural information. This significantly reduces the number 
of mutants employed in the procedure, while the optimisation process is still very 
effective.  
Since synthesis of artificial metalloenzymes involves an assembly between the host 
and the catalytic metal (complex), purified proteins will generally be required. 
Therefore, to facilitate screening efforts, efficient methodology for the parallel 
expression and purification of protein variants needs to be developed, which has been 
found to be a limiting factor in several systems.[94] 
Regarding the functionalisation of proteins with synthetic organometallic complexes, 
the use of generally applicable covalent anchoring methodology, such as cysteine-
modification, has a significant advantage of increased structural diversity compared to 
supramolecular systems. As covalent assembly is much less dependent on the protein-
structure, this brings much more flexibility to the design of the systems, and offers the 
possibility to make rational choices concerning the protein scaffold(s) to be employed. 
For example, Reetz set out to develop a platform for artificial metalloenzymes based 
on a robust protein specifically chosen for its suitability to develop en masse 
purification and bioconjugation procedures.[64, 114] Also particular protein structures 
may be rationally matched with the desired (shape) selectivity in a target reaction. 
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as their supramolecular counterparts, whose straightforward assembly greatly 
facilitates combinatorial screening efforts. The synthesis and screening of libraries of 
covalently modified proteins requires the development of assembly procedures which 
involve minimal purification and can be performed in a parallel fashion. Part of the 
current efforts by the group of Kamer is directed towards optimising the phosphine-
conjugation methodology in this direction. 
Structural information obtained from X-ray crystallography, NMR or modelling 
studies can be used to guide the design of optimal protein structure. Effective design 
still requires improved tools for the prediction of tertiary structure of proteins and a 
better understanding of all factors involved in protein dynamics has to be obtained. 
New computational methods have been developed which may aid artificial 
metalloenzyme optimisation. Using ORBIT (Optimisation of Rotamers By Iterative 
Techniques)[115] the group of Mayo created a p-nitrophenyl acetate hydrolase from a 
catalytically inert 108-amino acid residue of Escherichia coli thioredoxin.[116] Hellinga 
and co-workers developed a computational method called DEZYMER for the 
redesign of binding sites in proteins, to make them bind other substrates.[117] This 
program was successfully applied to design binding sites for trinitrotoluene, L-lactate, 
serotonin and pinacolyl methyl phosphonic acid.[118] More recently the group of Baker 
developed a computational method that screens protein structures to find optimal 
active site replacements named RosettaMatch.[119] This program was used to design a 
novel enzyme for retro aldol condensation of an unnatural substrate,[5] and to create 
new enzymes for the not naturally occurring Diels-Alder reaction[120] and Kemp 
elimination.[121] The last example involved both in silico enzyme design and directed 
evolution for catalyst development resulting in a 200-fold rate increase.  
The use of advanced biochemical and computational methods in combination with 
synthetic organic optimisation of cofactors provide a powerful set of tools for further 
development of new artificial metalloenzyme catalyst systems. 
 
1.6 Summary and outlook on bioinspired catalysis 
The last decade has witnessed an exponential growth of interdisciplinary research 
aimed at the construction of bioinspired ligand systems for transition metal catalysed 
reactions. The concepts underlying biomolecular assembly and biocatalysis have 
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a source of chirality but also elegantly exploited for supramolecular assembly. Natural 
and synthetic DNA is explored as a scaffold for the synthesis of hybrid catalysts, 
leading to the discovery of a catalytic activity hitherto not seen for any transition 
metal catalyst. The power of peptide- and DNA synthesis and the elegance of 
supramolecular chemistry offer fascinating prospects for the field of transition metal 
catalysis. 
The merging of transition metal catalysts with natural protein scaffolds leads to 
enzymes with unnatural catalytic activities. It is clear that the choice of the host 
protein is a major challenge in the field. Not only should the host be amenable to 
modification, it should have a structure which is appropriate to accommodate the 
desired catalyst and be compatible with the envisioned reaction conditions. For 
efficient chirality transfer from the scaffold to the catalytic reaction the catalytic 
centre should be in close proximity to the protein structure. On the other hand, the 
structure of the synthetic catalyst and the chemistry used for its introduction should 
not adversely affect the stability and tertiary structure of the scaffold. Finding the 
right balance between these factors is crucial for the development of successful 
systems.  
Whereas most of the systems described above show at least moderate levels of 
activity and selectivity, providing good starting points for further optimization, some 
perform very poorly. Low selectivity in catalytic reactions may arise from too little 
interaction of the catalytic moiety with the host. This probably underlies the poor 
performance of papain as host, whose cysteine used for catalyst anchoring lies in a 
very shallow groove on the protein surface. Decreasing the conformational freedom of 
the catalyst by designing additional interactions between host and catalyst (e.g. by a 
dual anchoring strategy) may improve the performance in such cases.  
Alternatively, the introduced catalyst may engage in adverse interactions with the 
host, leading to a system where the catalytic centre becomes inaccessible or inactive. 
This scenario probably underpins the poor results obtained using artificial 
metalloenzymes with PYP as host. 
Despite the various design challenges, the diversity of systems and applications 
reported to date underline the potential of this approach, and it is evident that the 
application of advanced biomolecular techniques such as site-directed mutagenesis 
and directed evolution in combination with traditional synthetic tools is a very 
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progress in the computational design and modelling techniques for both DNA and 
polypeptide structures will lead to further insight and possibilities of these systems. 
Additional major challenges that will need to be addressed are the miniaturisation and 
parallelisation of the synthesis of the hybrid systems in order to truly exploit the 
possibilities these systems offer for combinatorial screening. 
With the powerful tools available and considering the increasing research efforts in 
the field it is anticipated that further advances in the development of these hybrid 
catalyst systems will lead to effective solutions for demanding transition metal 
catalysed chemical reactions. 
 
1.7 Outlook on this thesis 
The true power of enzymes, i.e. their tremendous rate acceleration, high substrate 
selectivity and selective transformation of multifunctional unprotected substrates, is 
dependent on highly organised protein substrate interactions. Therefore, combining 
the shape selectivity and powerful substrate recognition of proteins with optimal 
catalyst performance achieved via rational ligand design requires the use of protein 
structures that can encapsulate the substrate to enforce optimal orientation with 
respect to the artificial cofactor (Figure 4).  
 
Figure 4. Protein induced shape selective binding of apolar substrates in aqueous 
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Covalent anchoring allows exploitation of protein structures, which have the desired 
structural properties for efficient substrate protein interactions, because, unlike for 
supramolecular assembled artificial metalloenzymes, the binding site is not required 
for the catalyst assembly. This can lead to the full exploitation of the shape-selectivity 
of promising protein structures.  
In this work we set out to design and create such catalyst systems. The envisioned 
catalyst system to which the main part of this thesis is dedicated is designed for 
application as shape selective catalyst in the hydroformylation of higher olefins. This 
reaction is not performed in nature and thus no natural hydroformylation enzymes are 
known. The protein part of this catalyst was selected based on its capacity to bind the 
substrates for this reaction, which will offer unique possibilities to obtain unequalled 
(chemo)selectivity and substrate specificity. For this purpose, we envisaged the use of 
a protein with binding affinity towards linear aliphatic substrates in combination with 
rhodium-phosphine complexes as the catalytically active centre. The approach taken 
for the development process described in this thesis can be divided into seven stages 
which are used as directive in the following chapters (Table 1).  
 
Table 1. The seven stages involved in the development of the artificial 
metalloenzymes described in this thesis. 
Stage Description 
1 Protein selection 
2 Design of unique cysteine protein templates 
3 Production and purification of the unique cysteine templates 
4 
Site selective conjugation of the ligands to the unique 
cysteine templates 
5 
Transition metal coordination to the ligand containing 
protein conjugates 
6 Application of the transition metal conjugates in catalysis 
7 Optimization 
 
Chapter 2 describes the first three stages in the development process of a shape 
selective system. The first stage is the choice of the protein structure based on desired 
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characteristics like substrate binding, structural characterisation of the binding site, 
stability etc. The second stage is the conversion of the desired protein into a unique 
cysteine containing template using site directed mutagenesis. The unique cysteine is 
required for site selective anchoring of the catalytically active transition metal ligand 
system. The locations of the cysteines inside the proteins have to be carefully 
considered as the transition metal should be placed in close proximity to the binding 
site of the protein to ensure selective catalysis. The third stage is the production and 
purification of the protein templates. This production by bacterial expression and 
purification has to be optimized to ensure appropriate scale production to be able to 
obtain enough material to perform combinatorial screening. 
Chapter 3 describes the fourth stage of the development process which is the site 
selective bioconjugation of phosphine ligands. This key step in the development 
process has to be achieved with high yield and selectivity as purification of the 
conjugates is problematic. In addition, the modification procedure needs to be 
generally applicable to any desired unique cysteine protein template to ensure 
applicability of protein structure optimisation techniques. 
Chapter 4 describes the rhodium complex formation step and application of the 
rhodium conjugates in hydroformylation. The main application will be the 
hydroformylation of linear aliphatic 1-alkenes in a biphasic process for which initial 
catalysis experiments will be reported. Natural enzymes underwent many millennia of 
the evolutionary process to become the efficient enzymes known to us. It is not likely 
that the particular system prepared in this thesis will represent the optimal structure 
for our purposes. Therefore, the catalyst optimisation is the very important last step of 
the development process and will have to be performed to obtain the envisioned 
highly selective and active catalyst system. The foundations and opportunities for this 
final process will be presented throughout this thesis. 
The fifth chapter will describe the application of created unique cysteine containing 
proteins in asymmetric reactions using copper-nitrogen donor ligand systems as 
catalytically active metal centres. In this approach the chiral environment of the 
protein is utilized to induced enantioselectivity in catalytic reactions. A model system 
will be created that can be optimised using all available synthetic and biochemical 
tools.  
Finally, the sixth chapter will give a summary, discussion and final conclusion on the 
taken approach and methodology applied in this thesis. 
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Chapter 2. Unique cysteine containing protein templates
Design and production of protein templates for the synthesis of artificial
metalloenzymes
2.1 Abstract
This chapter describes the synthesis of protein templates for the development of
artificial metalloenzymes that can bind substrates of interest for catalytic reactions.
Various unique cysteine containing mutants of lipid binding proteins mSCP2 and
SCP-2L were designed and created. Large scale production of SCP-2L V83C and
A100C was successfully achieved, with yields of more than 30 mg/L of bacterial
culture. CD-spectroscopy and 1H-NMR showed that the chosen mutations do not
influence the tertiary structures and fluorescent binding studies showed retention of
substrate binding capability. Variable temperature CD-spectroscopy showed that these
proteins have remarkable temperature stability.
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2.2 Introduction
2.2.1 Design of protein templates for artificial metalloenzyme synthesis
2.2.1.1 Protein template selection
A key part in the design and synthesis of artificial metalloenzymes is the choice of the
protein template.[1] A set of demands was created reflecting desired characteristic for
the approach taken in this work, to be able to select a suitable protein host from the
millions of available proteins. Regardless of recent advances in the field of
bioengineering it remains difficult to predict the tertiary structure of a protein solely
based on the amino acid sequence and so de novo design of an appropriate structure is
troublesome.[2] Hence, the first demand is that the protein has to be structurally
characterised by either X-ray crystallography or solution NMR to have a well-defined
basic structure on which modifications will be applied. Secondly, the 3D structure has
to contain a hydrophobic pocket for binding apolar substrates of our interest. Thirdly,
a clearly allocated site for binding must have been identified to be able to rationalize
the position for introduction of our transition metal catalyst. Fourthly, it is required
that the protein can be produced in considerable amounts to be able to produce
sufficient material for screening purposes. Finally stability of the protein is important.
The protein must be resistant to the conditions of the catalytic reactions, which would
preferably mean sufficient temperature stability and organic solvent tolerance.
2.2.1.2 Protein engineering to create a unique cysteine containing protein
template
The next step is to modify the selected protein template with our transition metal
catalyst system, which will be done through bioconjugation with a unique cysteine.
Cysteine is a thiol containing amino-acid with a particular nucleophilic character that
is generally exploited for site-selective bioconjugation.[3] This approach has already
been applied to some extent by Distefano et al..[1b, 4] The presence of a unique
cysteine is desired to incorporate one transition metal binding ligand into the protein
at a unique position to benefit from the selective binding properties of the protein.
Hence, when a desirable protein has been identified this protein may have to be
modified to position the cysteine at an appropriate location. The unique cysteine will
be introduced at a selected position using site directed mutagenesis on a DNA-vector
coding for the native protein. In addition, site directed mutagenesis of the same gene
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will have to be employed when the protein template also contains other undesired
cysteines. Site directed mutagenesis is performed using commercially available kits
which describe requirement for primers used and PCR conditions. The modified
plasmid containing the DNA coding for a unique cysteine containing mutant of the
original protein will than be transferred into an E. Coli production strain and the
protein will be produced using pET vectors and T7 promoters as this commonly leads
to high expression levels.[5]
2.2.1.3 Purification of the protein template
A high yielding and easy purification method is essential for catalyst screening, so the
preferred method for purification would be to use affinity chromatography. Well
known affinity tags are maltose,[6] glutathione-S-transferase,[7] chitin[8] and histidine
tags.[9] The latter will be used in this work in combination with nickel affinity
chromatography.
Figure 1. Schematic overview of nickel affinity purification including tag cleavage by
protease.
For this purification procedure the desired protein is equipped with a histidine tag
consisting of 6 sequential histidines that have high affinity for binding to nickel ions.
This histidine tag is usually introduced on the N-terminus with an amino acid linker
of choice by an extra DNA sequence on the plasmid. This linker can be designed to
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contain a protease cleavage site for removal of the tag.[10] For our approach this
removal is essential as the histidine tag also has high affinity for transition metals
which can interfere with our site selective transition metal introduction.[11] The
overall purification process is displayed in Figure 1. In the first step of nickel affinity
chromatography the cell-free extract will be loaded on a column containing
immobilized Ni2+ ions. After washing away contaminating proteins, the target-protein
is eluted by applying a buffer typically containing a high imidazole concentration to
compete with the histidine tag for nickel binding. The histidine tag will then be
cleaved off by a histidine tag containing protease followed by a second round of
nickel affinity chromatography to separate the removed tag, the protease and any
other nickel binding protein impurities still present after the first run from the desired
protein.
2.2.2 SCP as protein templates
In this project there is a special interest in proteins that can bind substrates of
relevance to the catalytic processes of our choice. Linear aliphatic substrates are
involved in many catalytic processes for which homogeneous transition metal
catalysts are applied. A few examples of such processes are hydroformylation of
linear alkenes to linear and branched aldehydes, oxidation of alkanes or alkenes and
oligomerisation or polymerisation of alkenes. Selectivity in such reactions is a key
issue that we will address by using our protein based catalysts. This will be done by
using shape-selectivity, an approach which is often used in heterogeneous catalysis.
For example selective α-oxidation of alkanes can be achieved by using porous 
materials containing appropriate size pores with catalysts embedded at key
positions.[12] This concept will be transferred by us to protein based catalysis by
choosing proteins with apolar cavities of appropriate size and shapes and subsequent
optimization by mutagenesis.
The protein databank contains over 50,000 structurally characterized proteins,[13]
providing plenty of choice for the selection of a protein-template according to the
demands described in the previous section. A class of proteins that caught our
attention is sterol carrier proteins (SCP’s). Proteins of this class, which were found to
be involved in the biosynthesis of cholesterol, often contain hydrophobic binding
pockets. Particular interest was developed for sterol carrier protein 2 (SCP2) and
analogues, because for several of these protein linear hydrophobic tunnel shaped
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binding pockets were reported (Figure 2).[14] SCP2 proteins from several organisms
have been well studied. These proteins are also known as a non-specific lipid transfer
protein (nsLTP), because in addition to high binding affinity for cholesterol and other
steroids also high affinity for various phospholipids was found.[15] These proteins
were also reported to bind long-chain fatty acids, which is of interest for our
purposes.[16] It has been shown that these proteins have evolved to transfer substrates
to assist enzyme complexes in α-oxidation of branched chain fatty acids and β-
oxidation of long chain fatty acids.[17] This was also confirmed by the finding that
SCP2 type proteins are often expressed as fusion proteins with enzymes involved in
oxidation pathways for fatty acid metabolism.[14c, 18]
Figure 2. Crystal structures of a) SCP-2L excluding the triton-X molecule[19] b)
osSCP2 excluding side chains M109 Q112 K118 P120 that cap the hydrophobic
cavity.[20]
Various analogues of SCP2 have been reported since its first isolation from rat
liver.[21] Several examples from mammals are osSCP2 from Oryctolagus cuniculus
(rabbit),[20] hSCP2 and SCP-2L from Homo sapiens (human)[19, 22] and other SCP2
analogues from beef liver.[23] Additional analogues are also found in insects like
aaSCP2 from Aedes aegypti (mosquito),[24] in plants as SCP-2 from Arabidopsis
thaliana (thale cress)[25] and in bacteria like Methanococcus jannaschii (thermophilic
methanogen and first archea of which the genome was sequenced).[26] Structural
characterization has shown that the general structure of these proteins contains a rigid
-sheet backbone structure and three C-terminal alpha helixes involved in substrate
recognition which can open up to bind aliphatic substrates inside the proteins
hydrophobic core. This hydrophobic core was well visualised in the structures of
SCP-2L and osSCP2 (Figure 2). Small structural variations in the main beta-sheet
a b
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backbone and flexible C-terminal alpha helixes are present in all these analogues
(Figure 3). Despite their structural similarity, differences have been found in the
binding modes of these analogues. SCP-2L co-crystallised with a molecule of Triton-
X-100 present in a linear apolar tunnel that traverses the entire protein, while aaSCP2,
which crystallised with a molecule of palmitate, shows an apolar cavity oriented
perpendicular to the cavity found in SCP-2L.[24] Extensive binding studies of mSCP2
using NMR have shown that especially the linear cavity as depicted for SCP-2L is
involved in binding aliphatic substrates.[27] The different binding modi and small
structural differences between SCP2 analogues result in small differences in substrate
binding affinity and dynamics. Nevertheless research with various SCP2 analogues
has shown stronger binding affinity for acyl-CoA derivatives compared to long chain
fatty acids typically by an order of 50.[15-16, 28]. The binding affinity was also found to
be dependent on the chain length and the branching of the substrate, with carbon
chains >24 and high linearity being favoured.[28b, 29] The affinity of these stretched
hydrophobic pockets for linear apolar substrates provides a good basis for the design
of our artificial metalloenzyme catalyst for reactions involving linear aliphatic
substrates. In this chapter the design, DNA-synthesis, production and purification of
several unique cysteine containing protein templates for the creation of our artificial
metallo enzymes based on SCP2 are described. In addition some structural and
stability investigations and some initial substrate binding studies are reported.
Figure 3. Crystal structures of a) SCP-2L in complex with a Triton X-100 molecule
(red) (pdb = 1IKT)[19] b) aaSCP2 in complex with a molecule of palmitic acid (red)
(pdb = 1PZ4)[24] c) osSCP2 (pdb = 1C44)[20] d) mSCP2 (in complex with pex5p which
has been excluded) (pdb = 2C0L).[30]
a b c d
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2.3 Results and discussion
2.3.1 Design and plasmid synthesis of unique cysteine protein templates
2.3.1.1 mSCP2
Human mSCP2 is the most studied of the SCP2 proteins. It has been crystallized as a
complex with the principal import receptor Pex5p[30] and also structurally
characterized by NMR.[31] mSCP2 is the product of a post-translational modification
of preSCP2, where part of the N-terminus is cleaved (mSCP2 = mature SCP2).[14c] To
create artificial metalloenzymes suitable for selective substrate binding mSCP2 has to
be altered to introduce a unique cysteine at a position in close proximity to the
hydrophobic pocket. The exact binding site of mSCP2 has been studied using
crystallography[30] and NMR structural analyses from which an inner cavity was
identified (Figure 4).[27, 31] This cavity was found to be located between the C-terminal
α-helices, very similar to other SCP2 analogues. NMR studies also indicated that the 
-sheet backbone remains rigid during the binding process while the α-helices 
undergoes conformational changes at fast (picosecond to nanosecond) and slow
(microsecond to millisecond) timescales. All these data indicate that the α-helical 
structure is involved in the access of the substrate into the hydrophobic pocket.
Figure 4. Visualisation of binding site of mSCP for hydrophobic part of long chain
fatty acid CoA’s as determined by 15N-NMR perturbations of amino acids indicated
with yellow dots (Reprinted with permission from numbered reference[27] Copyright
2007 American Chemical Society).
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Wild-type mSCP2 contains one native cysteine in position 91, located far away from
the known hydrophobic cavity as was evident from the model shown in Figure 5a. To
create a suitable artificial metalloenzyme template the native cysteine had to be
removed and a new cysteine introduced. A structurally similar serine residue was
chosen as replacement for cysteine 91. Positions K104 and M120 were considered for
introduction of the unique cysteines. These position are in the proximity of the apolar
cavity as was observed in SCP2 analogues and NMR-binding studies of this particular
protein.[27] To assess the suitability of these positions for the introduction of our
organometallic catalyst systems docking simulations were performed. The program
GOLD[32] was used for the docking studies, using the reported NMR-structure as
template[31] and applying protein templates generated by the SWISS-MODEL online
modelling service.[33] GOLD creates models based on an algorithm describing
hydrogen bonding, electrostatic and steric interactions between the protein cavity and
the ligand, keeping the ligand fully and the protein partly flexible.[32d] The program
then creates a range of structures by optimisation and ranks them based on most
favoured ligand protein interactions in the final structure. As covalent bound ligands
maleimide-triazacyclononane iron complexes were used for this set of docking
experiments as these were a potential catalytic cofactor for alkane oxidation. The
highest ranking structures obtained from these docking studies are shown in Figure 5b
and c. These structures show that for both these mutants the cofactor is in close
proximity of the binding site between the α-helixes. 
Figure 5. Highest ranking models from GOLD docking studies of a maleimide-
triazacyclononane iron complex (red) covalently bound to a) mSCP2 (cysteine at
position 91) b) mSCP2 C91S M104C c) mSCP2 C91S K120C.
a b c
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For initial studies mSCP2 C91S M104C was chosen as unique cysteine bearing target
mutant since the models show that the ligand is positioned in closer proximity to the
central cavity. The DNA for mSCP2 was acquired as part of the
pET24d::dΔhΔhSCP2 plasmid[27] (the pET24d used was modified and called
pETM30).[34] This particular pET24d plasmid attaches a histidine and GST tag to the
protein expressed in the multiple cloning site. The histidine tag allows for easy nickel
affinity chromatography purification. The GST-tag is a long aminoacid sequence
which has a high affinity for glutathione, which also makes the whole protein more
soluble and so improves the yield from the lysis step. Both the GST and the histidine
tag can be removed by Tobacco Etch Virus (TEV) protease.[35]
The removal of the native cysteine and the introduction of the unique cysteine at
position 104 could in principle be achieved using two rounds of regular site directed
mutagenesis. However nowadays multi-site-directed mutagenesis kits are available to
do multiple mutagenesis steps at once. A QuickChange® Multi Site-Directed
Mutagenesis Kit was used to introduce the M104C and C91S mutations
simultaneously. The isolated plasmids from five different bacterial colonies obtained
after polymerase chain reaction (PCR) were sent for sequencing. Three contained only
the C91S mutation and only one was found to contain both mutations. The desired
pET24d::dΔhΔhSCP2 C91S M104C plasmid was successfully transformed to 
production strain E. Coli BL21 (Rosetta).
2.3.1.2 SCP-2L mutants
SCP-2L originates, like mSCP2, also from Homo sapiens and is one of three domains
of Human Peroxisomal Multifunctional Enzyme Type 2 (MFE-2) a protein cluster
involved in the β-oxidation of long chain fatty acids.[36] SCP-2L was crystallized with
Triton X-100 revealing an apolar tunnel (Figure 6).[19] This tunnel has a length of 18
Å and a diameter of 9 Å at the smaller exit of the tunnel (where the “tail” of the Triton
X-100 molecule is located). The diameter is more than 10 Å at the wider entrance of
the tunnel. The location of the Triton X-100 is presumed to be similar to the location
of the binding site for long chain fatty acids as was found in NMR binding studies
with the analogue mSCP2.[27] Overall this crystal structure provides good insight into
where our transition metal centre has to be introduced to be in close proximity to the
binding site.
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Figure 6. Cartoon model including Triton X-100 (left) and surface model (right) of
SCP-2L showing the hydrophobic tunnel.
As SCP-2L does not contain any native cysteines one amino acid mutation suffices.
The locations for the introduction of the cysteine were chosen at various positions
around the tunnel. To test if these locations indeed bring the metal binding cofactors
in close proximity to the tunnel docking studies using GOLD were performed.[32] For
this purpose several models of mutants were created using the SWISS-MODEL
online service based on the reported crystal structure.[33] These models were then used
for docking with maleimide triazacyclononane iron complexes and several hydrazone-
phosphane ligands of which a selection is shown in Figure 7 (see appendix A4 for
more models). SCP-2L mutants: E14C, W36C, V82C, V83C and A100C were
selected as target unique cysteine templates based on these models. The amino acid
residues involved in E14C, V82C and V83C are located at the wide entrance of the
tunnel, E14C on the rigid β-sheet backbone and V82C and V83C on the flexible α-
helix structure. W36C is located in the middle of the tunnel and A100C at the smaller
exit of the tunnel, both on the β-sheet backbone.  
Initially both V82C and V83C mutants were selected because they are located at the
wider opening of the apolar tunnel, which might prevent low coupling efficiency due
to steric hindrance. The DNA of SCP-2L was obtained as part of the
pET3d::dΔhΔSCP-2L plasmid.[19] The mutants were created by site directed
mutagenesis on the original pET3d::dΔhΔSCP-2L plasmid to successfully create the 
pET3d::dΔhΔSCP-2L V82C and pET3d::dΔhΔSCP-2L V83C plasmids. However 
expression of the protein from this plasmid provides untagged protein, which
complicates the purification. Because of this it was decided to clone the inserts into
Tunnel dimensions:
90º
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the pEHISTEV vector to obtain a protein containing a histidine-tag and a TEV
protease cleavage site.[10]
Figure 7. Selected highest ranked models from GOLD docking studies using various
covalent bound ligands (red) to cysteine (purple) a) SCP-2L E14C b) SCP-2L W36C
c) SCP-2L I72C d) SCP-2L V82C e) SCP-2L V83C f) SCP-2L A100C.
Both dΔhΔSCP-2L and dΔhΔSCP-2L V83C were successfully inserted into 
pEHISTEV using BamHI and NcoI restriction enzymes to cut the insert from their
parent plasmids and sequential ligation with pEHISTEV treated with the same
restriction enzymes to obtain pEHISTEV::dΔhΔSCP-2L and pEHISTEV::dΔhΔSCP-
2L V83C (Figure 8). For unclear reasons the same method proved unsuccessful for
pET3d::dΔhΔSCP-2L V82C. Site directed mutagenesis was performed on 
pEHISTEV::dΔhΔSCP-2L to obtain plasmids coding for the E14C, W36C and 
A100C mutants, successfully creating pEHISTEV::dΔhΔSCP-2L E14C and 
pEHISTEV::dΔhΔSCP-2L A100C. Unfortunately no successful mutagenesis was 
achieved for the W36C mutation.
a b c
d e f
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Figure 8. Agarose gel analysis of subcloning dΔhΔSCP -2L and dΔhΔSCP -2L V83C 
into pEHISTEV, a) pET3d::dΔhΔSCP-2L, pET3d::dΔhΔSCP-2L V83C and 
pEHISTEV treated with BamHI and NcoI restriction enzymes b) Isolated SCP-2L and
SCP-2L V83C inserts and cleaved pEHISTEV c) Control for plasmid isolated after
ligation, transformation and isolation treated with BamH and NcoI.
2.3.2 Unique cysteine protein production and purification
2.3.2.1 mSCP2 and mSCP2 C91S M104C
Using the created pET24d plasmids, the mSCP2 protein is produced with a histidine
(His) and glutathione S-transferase (GST)-tag attached to the N-terminus. The His-tag
consists of 6 histidines which can be used for convenient purification of the protein by
nickel affinity chromatography. The GST-tag is a large (~30kDa) protein, which has a
high affinity for glutathione, which also makes the whole protein more soluble and so
improves the yield from the lysis step. This gives also the opportunity for a
purification step which involves glutathione affinity chromatography. Both tags can
be cleaved off using His-tag containing TEV-protease, after which final purification
can be achieved by another run of nickel affinity chromatography. Transformation of
the bacterial expression strain E. coli BL21(Rosseta) with the pET24d::dΔhΔhSCP2 
and pET24d::dΔhΔhSCP2 C91S M104C plasmids was successful. Both proteins were 
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expressed after addition of the expression initiator (isopropyl-1-thio-β-D-
galactopyranoside) IPTG. Purification of the wild type mSCP2protein was successful
following a procedure reported by Sattler et al.[37] This procedure included nickel
affinity chromatography followed by cleavage of the His/GST-tag by TEV and
another run of nickel affinity chromatography. The overall yield was only around 5
mg/L. Further optimisation of the production and purification was desired to improve
the yield for application of the protein as artificial metallo enzyme catalyst. The
purification of the mSCP2 C91S M104C mutant proved however more troublesome.
Although expression was similar to the wild type protein, this mutant proved to be
unstable especially during the TEV protease cleavage step. This step is usually
performed at room temperature to ensure full conversion to the cleaved protein.
However, this resulted in precipitation of the desired protein after cleavage as
observed on SDS-PAGE gel, where only a very weak band for the cleaved protein
could be observed (Figure 9). The precipitation could not be avoided by using lower
temperature.
Figure 9. SDS-PAGE analysis of TEV cleavage of mSCP2 C91S M104C, a) protein
ladder b) mSCP2 C91S M104C after cutting with TEV.
There have been previous reports concerning mSCP2 mutants[38] and it has been
reported that introducing the C91S mutation leads to decreased thermal stability of the
protein.[39] Therefore, screening for other amino acids to replace the cysteine at
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conclusion this particular SCP2 was found to be unsuitable for our purposes of
creating stable artificial transition metal catalysts.
2.3.2.2 SCP-2L unique cysteine mutants
The pET3d:dΔhΔSCP-2L V83C plasmid was transferred to BL21 (DE3) pLysS 
competent cells. Expression was successful using IPTG as initiator and purification
could be achieved using the reported procedure for SCP-2L with an average yield of
20 mg/L.[19] However, because this purification method proved time consuming the
plasmids pEHISTEV::dΔhΔSCP-2L V83C and pEHISTEV::dΔhΔSCP-2L were 
created, which allows for the production of His-tagged protein, which can be purified
by nickel affinity chromatography. In this construct the histidine-tag could be cleaved
off by the highly specific Tobacco Etch Virus (TEV) protease. This protease cleaves
at a specific E-N-L-Y-F-Q-G aminoacid sequence, cleaving between the glutamine
(Q) and the glycine (G). This glycine is left on the protein together with an alanine
(A) which is used as linker on this particular vector, resulting in a protein with a two
aminoacid extension compared to the original SCP-2L.
Optimisation of the expression and purification procedure was done for SCP-2L
V83C, and the same conditions were later applied for other mutants. Bacterial
expression strain E. coli BL21(Rosetta) was successfully transformed with
pEHISTEV::dΔhΔSCP-2L V83C. Good over-expression of the His-SCP-2L V83C 
protein was observed on SDS-PAGE, however after lysis only small amounts of
soluble protein were obtained. The problem was successfully circumvented by
performing the expression over 16 hours at 16ºC instead of 37ºC, which resulted in
slightly lower expression, but significantly more soluble protein after lysis (Figure
10). The conditions for the lysis were also optimised for several parameters like
buffer, pH and amount of lysozyme. Freezing the cells to -80ºC before lysis and
sonication after lysis also proved very effective for increasing the yield of soluble
protein.
The first run of nickel affinity chromatograph already yielded the desired protein with
a purity of more than 99% according to SDS-PAGE analysis. However, the efficient
removal of the histidine tag by TEV protease proved problematic. The application of
standard conditions[40] for this step resulted in large amounts of precipitated protein
leaving only small amounts of cleaved SCP-2L V83C. The cleavage was optimised
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for buffer, pH and temperature but the most important factor appeared to be the
concentration of the protein and TEV (Figure 11a). High concentrations of Hist-SCP-
2L V83C resulted in large amounts of precipitation. Lowering the protein
concentration to below 1.5 mg/ml and performing the cleavage at room temperature to
ensure full cleavage proved to be the optimal conditions for removal of the histidine
tag from Hist-SCP-2L using TEV protease (Figure 11b).
Figure ##
Figure 10. Comparison of expression and amount of soluble Hist-SCP-2L V83C at a)
37ºC and b) 16ºC with expected location of protein with molecular weight of 16344.7
Da indicated in red on the ladder.
After a second run of nickel affinity chromatography SCP-2L V83C could be
obtained with very high purity (no other protein bands could be detected upon SDS-
a) b)
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PAGE analysis). The yields proved to be high reaching an average of more than 60
mg per litre of bacterial culture.
Figure 11. SDS PAGE analysis of TEV protease cleavage experiments of Hist-SCP-
2L V83C. Expected bands, Hist-SCP-2L V83C (red) SCP-2L V83C (blue), TEV
protease (green) as depicted on the ladder. Conditions; a) 50 mM Tris 300 mM NaCl
20 mM imidazole pH 8 buffer, 0.5 mM EDTA (from 50 mM stock in 50 mM kPi pH
8 buffer), 1 mM DTT (from 100 mM stock in H2O), 3 mg (180 nmol)/ml or 1.5 mg
(90 nmol)/ml Hist-SCP-2L V83C (from 3 mg/ml stock in 50 mM Tris, 150 mM NaCl
10 mM imidazole pH 8 +20% glycerol), 0.07 mg (2.5 nmol)/ml or 0.017 mg (0.06
nmol)/ml TEV-protease (from 1.7 mg/ml stock in 25 mM Tris 150 mM NaCl 50%
glycerol) at 4ºC overnight. Spun down next morning 16100 g for 30 min and separate
precipitate (Prec.) from supernatant (Sup.). b) Diluted to below 1.5 mg/ml 0.014 eq
TEV at room temperature overnight).
The wild type SCP-2L, SCP-2L A100C and SCP-2L E14C were successfully purified
using the same procedure as developed for SCP-2L V83C. The yield for SCP-2L was
the same as for SCP-2L V83C. The yield for SCP-2L A100C was lower with an
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average of 30 mg per litre bacterial culture. SCP-2L E14C was found to be unstable
forming large amounts of precipitate during the purification procedure resulting in a
yield of only 5 mg per litre bacterial culture. This mutant could not be stored in 20
mM MES, 50 mM NaCl pH 6 at 4ºC like the other proteins as this resulted in slow
precipitation of the protein over time.
2.3.2.3 15N-SCP-2L
In general, solution structures of proteins are determined by 13C-NMR and 15N-NMR
of isotopically labelled proteins. Although a solution structure of SCP-2L would be
very valuable to acquire, obtaining such NMR-structures is a time consuming and
costly process, and is not within the scope of this project. The creation of 13C labelled
protein is very expensive because of the 13C-labelled glucose that has to be used. The
production of 15N-labelled protein is done by growing cells on medium containing
15N-labelled ammonia as nitrogen source, which is affordable compared to 13C
glucose. Several structural features of the protein can be determined using 15N-
labelled protein, and it can be used for substrate binding characterization. Also for
EPR-studies of artificial metalloenzymes containing EPR active transition metals it
would be interesting to be able to use 15N-labelled protein as this would help to
determine the environment of EPR-active metal centres by comparison with the
unlabeled protein.
Production of isotopically labelled protein is performed using a defined medium to
make sure the bacteria solely use the nitrogen from the isotopically labelled source for
protein synthesis. This has the disadvantage that yields are usually ten fold lower than
from growth in rich media such as the production broth (PB) used for large scale
production of unlabelled SCP-2L and mutants. By growth at 16ºC overnight good
expression of the 15N-labelled SCP-2L could be achieved. The protein was purified
using the same protocol used for unlabelled SCP-2L giving a good overall yield of the
labelled protein of 6 mg/L culture compared to the 60 mg/L usually obtained for
unlabelled SCP-2L. Peak analysis of the mass-spectrum of the protein indicated more
than 99% incorporation of 15N (calculated 13533.1 Da; found 13533.9 Da).
A 1H,15N 2D HSQC NMR-spectrum of a 0.1 μM protein solution in H2O containing
6% D2O was recorded (Figure 12). The number of peaks found (~120) is about the
correct amount of expected signals when overlap of several peaks is considered. Two
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distinct signals could be assigned to the two tryptophan side chains present in SCP-
2L. The signals for these residues 35 and 47 are found in the bottom left corner of the
spectrum (red rectangle). As these two residues are located at the entrance of the
hydrophobic tunnel in SCP-2L these may be potential indicator signals for the binding
of substrates in titration experiments.
Figure 12. 1H,15N 2D HSQC NMR-spectrum of 15N-SCP-2L.
2.3.3 Structure, stability and binding capacity of SCP-2L and mutants
2.3.3.1 Protein folding
When the models of the SCP-2L V83C and SCP-2L A100C proteins generated by the
SWISS-MODEL service[33] are compared to the original crystal structure of SCP-2L
the fold seems largely unaffected by the mutations (Figure 13). Experimentally the
fold of the protein is often investigated using circular dichroism (CD).[41] In addition
watergate 1H-NMR, which is often used for obtaining 2D NMR spectra used for
structural characterization, can be used as a relatively quick experiment to compare
the fold of two proteins by assessment of the perturbations in the signals.
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Figure 13. Models created by the SWISS-MODEL service[33] of a) SCP-2L b) SCP-
2L V83C c) SCP-2L A100C (cysteines highlighted in purple).
The near UV-CD-spectra of SCP-2L, SCP-2L V83C and SCP-2L A100C proved to be
identical (Figure 14). The chosen wavelength region shows the signals for aromatic
amino acid residues in the protein.[41] The signal observed shows that the residues are
in a chiral environment giving a finger print for this particular protein fold. As the
signals for SCP-2L and the two mutants are almost identical it can be concluded that
the structure of the protein is unaffected by the two mutations.














Figure 14. Near UV CD-spectra of SCP-2L (red), SCP-2L V83C (blue) and SCP-2L
A100C (black).
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Figure 15. Watergate 1H-NMR spectra of SCP-2L (blue) and SCP-2L V83C (red) in
1.5 mM in 20 mM MES pH 6 buffer a) overlay for the region between 11 and 6 ppm
b) overlay for the region between 2.3 and –0.5 ppm c) full spectra, offset for clarity.
Figure 16. Watergate 1H-NMR spectra of SCP-2L (blue), SCP-2L V83C (red) and
SCP-2L A100C (green) in 1.5 mM in 20 mM MES pH 6 buffer a) overlay for the
region between 0.75 and -0.5 ppm b) overlay for the region between 2.3 and –0.5 ppm
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Also the watergate 1H-NMR spectra of SCP-2L and SCP-2L V83C were recorded
(Figure 15). In watergate (water suppression by gradient tailored excitation) 1H-NMR
experiments[42] the water signal is suppressed like in other solvent suppression 1H-
NMR experiments.[43] However, the difference is that in a watergate experiment no
irradiation saturation is used, which means that protons that exchange with the solvent
like N-H’s using water as the solvent can be observed. From the spectra it can be seen
that the proteins are both folded as the signals are spread out over the full region of
the spectrum. Again the spectra of SCP-2L and SP-2L V83C were found to be very
similar indicating a similar tertiary structure. Interestingly a significant difference is
observed at round 0.5 ppm (Figure 15b and Figure 16a and b). This region
corresponds to aliphatic residues in a hydrophobic surrounding. The V83C mutation is
the replacement of a valine containing an isopropyl side chain with a cysteine so the
loss of a signal in this particular region in SCP-2L V83C indicates that the signal for
the valine at position 83 in SCP-2L is found here. Also the watergate 1H-NMR of
SCP-2L A100C mutant was recorded, however due to problems with the phasing the
whole spectrum could be not overlapped as well as the WT protein and the V83C
mutant. Overall the spectrum was found to be very similar to the WT protein as can
be seen in Figure 16. Interestingly, differences can be observed again in the region
around 0 ppm. The signal at -0.25 ppm has clearly shifted upfield and now another
signal has disappeared at 0 ppm compared to V83C. As this mutant has an alanine
replaced by a cysteine it is likely that this missing signal in the spectrum of SCP-2L
V83C belongs to the alanine methyl in SCP-2L. The disappearance of signals in this
region in both mutants confirms that amino acids inside the hydrophobic core have
been replaced in both mutants.
2.3.3.2 Thermal stability
The protein thermal stability is usually expressed in Tm, the temperature at which
protein denaturates in solution and can be determined by measuring circular
dichroism at different temperatures.[44] The Tm of proteins can range from 20 to over
100ºC and is usually linked to the living environment of the natural host organism.
The thermal stability of the proteins used in this study is very important to assess as
for most catalytic processes elevated temperatures are desired.[45]
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Figure 17. Variable temperature CD-analysis a) spectra of SCP-2L and SCP-2L V83C
between 250 and 320 nm b) signals at 290 nm and 286 nm of SCP-2L and SCP-2L
V83C, CD-signal (black) and stray light (blue).
Figure 17 shows the results for the variable temperature CD-spectroscopy analysis of
wild type SCP-2L and SCP-2L V83C. For SCP-2L the CD signal appears to be
constant up to 70 ºC, after which it gradually starts to decrease before rapidly
decreasing at temperatures over 80 ºC (Figure 17 first column). At this stage a
significant amount of precipitate had formed and when the sample was cooled down
again only 1% of the original signal returned and most of the protein seemed to have
precipitated. Therefore, no Tm could be determined as this requires reversible
b)
a) SCP-2L SCP-2L V83C
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unfolding. Based on these results the Tm can be estimated and must be over 70 ºC.
Overall the protein fold appears to be stable at elevated temperatures but at high
temperature above 70 ºC it starts to denature irreversibly. High melting temperatures
(>70 ºC) have been reported for structurally similar mSCP2 consistent with the results
shown above.[39] However in that study it was suggested that unfolding of the protein
was reversible.
Similar results were obtained for SCP-2L V83C, with the difference that the signal
started to decrease about 10ºC lower in temperature compared to the wild type protein
(Figure 17 second column). Irreversible denaturation of the protein was also observed
for this mutant. A closer look reveals that in both the spectra of SCP-2L and SCP-2L
V83C the signals at the minima at 286 and 294 nm increase with raising the
temperature before disappearing upon denaturation. If the temperature is plotted
against the CD signal at 286 and 290 nm this effect can be seen more clearly (Figure
17b). The graph for SCP-2L obtained at 286 nm shows that around 55ºC the protein
seems to go through a small conformational change. Although less clearly, the same
effect can also be seen in the 286 nm graph for SCP-2L V83C, but at a slightly lower
temperature (~45ºC). Interestingly at about the same temperature there is a peak in the
amount of detected stray light. An increase in the amount of stray light is usually
caused by scattering of the light beam by particle or precipitate formation inside the
sample.[46] It seems likely that the small conformational change initiates the
irreversible protein denaturation. Overall the protein appears remarkable stable to
increased temperature, which is very useful for application as template for artificial
metalloenzyme catalysts. The observation that the protein seems to precipitate after
denaturation can also be used as an advantage as denatured protein can be easily
removed by centrifugation.
2.3.3.3 Substrate binding capability of SCP-2L and SCP-2L V83C
Substrate binding to proteins can be measured using various techniques. A frequently
used technique to monitor fatty acid binding is titration of the protein with fluorescent
fatty acids.[15] Particularly a method using “Förster resonance energy transfer”
(FRET) between tryptophan residues in the protein and a fluorescent probe proved
useful.[28b] By titration of the proteins with a fluorescent probe Kd-values can be
determined as schematically depicted in Figure 18 for the present system using 12-
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pyrene dodecanoic acid (Pyr-C12) as probe. During this type of titration the native
fluorescence of the tryptophan at 336 nm is quenched (red arrow) by energy transfer
to the pyrene of the fatty acid which emits fluorescence at various wavelengths (blue
arrows). This energy transfer is only possible if the donor and acceptor are in close
proximity (~5 nm), making the amount of observed FRET a measure for binding.
Also binding of non-fluorescent substrates can in principle be studied by competitive
binding experiments.






















Figure 18. Example of FRET between SCP-2L tryptophan residues (shown in red)
and fluorescent Pyr-C12 as observed by measuring the fluorescence upon titration of
SCP-2L with Pyr-C12.
Titrations of SCP-2L, SCP-2L V83C were performed and the calculated Kd values are
shown in Table 1 (entries 1 and 2). Although the error margins are significant the
obtained Kd values show that the mutations do not affect the binding affinity of the
protein for the aliphatic substrate used in this titration.
The found Kd values are in same order of magnitude as those of the same and similar
fatty acids obtained for mSCP2 (Table 1, entries 3-5). Interestingly, the found Kd
values are lower than those for fatty acid CoA binding to SCP-2L. Usually stronger
binding is observed for CoA derivatives for this class of proteins. This could indicate
+
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that SCP-2L actually does not have a higher preference for binding fatty acid CoA
derivatives. This unusually high affinity for long chain fatty acids is supported by
patient studies containing defects in the gene coding for MFE2 (in which SCP-2L is
located). The patient typically show high levels of these fatty acids in plasma and
fibroblasts are found, showing that the metabolic pathway for these compounds is
deregulated.[18, 47] These results indicate that SCP-2L has a high affinity for linear
aliphatic substrates which are of interest to this study.
Table 1. Kd values of (un)modified SCP-2L and reported values.
Entry Protein. Kd (μM) (+/-) Substrate
a Methodb Reference
1 SCP-2L 0.18 (+/-0.05) Pyr-C12 FRET This work
2 SCP-2L V83C 0.18 (+/-0.07) Pyr-C12 FRET This work
3 mSCP2 0.24 Pyr-C12 FRET [28b]
4 mSCP2 0.18 (+/-0.01) cis-Par Direct [15]
5 mSCP2 0.56 (+/-0.04) trans-Par Direct [15]
6 mSCP2 4.57 (+/-0.75)c cis-Par-CoA Direct [15]
7 mSCP2 2.76 (+/-0.1)c trans-Par-CoA Direct [15]
8 SCP-2L 20 Pal-CoA SPR [19]
9 SCP-2L 40 trans-C16-CoA SPR [19]
a) Pyr-C12: pyrene dodecanoic acid, cis-Par: cis-parinaric acid, trans-Par: trans-
parinaric acid, Pal-CoA: palmitoyl-CoA, trans-C16-CoA: trans-2-hexadecenoyl-CoA
b) FRET: Förster resonance energy transfer, Direct: direct measurement of
fluorescence of the probe, which has its emission wavelength altered upon binding,
SPR: Surface plasmon resonance measurements c) Kd in nM instead of μM. 
2.3.3.4 The free cysteine
For the creation of artificial metallo enzymes by our methodology it is essential that
the unique cysteine is available for selective modification. In order to confirm this,
several test experiments were performed. Maleimides conjugate very selectively to
the thiol of a cysteine at low pH (<7). Maleimide M1[48] was chosen as a test
maleimide for modification of the cysteine in SCP-2L V83C and A100C (Scheme 1).
After reaction of the proteins with maleimide only one set of peaks was observed by
LCMS(ES+) analysis corresponding to the expected modified proteins.
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Scheme 1. Reaction between unique cysteine of SCP-2L V83C and A100C with
maleimide M1.
Selective modification of the cysteine was confirmed by application of Ellman’s
reagent[49] to the modified and unmodified proteins. Ellman’s reagent (5,5′-dithio-
bis(2-nitrobenzoic acid) (DTNB) forms disulfide bridges with cysteine releasing an
equivalent of the yellow free 5-thio-2-nitrobenzoic acid (TNB) (Scheme 2).[50] The
yellow colour of the reaction mixture after 5 minutes clearly showed the formation of
TNB upon reaction of DTNB with the unmodified proteins compared to no colour
change for the modified proteins. This indicated that the unique cysteine is indeed
modified by maleimide M1. Further analysis of the reaction mixtures by LCMS(ES+)
confirmed this.[51] While for the reaction of the unmodified SCP-2L mutants full
conversion to the SCP-2L A100C-TNB and nearly quantitative conversion to SCP-2L
V83C-TNB was found, no new products were observed for the reactions with SCP-2L
V83C-M1 and SCP-2L A100C-M1.
Scheme 2. Reaction between unique cysteine of SCP-2L V83C and A100C with
Ellman’s reagent (DTNB).
The reaction mixtures of the reactions between the SCP-2L mutants and maleimide
M1 were also subjected to a tryptic digest followed by detailed analysis by MALDI-
SCP-2L V83C 13376.6 Da
SCP-2L A100C 13404.6 Da SCP-2L V83C-M1 (calc 13619.9 Da)
Found: LCMS (ES+) 13619.1 Da
SCP-2L A100C-M1 (calc 13647.9 Da)
Found: LCMS (ES+) 13646.9 Da
SCP-2L V83C-TNB (calc 13573.8 Da)
Found: LCMS (ES+) 13573.5 Da
SCP-2L A100C-TNB (calc 13601.8 Da)
Found: LCMS (ES+) 13601.0 Da
SCP-2L V83C 13376.6 Da
SCP-2L A100C 13404.6 Da
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MS. Trypsin is a protease that digests the protein by cleavage at the carboxylic side of
lysines or arginine amino acid residues in the peptide sequence except when the
amino acid is modified or followed by a C-terminal proline.[52] By using the protein
peptide sequence the results of the MALDI MS analysis after tryptic digest can be
compared to the expected most abundant oligopeptides after cleavage (Figure 19 a
and b). This way a search can be performed for oligopeptides which have been
modified. By applying MS-MS the full amino acid sequence of the oligopeptide can
often be obtained providing the exact location of the modification. Analysis of the
digests of SCP-2L V83C-M1 and SCP-2L A100C-M1 by MALDI MS showed for
both proteins modification of the expected oligopeptide only. For SCP-2L V83C-M1
also a signal of +18 compared to the expected oligopeptide was found which is likely
to correspond to maleimide ring opening by water, which is known to occur at basic
conditions such as used for the trypsin digest (pH 8). MS-MS analysis of the peak
corresponding to the expected oligopeptide sequence is shown in Figure 19c. The
found sequence does confirm that the correct oligopeptide is modified. Also the
precise location of the modification can be narrowed down to the short peptide
CLGK. Because trypsin does not cleave near modified lysines (the only reactive
amino acid except for cysteine in this short peptide),[53] this spectrum confirms the
successful modification of the cysteine.
Maldi-MS analysis SCP-2L A100C-M1 was challenging because the signals usually
observed for the matrix are found in the same region as the signal for the expected
short peptide containing the modified cysteine after trypsin digestion. A signal was
found that corresponded to the expected peptide including the N-terminal lysine of the
cleavage site (KC(M1)R). Signals corresponding to lysine (K) and arginine (R) which
are part of this small peptide could be found upon MS-MS analysis confirming the
signal belongs to this short oligopeptide. Although lysines are known for their
nucleophilic character modification of this lysine is highly unlikely as trypsin is
known to be unable to cleave peptide chains next to modified lysines confirming the
modification of the expected cysteine.[53]
All the above experiments confirm that the unique cysteine is present and available
for modification using known bioconjugation techniques. This enables the use of
these proteins as templates for artificial metalloenzymes by site selective covalent
modification with transition metal ligands. The results of these experiments will be
described in the following chapters.
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Figure 19. Amino acid sequence of a) SCP-2L V83C and b) SCP-2L A100C showing
expected cleavage sites with “/”, expected modified peptide in bold and modified
cysteine in red. This figure only shows the expected most abundant cleave site but
cleavage at the other sides of the lysines can also occasionally be observed c) MS-MS
analysis of cysteine containing oligopeptide of SCP-2L V83C confirming the
expected sequence.
2.4 Conclusions and future prospects
In this chapter the production and purification of unique cysteine containing protein
templates for the development of artificial metalloenzymes is described. This was
successful for several SCP-2L mutants which according to structural investigations
and substrate binding studies maintain the same tertiary structure as the wild-type
protein. Mutants of this protein were found suitable for use as artificial
metalloenzymes as good thermal stability was found as well as full selective
modification using a model maleimide. Further investigation into the structure should
be possible using 15N-labelled proteins as shown by the example of the expression and
purification of 15N labelled SCP-2L. Crystal structures and NMR-structures of
modified proteins would be very useful in the further design of artificial
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the reliability of the obtained structures still has to be assessed. Although in principle
any protein template can be used by this approach to create artificial metalloenzymes,
this chapter also shows some limitations. Some of the desired protein templates could
not be obtained in sufficient quantities and some were lacking long term stability. The
removal of the unique cysteine in mSCP2 leading to an unstable protein and the
unstable SCP-2L E14C protein are examples of this instability. Other limitations are





For processing of the mass-spectra the MaxEnt algorithm of Masslynx V4.0
(Micromass Ltd) was used. Plasmids were sequenced by the Sequencing Service,
School of Life Sciences, University of Dundee, Dundee. Protein concentrations were
determined using Bradford’s reagent.[54] Curve fits to calculate Kd values were
performed using OriginPro 8.
2.5.1.2 Equipment
Nickel affinity column protein purifications were done using 5 ml HisTrap FF
columns (Amersham Bioscience UK Limited). LC-MS (ES) used for analysis of
protein and protein reactions, Waters Alliance HT 2795 equipped with a Micromass
LCT-TOF mass spectrometer, using positive electrospray ionisation and using a
Waters MASSPREP® On-line Desalting 2.1x 10 mm cartridge and application of a
gradient of 1% formic acid in H2O to 1% formic acid in acetonitrile. Spin-filter
concentrators with a molecular weight cut-off of 10kDa (Amicon® Millipore Ultra®,
Ultracel 10K, Millipore®, Carrigtwohill, Co. Cork, Ireland) were used to concentrate
and/or wash protein solutions. CD-spectra and variable temperature CD-spectra were
recorded of 2 mg/ml protein solutions in 20 mM MES pH = 6 on a Jasco J-810
spectropolarimeter equipped with a CDF-426S temperature and stirring controlling
unit connected to a Julabo awc100 cooler/heater. Watergate 1H-NMR and 1H,15N 2D
HSQC NMR spectra were recorded on a Bruker Avance 500 spectrometer. A Varian
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Cary Eclipse was used for fluorescent binding assays equipped with a temperature
controller and magnetic stirring unit.
2.5.1.3 Materials
His-TEV(S219V)-Arg[55] obtained from the E. Coli BL21(DE3)-pRK793 strain[35, 56]
was used as protease for TEV cleavage of the histidine and GST-tags. The
pET24d::dΔhΔhSCP2 plasmid[27] was kindly provided by M. Sattler from the
European molecular Laboratory of Heidelberg, Germany (the pET24d used was a
modified version, which is also known as pETM30).[34] The pET3d::dΔhΔSCP-2L 
plasmid,[19] kindly provided by T. Glumoff of the Biocenter Oulu and the Department
of Biochemistry of the University of Oulu. All protein sequences used in this thesis
can be found in appendix A1. Production Broth medium (PB); containing 20g/L
tryptone, 10g/L yeast extract, 5 g/L dextrose, 5 g/L NaCl, 8.7 g/L K2HPO4, pH = 7.0
was used for protein expression.
2.5.2 Plasmid construction
2.5.2.1 Construction of pET24d::dΔhΔhSCP2 C91S M104C and 
pET24d::dΔhΔhSCP2 C91S plasmids 
The mSCP2 C91S M104C mutant was constructed from pET24d::dΔhΔhSCP2 
plasmid with a QuickChange® Multi Site-Directed Mutagenesis Kit (Stratagene. La
Jolla, CA, USA) using the provided pET24d::dΔhΔhSCP2 plasmid as the template
and the primers shown in Table 2 for PCR. The construct was verified by sequencing.
One of the failed constructs was identified as pET24d::dΔhΔhSCP2 C91S coding for 
the mSCP2 C91S mutant. pEHISTEV was kindly donated by the group of Prof. Dr. J.
H. Naismith (University of St. Andrews).
Table 2. Primers used for mutagenesis to create mSCP2 C91S M104C.
Primer Mutation acquired Sequence
Primer 1 C91S TGC/AGC 5’-CAGATAAGAAGGCTGACAGCACAATCACAATGGCT GACTC-3
Primer 1 M104C ATG/TGC 5’-CCTGGCTTTATGCAC TGGTAAAATGAATCCTCAGTCGGCC-3’
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2.5.2.2 Construction of the pET3d::dΔhΔSCP-2L V82C  and 
pET3d::dΔhΔSCP-2L V83C plasmid 
Mutations were introduced using the Quick-Change Site-Directed Mutagenesis Kit
(Stratagene). pET3d::dΔhΔSCP-2L plasmid was used as templates for the PCR 
reactions to create the plasmids coding for SCP-2L and SCP-2L mutants V82C and
V83C. The primers shown in Table 3 were used for site directed mutagenesis. The
constructs were verified by sequencing.
Table 3. Primers used for mutagenesis to create SCP-2L mutants.











2.5.2.3 Construction of the pEHISTEV::dΔhΔSCP-2L  and 
pEHISTEV::dΔhΔSCP-2L V83C plasmids  
To enhance the production yield of SCP-2L mutants the DNA coding for SCP-2L and
mutants V82C and V83C from pET3d::dΔhΔSCP-2L plasmids were subcloned into 
pEHISTEV.[10]. The pEHISTEV plasmid was digested with BamHI and NcoI in
BamHI buffer (Fermentas Life sciences) and isolated from a 0.8% agrose gel. The
SCP-2L inserts were similarly isolated from digestion of the pET3d::dΔhΔSCP-2L 
plasmids. The digested pEHISTEV and corresponding insert were ligated using a
Rapid DNA Ligation Kit (Roche Diagnostics GmbH Mannheim, Germany) to create
the pEHISTEV::dΔhΔSCP-2L and pEHISTEV::dΔhΔSCP-2L V83C plasmid. The 
constructs were verified by sequencing. This process was unsuccessful for the SCP-
2L V82C. These constructs afford the corresponding protein with an N-terminal
hexahistidine tag attached which can be removed in vitro by TEV-protease.[35]
2.5.2.4 Construction of pEHISTEV:: dΔhΔSCP-2L A100C, pEHISTEV:: 
dΔhΔSCP-2L E14C and pEHISTEV:: dΔhΔSCP-2L W36C plasmids 
Mutations were introduced applying a Quick-Change Site-Directed Mutagenesis Kit
(Stratagene) using pEHISTEV::dΔhΔSCP-2L as template. Table 4 shows the primers 
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used for mutagenesis to create SCP-2L mutants: SCP-2L E14C, W36C and A100C.
The constructs were verified by sequencing.
Table 4. Primers used for mutagenesis to create SCP-2L E14C, W36C and A100C
mutants.
















2.5.3 Protein expression and purification
2.5.3.1 mSCP2
PB medium with 50 μg/ml kanamycin and 34 μg/ml chloramphenicol (in ethanol) 
was used for expression experiments. 10 ml of an overnight culture of E. coli
BL21(Rosetta) cells harbouring plasmid pET24d::dΔhΔhSCP2 was used to inoculate
0.5 litre of PB medium using the same antibiotics concentration as during the
expression experiments. The cells were allowed to grow under aerobic conditions in
3L baffled conical flasks at 37ºC to an OD600 of 0.6 after which the temperature was
lowered to 21ºC. IPTG was added after one hour to a final concentration of 0.2 mM,
which initiated the expression of the recombinant protein. The culture was than
allowed to growth overnight at 21ºC. The cells were harvested by centrifugation (20
min, 3000 g, 4ºC). A portion of the pellet (3.5 g of wet weight) was suspended in 30-
40 ml 30 mM Tris, 20 mM imidazole, 150 mM NaCl, 2 mM β-mercaptoethanol, pH 8 
(Wash) buffer. To this suspension 1 mg/ml lysozyme, 25 μg/ml DNase A and a 
spatula tip of Pefabloc® (Roche, Applied sciences UK)[57] were added. The resulting
mixture was shaken at 4 ºC for 1 hour and sonicated for 15 minutes with pulses of 15
sec with 90% power output. The cell-extract, obtained after centrifugation (50 min,
30000 g, 4ºC) was filtered and applied on a 5 ml nickel column equilibrated with
wash buffer. The flow through was collected and the protein was obtained by eluting
with 30 mM Tris, 330 mM imidazole, 150 mM NaCl, 2 mM β-mercaptoethanol, pH 8 
(Elutrion) buffer. The combined fractions containing the mSCP2 protein were
dialysed against a 30 mM Tris, 10 mM imidazole, 150 mM NaCl, 5 mM β-
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mercaptoethanol, pH 8 (TEV) buffer. To the resulting mixture add 1-2 mg TEV-
protease was added per 30-40 mg protein and was left to stand overnight at 4ºC. This
mixture was than applied again on a nickel column equilibrated with the (TEV)
buffer. The flow-through containing purified mSCP2 was collected and stored at 4ºC.
The yield was 4.4 mg (0.3 μmol) per litre culture, with a purity of more than 99%
according to SDS-PAGE. Electron spray mass-spectrometry provided a mass of
13334.9 Da (calculated mass 13471.5 Da). The found mass corresponded to the loss
of a N-terminal glycine and alanine (calculated mass 13341.3 Da).
2.5.3.2 mSCP2 C91S M104C
The protein mSCP2 C91S M104C was produced by the same procedure as used for
the production of mSCP2 using the pET24d::dΔhΔhSCP2 C91S M104 plasmid. The 
yield was lower than 1 mg per litre culture. Electron spray mass-spectrometry
provided a mass of 13427.5 Da (calculated mass 13427.5 Da). A second signal at
13503.5 Da was observed corresponding to the protein containing a disulfide bond to
β-mercaptoethanol and one oxidation 
2.5.3.3 SCP-2L V83C
PB medium with 100 μg/ml ampicillin was used for expression experiments. Six 
portions of 10 ml of an overnight culture of E. coli BL21(DE3) cells harbouring
plasmid pET3d::dΔhΔSCP-2L V83C were used to inoculate six times half a litre of 
PB medium. The cells were allowed to grow under aerobic conditions at 37ºC to an
OD600 of 1.5. The addition of IPTG to a final concentration of 0.2 mM initiated the
expression of the recombinant protein, followed by further growth overnight. The
cells were harvested by centrifugation (20 min, 3000 g, 4ºC) and washed wit ice-cold
120 mM NaCl, 16 mM potassium phosphate, pH 7.4 buffer. A portion of the pellet
(3.5 g of wet weight) was suspended in 50 ml of 20 mM 3-cyclohexylamino)-1-
propanesulfonic acid (CAPS), 0.5 mM benzamidine (BA), pH 11.0. To this
suspension 1 mg/ml lysozyme, 25 μg/ml RNase A and 10 mM MgCl2 was added. The
resulting mixture was shaken at 4 ºC for 1.5 hours. To the cell-extract, obtained after
centrifugation (50 min, 30000 g, 4ºC), 0.1 M NaCl was added. The resulting mixture
was applied on an anion exchange Hiload Q Sepharose High performance 16/10
column (GE Healthcare, Amersham Biosciences limited, Uppsala, Sweden),
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equilibrated with 20 mM CAPS, 0.5 mM BA, 0.35 M NaCl, pH 11. The flow-through
was collected by eluting with the equilibration buffer. The combined fractions (250
ml), containing the V83C protein, were dialysed in two steps against a 20 mM 2-(N-
morpholino)ethanesulfonic acid (MES), 35 mM NaCl, pH 6.0 buffer and applied in
portions of 50 ml on a cation exchange Hitrap SP XL 1 ml column (GE Healthcare,
Amersham Biosciences AB, Uppsala, Sweden), equilibrated with the dialysis buffer.
The bound proteins were eluted with a gradient of 0.35 to 1 M NaCl in the
equilibration buffer. The combined fractions containing the V83C protein were
combined to give a yield 10-20 mg (0.75-1.5 μmol) / litre culture, with a purity of 
more than 99% according to SDS-PAGE. Electron spray mass-spectrometry provided
a mass of 13245.3 Da, (calculated mass 13248.4 Da).
2.5.3.4 SCP-2L V83C with hexahistadine tag
The reported expression and purification method for SCP-2L[19] resulted in low yields
in our hands for both SCP-2L and SCP-2L V83C (<10 mg (0.75 μmol) /L medium,). 
Therefore the expression and purification procedure was optimized using an attached
histidine tag in combination with affinity chromatography:
PB medium with 50 μg/ml kanamycin and 34 μg/ml chloramphenicol (in ethanol) 
was used for protein production. 10 ml of an overnight culture of E. coli
BL21(Rosetta) cells harbouring plasmid pEHISTEV::dΔhΔSCP-2L V83C was used 
to inoculate 0.5 litre of PB medium. The cells were allowed to grow at 37ºC in 3L
baffled conical flasks to an OD600 of 0.6 after which the temperature was lowered to
16ºC. IPTG was added to a final concentration of 0.2 mM after one hour to initiate
the expression of the recombinant protein. The culture was left overnight at 16ºC.
The cells were harvested by centrifugation (20 min, 7500 g, 4ºC), washed with 16
mM kPi (potassium phosphate) 120 mM NaCl pH 7.4 buffer and centrifuged again
(20 min, 3000 g, 4ºC). The pellet from 2 litre culture was suspended in 100 ml 50
mM Tris, 20 mM imidazole, 150 mM NaCl, 0.5 mM benzamidine, pH 8 (4ºC) buffer
and frozen at -80ºC. After defrosting 20 mg lysozyme, 1 mg DNAse and 1mM MgCl2
was added to the suspension. The suspension was left for 1 hour at 4ºC and was
sonicated in portions of 10 ml (Hielscher 4P200S ultrasonic processor, 0.5s pulses
90% power) with 0.5 second pulses for 1 minute. The cell-extract, obtained after
centrifugation (50 min, 30000 g, 4ºC) was filtered (0.22 μm Millex Filter unit, 
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Carrigtwohill Co. Cork, Ireland) used for nickel affinity chromatography on a nickel
column equilibrated with 30 mM Tris-HCl, 20 mM imidazole, 150 mM NaCl, pH 8
(wash buffer). The column was washed with 5 column volumes of wash buffer, 5
column volumes of high salt buffer (wash buffer containing 1M NaCl) and another 5
column volumes of wash buffer. The protein was obtained by eluting with 6 column
volumes elution buffer (wash buffer containing 330 mM imidazole). To the elution
containing the Hist-SCP-2L V83C protein, was immediately added an equal volume
of wash buffer (to prevent precipitation of the protein) and the resulting solution was
dialysed against 5 litre 30 mM Tris, 10 mM imidazole, 150 mM NaCl, pH 8 buffer. If
precipitate had formed the resulting mixture was centrifuged (50 min, 30000 g, 4ºC).
To this resulting Hist-SCP-2L V83C solution was added 0.014 equivalents of TEV-
protease and final concentrations of 1 mM DTT and 0.5 mM EDTA from 100x
concentrated stocks. This mixture was left overnight at 4ºC. If precipitate had formed
the mixture was again centrifuged (50 min, 30000 g, 4ºC) and the supernatant used.
The resulting mixture was then filtered and used for nickel affinity chromatography
on a nickel column equilibrated with wash buffer. The flow-through containing pure
SCP-2L V83C was collected and concentrated and buffer exchanged to 20 mM MES
pH 6.6 using a centrifugal concentrator. To the resulting concentrated SCP-2L V83C
mixture 20% glycerol was added and stored at -20ºC. Average yield is ~60 mg (4.5
μmol) / litre culture, with a purity of more than >99% according to SDS-PAGE. 
Electron spray mass-spectrometry provided a mass of 13376.0 Da (calculated mass
13376.6 Da).
2.5.3.5 SCP-2L A100C and E14C
Expression and purification of SCP-2L A100C and E14C was performed using the
same method as for SCP-2L V83C containing a hexahistidine tag except for a small
difference in the preparation of the overnight culture before expression. For the
overnight culture 10 ml LB medium (Lysogeny Broth medium; containing 10 g/L
tryptone, 5 g/L yeast extract, 10 g/L NaCl, pH 7.0) was used for plasmid pre-culture
which was inoculated with a glycerol stock with E. coli BL21(Rosetta) cells
containing the pEHISTEV::dΔhΔSCP-2L A100C or E14C plasmid. A small amount 
(100 μl) of the preculture was than used for the actual overnight culture.  
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The yield for SCP-2L A100C was ~30 mg (2.23 μmol) / litre culture, with a purity of 
more than >99% according to SDS-PAGE. Electron spray mass-spectrometry
provided a mass of 13405.30 Da (calculated mass 13404.60 Da).
The yield for SCP-2L E14C was ~5 mg (0.37 μmol) / litre culture, with a purity of 
more than >99% according to SDS-PAGE. Electron spray mass-spectrometry
provided a mass of 13346.0 Da (calculated mass 13346.6 Da).
2.5.3.6 15N labelled SCP-2L
An Erlenmeyer flask containing LB with 50 μg/ml kanamycin stock and a 34 μg/ml 
chloramphenicol (from stock in ethanol) was inoculated with E. coli BL21(Rosetta)
cells harbouring plasmid pEHISTEV::dΔhΔSCP-2L from a glycerol stock and left 
overnight at 37ºC. 10 ml of overnight culture was centrifuged (30 min, 3000 g, 4ºC),
and the pellet was suspended in 500 ml M9 medium (500 ml M9: 380 ml H2O, 100
ml M9 salts (39 g/L Na2HPO4, 15 g/L KH2PO4, 2.5 g/L NaCl), 1 ml 1 M MgSO4, 0.5
ml 0.5 M CaCl2, 10 ml 20% glucose, 7.5 ml 10% NH4Cl, 0.1 ml 1% thiamine and 0.1
ml trace elements mix (3.3 mg/ml biotin, 160 μM MnSO4, 10 μM CuSO4, 30 μM 
CoCl2, 0.4 mM boric acid, 10 μM ZnSO4)) containing 50 μg/ml  kanamycin and 34 
μg/ml chloramphenicol. The cells were allowed to grow under aerobic conditions at 
37ºC to an OD600 of ~0.55 after which the temperature was lowered to 16ºC. After
about 20 minutes IPTG was added to a final concentration of 0.2 mM, to initiate the
expression of the recombinant protein. The culture was than allowed to grow
overnight at 16ºC after which a final OD600 of about 2 was reached. The harvesting
and purification of the protein was done according to the same procedure as for the
non-isotopic labelled protein described above. Electron spray mass-spectrometry
provided a mass of 13528.9 Da (calculated mass 13533.13 Da). The obtained yield
was ~6 mg (0.44 μmol) / litre culture 
2.5.4 Fluorescent binding assay
A 1 cm cuvette was used equipped with a stirring bar. Samples were only carefully
stirred. Pyr-C12 was diluted from a DMSO stock to 75 μM in 17.5 mM β-
cyclodextrin in a 20 mM MES 35 mM NaCl pH 6 buffer. This solution was vortexed
for 1 min and sonicated for 15 min. The obtained solution was directly used for the
titration measurements. The titrations were done by addition of increasing amounts of
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the Pyr-C12 stock to a 0.5 μM SCP-2L V83C solution in 20 mM 50 mM NaCl pH 6 
buffer. To measure the binding the emission maximum of Pyr-C12 at 378.93 nm was
followed after excitation of the tryptophans at 280nm. The emissions were corrected
for direct excitation of Pyr-C12 and dilution. The Kd was obtained as by a non-linear
curve fit using Equation 1.to the obtained data provided by measurement of the
increase in sensitised emission at 378.93 nm versus increasing Pyr-C12 concentration.
Equation 1. Equations used for curve fits to calculate Kd
2.5.5 Experiments to confirm the incorporation of the free cysteine
2.5.5.1 Bioconjugation of maleimide M1 to unique cysteine mutants of SCP-2L
A 25-50 μM solution of protein in buffer (20 mM MES 50 mM NaCl pH 6) was 
incubated with 10 equivalents maleimide M1 added from a 50 mM stock solution in
DMF. ESI-MS analysis after mixing overnight yielded a set of signals for SCP-2L
V83C corresponding to a mass of 13619.1 Da (SCP-2L V83C-M1 calculated 13619.9
Da) and for SCP-2L A100C corresponding to a mass of 13646.9 Da (SCP-2L A100C-
M1 calculated 13647.9 Da). Typically no residual free protein was observed. The
mixture was washed using a centrifugal concentrator with buffer to remove the excess
M1.
Curve fit to the equation
Y=c*((1+G0*Kd+H0* Kd-sqrt(-4*G0*H0*Kd^2+(-1-G0*Kd-H0*K)^2))/(2*a))
Obtained from
G = G0 – H0
H = H0 – HG
Kd * H G = HG
with
Y = measure fluorescence
c = constant
G = Concentration guest
H = Concentration host
H0 = Host concentration before addition of G
G0 = Total concentration of added G
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2.5.5.2 General procedure for coupling reactions with Ellman reagent
These experiments are based on a published procedure.[51] A final concentration of 0.6
mM 5,5’dithio-bis(2-nitrobenzoic acid) (Ellman’s reagent/DTNB) was added from a
20 mM stock solution in water to a 13 μM solution of protein in 0.1 ml of buffer 
solution (20 mM MES, 50 mM NaCl, pH 6). The reaction was shaken for an hour at
room temperature before analysis by LCMS (ES+). For the unique cysteine containing
proteins conversion to the TNB adducts was found, while for the modified proteins no
modification with TNB was observed.
2.5.5.3 Tryptic Digests
The samples (5 μL, 10 pmoles/μL) were dialysed against buffer (50 mM ammonium 
bicarbonate pH 8.0) using a membrane filter (Millipore, Billerica, MA). Trypsin (0.5
μL, 0.1 μg, Promega, Madison, WI) was added to the resulting solutions. The 
solutions were incubated at 37C overnight and the digested solution (0.5 μL). This 
solution together with an alpha-cyano-4-hydroxycinnamic acid matrix (0.5 μL, 10 
mg/mL in 50:50 acetonitrile:0.1% TFA) and 0.1% TFA (0.5 μL) was applied to the 
MALDI target, and after being allowed to dry, analyzed by MALDI-MS.
MALDI MS was acquired using a 4800 MALDI TOF/TOF Analyser (Applied
Biosystems, Foster City, CA) equipped with a Nd:YAG 355 nm laser and calibrated
using a mixture of peptides. The samples were initially analysed in positive MS mode
between 800 and 4000 m/z, by averaging 1000 laser shots. The most desired peptides
were selected for MSMS analysis and acquired to a maximum of 3000 laser shots or
until the accumulated spectrum reached a S/N ratio of 35. All MS/MS data were
acquired using 1 keV collision energy.
The combined MS and MSMS data were analysed, using GPS Explorer (Applied
Biosystems) to interface with the Mascot 2.1 search engine (Matrix Science, London,
UK), against the UniProt (Swiss-Prot and TREMBL combined) database (April
2009). No species restriction was applied. The data were searched with tolerances of
100 ppm for the precursor ions and 0.5 Da for the fragment ions, with trypsin as the
cleavage enzyme, assuming up to one missed cleavage, carbamidomethyl
modification of cysteines as a fixed modification and methionine oxidation selected as
a variable modification. The depicted peptides were the only peptides found matching
maleimide (including +18) modification.
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In the above experiment an active search was performed for other peptides with the
same modification but no evidence for those was found. In addition, the samples were
analysed by ESI where again no evidence was found for other peptide sequences
containing the modification. For ESI analysis the peptides were acidified with TFA
and then separated using an UltiMate nanoLC (LC Packings, Amsterdam) equipped
with a PepMap C18 trap & column, using a 60 min gradient of increasing acetonitrile
concentration, containing 0.1 % formic acid (5-35% acetonitrile in 35 min
respectively, 35-50% in a further 20 min, followed by 95% acetonitrile to clean the
column). The eluent was sprayed into a Q-Star XL tandem mass spectrometer
(Applied Biosystems, Foster City, CA) and analysed in Information Dependent
Acquisition (IDA) mode, performing 1 sec of MS followed by 3 sec MSMS analyses
of the 2 most intense peaks seen by MS. These masses are then excluded from
analysis for the next 60 sec. MS/MS data for doubly and triply charged precursor ions
were converted to centroid data, without smoothing, using the Analyst QS1.1
mascot.dll data import filter with default settings. The MS/MS data file generated was
analysed using the Mascot 2.1 search engine (Matrix Science, London, UK) against
an internal database containing the protein sequence of interest. The data were
searched with tolerances of 0.2 Da for the precursor and fragment ions, with trypsin as
the cleavage enzyme and allowing for one missed cleavage. Maleimide M1
modification of cysteine and lysine and the oxidation of methionine were selected as
variable modifications.
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Chapter 3. Phosphine-protein conjugates
The development of an efficient modification procedure of unique
cysteine SCP-2L templates with phosphine ligands
3.1 Abstract
In this chapter, strategies are explored for cysteine selective modification of the SCP-
2L templates described in chapter 2 with phosphine-ligands. A reported modification
procedure using carboxylic acid modified phosphines was found to be unselective and
two-step procedures using the copper catalysed Huisgen 1,3-dipolar cycloaddition and
a light induced 1,3 dipolar cycloaddition were found to be inefficient. A two-step
procedure involving introduction of a hydrazide via maleimide linkage followed by
hydrazone bond formation with phosphine aldehydes proved highly selective and
efficient, and several phosphine moieties were successfully introduced using this
methodology. This is the first generally applicable and effective bioconjugation
procedure for phosphine-ligands to proteins. The conjugation products were analysed
by LC-MS and 31P-NMR to study the modification products. The cysteine selectivity
of the reactions was confirmed by analysis of the products of tryptic digestion of the
protein and by the application of Ellman reagent. The effects of the modifications on
the protein fold were studied using CD-spectroscopy and watergate 1H-NMR. The
extent of the distortion to the protein structure upon modification was highly
dependent on the ligand used, but using a study with a fluorescent probe it was
demonstrated that the substrate binding capability of the protein remains largely
unaffected. This work resulted in a set of phosphine modified proteins ready for
transformation into phosphine containing artificial metalloenzymes.
The developed phosphine modification procedure has been published as a
communication in Angewandte Chemie International Edition:
P. J. Deuss, G. Popa, C. H. Botting, W. Laan, P. C. J. Kamer, Angew. Chem., Int. Ed.
2010, 49, 5315.
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3.2 Introduction
3.2.1 Phosphines as ligands in homogeneous catalysis
In chapter 1 the diversity of the various artificial metalloenzymes developed to date is
outlined. A wide variety of transition metal complexes have been introduced in a
number of different proteins, and the assemblies have been applied in a variety of
catalytic reactions, showing the versatility and promise of these systems. The
developed protein templates described in the previous chapter were specifically
chosen for the particular shape of their hydrophobic pocket and the possibilities this
offers in catalytic reactions involving linear aliphatic substrates.
Since the first report on the use of rhodium phosphine complexes as hydrogenation
catalysts,[1] phosphine-transition metal complexes have evolved to one of the most
successful types of homogeneous catalysts for industrial reactions. They have been
successfully applied in a variety of reactions like hydroformylation, hydrogenation,
hydrocyanation, oligomerization and cross-coupling reactions.[2] Phosphine transition
metal complexes are renowned for their tunability of their activity and selectivity by
applying small changes to the ligand structure.[3] Thus, such complexes are a very
attractive class of catalysts for the development of artificial metalloenzymes via
introduction into our unique cysteine bearing protein template.
3.2.2 Phosphine containing artificial metalloenzymes
Phosphine transition metal complexes have already been successfully applied in
artificial metalloenzymes. Whitesides successfully employed a supramolecular
assembly of avidin with a biotin modified rhodium diphosphine complex in the
enantioselective hydrogenation of prochiral alkenes (Figure 1a).[4] This system was
later optimized in the groups of Ward[5] and others[6], demonstrating that combining
chemical and biomolecular techniques is a very effective approach for hybrid catalyst
optimization. Ward applied the same approach to create phosphine based artificial
metalloenzymes for the palladium catalysed asymmetric allylic alkylation.[7] Another
very interesting system is the use of monoclonal antibodies generated against
compound CA (Figure 1b).[8] A combination of this rhodium diphosphine and one
such antibody resulted in a very enantioselective hydrogenation catalyst. Reetz
covalently attached the same diphosphine moiety to lipases via a phosphonate
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linkage; however the formed phosphonate bond proved hydrolytically unstable
(Figure 1c).[9]
Figure 1, a) Diphosphine systems based on the supramolecular anchoring of modified
biotin to avidin b) Catalyst system based on monoclonal antibodies raised against
diphosphine complex CA c) Diphosphine ligand covalently linked to a lipase by
phosphonate linkage to serine 77.
All the assembly approaches outlined above have the disadvantage that only specific
proteins can be used. In our approach a free choice of the protein structure is desired
in order to be able to choose the protein based on specific characteristics like affinity
for a substrate of choice. This is why we opt for the phosphine transition metal
complex to be covalently and site selectively introduced. Such a covalent
modification approach has already been applied to DNA.[10] Phosphines were
successfully introduced into DNA by site selective modification of amine modified
oligonucleotides using N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (EDC)/ N-
hydroxysuccinimide (NHS) activated carboxylic acid phosphines. Unfortunately these
systems have so far proved difficult to employ in catalysis.[11]
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3.2.3 Site selective introduction of phosphine ligands into proteins
We decided to use selective cysteine bioconjugation for the site selective covalent
introduction of transition metal binding ligands. A variety of methods for cysteine-
selective bioconjugation has been developed,[12] but selective cysteine modification of
proteins with phosphines using such techniques has proven anything but
straightforward.[13] Unprotected phosphines containing a maleimide or iodo-alkane
cannot be synthesized because of the nucleophilic character of the phosphine, leading
to the formation of phosphonium salts and phosphorus ylides.[14] Disulfide-bridge
formation is also incompatible with free phosphines because free phosphines are
known to reduce this bond.[15] Copper catalysed or copper free Huisgen 1,3-dipolar
cycloadditions have proven very successful in protein modification,[16] but azides are
incompatible with free phosphines as demonstrated by the Staudinger reaction[17],
which in fact has been employed for biofunctionalisation.[18] Our group has
introduced borane protected phosphine maleimides in different proteins, however
subsequent attempts at deprotection using various methods proved unsuccessful or
ineffective.[13b] Several other transition metal catalysed reactions have been applied in
protein modification,[16b, 19] however the phosphine ligand to be introduced can
interfere with the reaction and/or complicate transition metal removal following the
coupling reaction. Because a generally applicable method for the cysteine-selective
covalent modification of proteins with phosphines was lacking, we have explored
several different approaches towards such a method.
3.3 Results and discussion
3.3.1 Bioconjugation using CDI activated phosphino-carboxylic acids
3.3.1.1 Modification of SCP-2L V83C using CDI activated carboxylic acid
containing mono and diphosphines
Recently our group selectively functionalized the cysteine of photoactive yellow
protein using 1,1-carbodiimidazole (CDI) activated carboxylic acid bearing
phosphines.[20] This is a straightforward procedure as carboxylic acid bearing
phosphines are commercially available or can be readily synthesised. The carboxylic
acid is activated with CDI, a reaction that can be monitored with 31P-NMR. The
obtained (crude) imidazolide solution is added upon completion of the activation
reaction to the unique cysteine bearing protein template. This results in highly
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selective and efficient thioester bond formation with the cysteine of PYP. We
investigated whether we could apply the same method for the modification of the
SCP-2L V83C template described in chapter 2. Phosphine carboxylic acids C1-C8
were used for modification reactions using conditions similar to those established for
PYP (Scheme 1, Table 1).[20b] The modification of PYP was successfully performed at
pH 8, although the primary amine of lysines present in proteins are expected to act as
nucleophiles at this pH. Modification of lysines was found to be a problem when this
method was applied to other unique cysteine containing proteins used in our
group.[13b] A 20 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) pH
7 buffer was used for the modification reactions to decrease the reactivity of the
lysines.
Scheme 1. Reaction of unique cysteine of SCP-2L V83C with CDI activated
carboxylic acids C1-C8.
Conversion to mono modified SCP-2L V83C was found to be low using up to 5
equivalents of CDI activated carboxylic acids (entries 1-5). It was attempted to
improve the conversion by increasing the excess of CDI activated carboxylic acids
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give, however this gave rise to double, triple and even quadruple modification (entries
6-10 and 12). Experiments were also performed at lower pH by using a 20 mM 2-(N-
morpholino)ethanesulfonic acid (MES) pH 6.6 buffer, however the same modification
patterns were obtained for the modification of SCP-2L V83C. The use of an even
lower pH (<6.5) resulted in very little or no modification. For ligands C6 and C8
remarkably low conversion was found even with high excesses of ligand (entries 11
and 13).







(%) 2x (%) 3x (%) 4x (%)
1 C1 5 69 24 4 3 -
2 C2 5 65 30 4 - -
3 C3 5 32 55 8 2 1
4 C5 5 97 3 - - -
5 C7 5 93 7 - - -
6 C2 10 41 46 13 - -
7 C1 20 72 22 4 2 -
8 C2 20 18 51 26 4 -
9 C3 20 14 52 22 10 2
10 C5 20 61 38 1 - -
11 C6 20 93 7 - - -
12 C7 20 62 31 7 - -
13 C8 20 88 12 - - -
14 C4 20 12 88 - - -
a) Conditions: 15 μM SCP-2L V83C, 5-20 equivalents of CDI activated carboxylic 
acid phosphines (from 25 mM stock in DMF) in 20 mM HEPES pH 7 buffer. Product
formation (%) determined by signal ratio in mass spectroscopy (ES+).
It is well known that cysteine containing proteins may form dimers via disulfide
bridge formation rendering bioconjugation to these cysteines ineffective.[21] However,
addition of various amounts of the commonly used disulfide bridge reducing agent
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tris(2-carboxyethyl)phosphine (TCEP)[22] (1-100 eq.) to the conjugation reactions did
not improve the conversion or selectivity of the reaction. In addition, no proof for the
formation of dimers was observed upon LCMS(ES+) analysis demonstrating that this
protein does not readily form dimers. Using EDC as an alternative activator for the
carboxylic acids resulted in even poorer selectivity.
These results prove that other amino acid side chains get modified in these reactions
using CDI activated carboxylic acid phosphine for cysteine modification. The extent
of the formation of multiple-modification products is determined by the excess and
nature of the phosphine used. These results show that the chemoselectivity of the
conjugation reaction is low, in line with results obtained with other unique cysteine
bearing proteins used in our group.[13b] Low cysteine-selectivity of the CDI-
methodology can be expected as activated carboxylic acids are generally used for
lysine specific protein modification.[8] PYP, whose cysteine is also used in vivo for
modification with a cofactor via thioester formation, seems exceptionally suited for
cysteine-selective bioconjugation with carboxylic acids.
Interestingly, the most intense signal for the modification products found upon LCMS
(ES+) analysis was typically of protein containing non oxidized phosphine(s) even
though the conditions under which the mass-spectra are obtained are not oxygen free.
In addition, a small signal (5-20%) of +16 mass units compared to the expected
modification is usually observed. Although this signal corresponds to the oxidation of
the phosphine, a signal with an increase mass of 16 Da is also present for the protein
not containing the phosphine and is most likely the result of methionine oxidation,
which is a commonly observed phenomenon in mass spectroscopy on proteins.
3.3.1.2 Bioconjugation of CDI activated C4
Interestingly CDI activated carboxylic acid C4 did give very high mono modification
using 20 equivalents ligand at pH 7 (Table 1 entry 14). For this particular ligand better
conversion and reproducibility were obtained using a 20 mM MES buffer of pH 6.6.
LCMS(ES+) analysis of mixtures of modified and unmodified protein showed that the
unmodified protein ionizes about five times better than the modified, indicating that
the conversion to the mono modified protein is in fact higher than 95%. Using 31P-
NMR it was demonstrated that the C4 can be introduced without oxidation of the
phosphines, which is very important for application of these phosphine containing
Chapter 3. Phosphine-protein conjugates
Artificial Metalloenzymes; Modified Proteins as Tuneable Transition Metal Catalysts 101
proteins as artificial metalloenzymes (see appendix A3). However, since the other
reactions involving CDI activated carboxylic acid ligand presented above, clearly
appeared unselective, the question remained if this modification is exclusive to the
cysteine. Determining the selectivity of the reaction by analysis of tryptic digest of the
protein proved troublesome, as the conditions used for this led to hydrolysis of the
thioester bond. However, upon the reaction of wild-type SCP-2L with 5 equivalents of
C4 the same extent of mono modification was found as for SCP-2L V83C (Table 2).
This experiment was performed at pH 6.6 (compared to 7 for above experiments)
where cysteine modification should be more selective. Thus, this result demonstrates
that the modification of SCP-2L V83C with ligand C4 is clearly unselective for the
cysteine. The reason for this apparent selective mono modification might be the result
of protein instability after modification with two or more ligands causing it to
precipitate and not appear in LCMS(ES+) analysis of the soluble fraction of the
modification reaction. This also explains the low amount of soluble protein (~10%)
measured in solution after the coupling reaction and subsequent concentration and
washing steps. Nonetheless, several experiments were performed to study the effect of
the modification of C4 on the protein fold (see appendix A3).
Table 2. Bioconjugation of CDI-activated C4 to SCP-2L (WT) and SCP-2L V83C.a
# SCP-2L mutant Cofactor Equivalents Conversion (%)
1 WT C4 1 17
2 WT C4 5 23
3 V83C C4 1 21
4 V83C C4 5 32
a) Conditions: 15 μM protein solution, 1-5 equivalents of activated CDI activated 
carboxylic acid phosphine C4 (from 25 mM stock in DMF) in 20 mM MES pH 6.6
buffer. Product formation (%) determined by signal ratio in mass spectroscopy (ES+).
In the above experiments it was demonstrated that using CDI activated carboxylic
acids to selectively functionalize the unique cysteine in SCP-2L V83C was
unsuccessful. Especially the modification of other amino acid residues hinders
application of the resulting conjugates as well-defined phosphine modified artificial
metalloenzymes. Another method for selective introduction of phosphines that is
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applicable to unique cysteine containing SCP-2L mutants and other such protein
templates had to be developed.
3.3.2. Modification using two-step conjugation procedures
3.3.2.1 Advantages of a two-step modification procedure
Because most common single step modification procedures for bioconjugation to a
unique cysteine[12] proved incompatible or ineffective for introduction of phosphines
we started looking for possible modification procedures employing two-steps. In a
two step procedure a functionality can be introduced that can be specifically modified
in a second step with a phosphine moiety. This gives the opportunity to select a
method for the second modification step that is compatible with phosphines. For the
first step standard cysteine bioconjugation techniques can be employed to introduce a
new functional group that will be selectively modified in the subsequent step. It is
important that both reaction steps are “click” type reactions where no side products
are formed.
3.3.2.2 Huisgen copper catalysed 1,3-dipolar cycloaddition
In our group we did try to employ a two step modification process using modification
by the copper catalysed Huisgen 1,3-dipolar cycloadditions. Maleimides M2[23] and
M3[24] (Scheme 2) were easily introduced into SCP-2L V83C using standard
conditions for maleimide modification described in section 2.3.3.4.
Scheme 2. Maleimide azide and alkyne cross linkers M2 and M3 for subsequent
copper catalysed Huisgen 1,3-dipolar cycloaddition reactions at the azide or alkyne
(red) to azide or alkyne containing phosphines K1-K3.
However, the subsequent copper catalysed reaction with the protein conjugates using
borane protected phosphines K1-K3 was unsuccessful.[13b] This reaction had the
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additional disadvantage of the incompatibility of phosphines with azides. Because of
this the phosphine has to be introduced as a borane protected phosphine.[25] In our
group we found that general procedures for phosphine deprotection on the phosphine
were ineffective.[13b] These results demonstrated that a second reaction compatible
with free phosphines is essential, thus we refined our search for a suitable
modification procedure to such reactions.
3.3.2.3 UV mediated 1,3-dipolar cycloaddition
Recently a novel method for the site-selective modification of proteins was
reported,[26] which uses a 1,3-dipolar cycloaddition between an alkene and an in situ
photogenerated nitrile imine (Scheme 3).[27] UV-light activates a tetrazole to form the
nitrile imine intermediate after loss of dinitrogen. This intermediate reacts with
alkenes to form the pyrazoline product. Lin et al reported bioconjugation of a range of
compounds to proteins by introduction of either the alkene or the tetrazole into the
protein using standard conjugation procedures and a subsequent photo induced 1,3-
dipolar cycloaddition. [26, 28] An additional advantage of the reaction is that the formed
pyrazoline products are fluorescent, which allows for easy identification on SDS-
PAGE when subjected to UV-light. The mild conditions and the large reported
functional group compatibility of this reaction prompted us to investigate the
possibility to use this reaction for our purpose of introducing phosphines in to
proteins. In order to apply this reaction to our protein templates we set out to
introduce an alkene functional group into our proteins.
Scheme 3. Overview of the photoinducible 1,3-dipolar cycloaddition between
tetrazoles and alkenes.
The first procedure we investigated for introducing an alkene into our unique cysteine
containing protein was the procedure using O-mesitylenesulfonylhydroxylamine
(MSH) to convert cysteine (Cys) into dehydroalanine (Dha) as reported by the group
of Davis (Scheme 4).[29] Several oxidative procedures for conversion of cysteine to
Dha have been previously reported[30] but this procedure has the advantage that it does
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not oxidize methionines, which can cause protein destabilization. In addition, this
procedure allows for a very short linker between the protein and the phosphine, which
is desired to be able to control the localization of the phosphine inside the protein.
However, after the incubation of SCP-2L V83C with 50 to 200 equivalents of MSH
no change to the protein was observed upon LCMS(E.S+) even after an overnight
reaction at room temperature. Reactions at different pH (7.5 and 8.5) and in MES (pH
6.5) buffer gave no indication of any product formation either. Also for other proteins
used in our group this reaction was found to be ineffective. The exposed nature of the
cysteine in the protein used by Davis could play an important role in the reaction. This
makes this procedure unsuitable as in all proteins used in our studies the cysteines are
located in hydrophobic cavities.
Scheme 4. Selective formation of dehydroalanine (Dha) from cysteine using O-
mesitylenesulfonylhydroxylamine (MSH).
Scheme 5. Modification of SCP-2L V83C via alkene containing maleimide M4
followed by photoinduced 1,3-dipolar cycloaddition of tetrazoles T1 and T2 with the
obtained SCP-2L V83C-M4.
An alternative approach for the introduction of an alkene involved the introduction of
allyl-maleimide M4, synthesised in our group.[31] Using standard conditions for
Chapter 3. Phosphine-protein conjugates
Artificial Metalloenzymes; Modified Proteins as Tuneable Transition Metal Catalysts 105
bioconjugation of maleimides to cysteine full conversion to the expected modification
product was observed by mass spectroscopy (found 13513.3 Da, calculated 13513.7
Da) (Scheme 5). As a model reaction for modification of the alkene modified protein
the 1,3-dipolar cycloaddition was performed using phenyl bromide substituted
tetrazole T1,[32] which served as a precursor in the synthesis of T2.
Figure 2. The SDS-PAGE analysis of the reaction between modified SCP-2L V83C-
M4 and tetrazoles T1 and T2 using gel staining and UV-light.
An overnight reaction with modified SCP-2L V83C-M4 and tetrazole T1 with
excitation at 320, gave rise to an emission band at 450 nm. This emission band was
assigned to the product using literature data.[26] The intensity of this band increased
slowly over 6 hours after which reaction progress seemed to have ceased. Mass-
spectroscopy after the reaction did show a signal with the expected mass for the
pyrazoline product (calculated m/z 13785.6; found m/z 13783.2), however, this signal
was very weak. SDS-PAGE gel did show a fluorescent band at the position of the
protein band when exposed to UV-light using a hand-held UV-lamp, indicating
modification of the protein (Figure 2 lanes 1-4). Performing the reaction with the
phosphine modified tetrazole T2 also gave rise to an emission band at 450 nm.
Although, analysis of SDS-PAGE confirmed the presence of the pyrazole modified
protein, unfortunatly no signal for the modified protein was found by mass-
spectroscopy. SDS-PAGE gel showed that the intensity of the fluorescent band for the
reaction with T2 (Figure 2 lane 6) is lower than that obtained for the reaction with T1
(Figure 2 lane 4).
#1 #2 #3 #4 #5 #6
Lane # Contents Analysis
1 SCP-2L V83C-M4 Gel stain
2 SCP-2L V83C-M4 UV-light
3 SCP-2L V83C-M4 + T1 Gel stain
4 SCP-2L V83C-M4 + T1 UV-light
5 SCP-2L V83C-M4 + T2 Gel stain
6 SCP-2L V83C-M4 + T2 UV-light
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In summary, it appears that the protein can be modified with the phosphine modified
tetrazole, but the conversion was low. Attempts to improve the conversion by addition
of more tetrazole only resulted in increased protein precipitation and formation of a
product with an emission band at 370 nm, which is attributed to the product of the
reaction between the nitrile imine intermediate and water, as reported in literature.[26]
It seems that modification of the protein can be achieved using this approach applying
a 1,3-dipolar cycloaddition reaction, however the low conversion and formation of
side products and protein precipitate render this procedure unsuitable for the
formation of phosphine modified proteins.
3.3.3 Introduction of phosphines via hydrazone formation between
hydrazide modified proteins and phosphine aldehydes
Another reported efficient method for bioconjugation is hydrazone linkage between a
hydrazide and an aldehyde.[33] This reaction is often used for protein cross-linking and
also for aldehyde detection.[14, 34] Importantly, this reaction has been reported to be
compatible with phosphines.[35] The syntheses of various phosphine aldehydes have
been reported and several are even commercially available.
Scheme 6. Modification of SCP-2L through hydrazone formation and subsequent
hydrazone formation using phosphine aldehydes.
To exploit this reaction using phosphine aldehydes the hydrazide has to be introduced
into the protein. Maleimide-hydrazides are often used as cross-linkers and several are
commercially available. This allows for the approach outlined in Scheme 6. In this
approach the hydrazide is site selectively introduced by modification of the unique
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cysteine by maleimide addition, which was shown before to be very efficient. In a
second step the phosphine aldehyde is reacted with the hydrazide to obtain the
phosphine modified protein.
3.3.3.1 Modification of proteins using hydrazide-maleimide cross linker M5
The first step of the modification sequence was performed using 3-
maleimidopropionic acid hydrazide hydrochloride M5, a commercially available
cross linker often used for bioconjugation (Scheme 7).[33, 34b] Full conversion was
observed upon LCMS(ES+) analysis of the reaction mixture obtained after overnight
mixing of a solution of SCP-2L V83C with 10 equivalents M5 (see Figure 4 for an a
representative mass-spectrum). Complete modification could be achieved with as little
as three equivalents of the maleimide M5 and reaction times of several hours on nmol
scale. However it was found that especially at large scale the reaction should be
monitored by mass-spectroscopy as reaction times can be long (up to three days at a 5
μmol scale). The reaction rate could be greatly increased by using up to 20 
equivalents of M5. As for the model maleimide reactions described in chapter 2
section 2.4.3.4, the modification of the cysteine was confirmed using Ellman’s
reagent followed by analysis with mass spectroscopy (ES+).[36] The reaction proved to
be equally effective for the SCP-2L A100C mutant providing quantitative
modification to the hydrazide modified proteins.
Scheme 7. Modification of unique cysteine bearing SCP-2L templates V83C and
A100C with 3-maleimidopropionic acid hydrazide hydrochloride M5.
Th effect of the modification of SCP-2L A100C and V83C with M5 on the folding of
the protein was investigated by CD spectroscopy (Figure 3). The near UV CD spectra
of the A100C mutant before and after modification appear to be nearly identical,
showing that the modification does not have a significant influence on the protein
fold. The spectrum of the V83C mutant after modification does show a slight increase
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of the signals around 287 and 294 nm, meaning that some residues that cause negative
signals in that area are affected by the modification. Also a slight rise in the intensity
of the signal from 250 to 260 nm can be observed upon modification of SCP-2L
V83C with M5. This signal increase can be caused by a partial loss of the α-helical 
structure of which the cysteine at position 83 is a part. The α-helical structures give a 
strong negative signal in the area of 190-240 nm (explained in more detail in section
2.4.3). Overall the major part of the structure seems to be retained indicating that the
modification of the SCP-2L mutants with M5 does not cause the protein fold to
change significantly. This can be explained by the hydrophilicity of the ligand causing
it to point outward into the solution and consequently not disturbing the inner
structure of the protein.














Figure 3. Near UV CD spectra of SCP-2L V83C (black), SCP-2L A100C (red), SCP-
2L V83C-M5 (blue) and SCP-2L A100C-M5 (green).
Hydrazide modified SCP-2L V83C (SCP-2L-V83C-M5) was reacted with fluorescent
1-pyrenecarboxaldehyde A1 to test the second step of the modification procedure and
be able to quantify the product formation using fluorescence (Scheme 8). Although
A1 is insoluble in water, analysis of the soluble fraction, obtained after centrifugation
of the modification reaction, by LCMS(ES+) did show almost full conversion to the
hydrazone linked adduct (expected 13771.7 Da, found 13772.1 Da). The signal of the
hydrazide modified protein (SCP-2L V83C-M5) was also still present. The overall
signal to noise ratio was very low which was attributed to the considerable amount of
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protein lost by precipitation. The formation of the precipitate hindered quantification
of the reaction progress using fluorescence. Nevertheless, the coupling reaction was
successful which showed promise for the modification with phosphine-aldehydes.
Scheme 8. Modification of SCP-2L V83C-M5 with 1-pyrenecarboxaldehyde A1.
3.3.3.2 Modification of SCP-2L V83C-M5 using a commercially available
phosphine aldehyde P1
A test reaction was also performed with the commercially available 2-diphosphino
benzaldehyde P1[37] using SCP-2L V83C-M5 (Scheme 9). This phosphine is not
water soluble and was added to the protein solution from a concentrated solution in
DMF to obtain a suspension. Full conversion to the phosphine modified protein was
achieved after overnight mixing (LCMS (ES+) analysis, expected 13831.74 Da, found
13832.06 Da, Figure 14).
Scheme 9. Conjugation of 2-diphenylphosphino benzaldehyde P1 to SCP-2L V83C-
M5.
The obtained signal had a very good signal to noise ratio and only a small amount of
protein precipitate was observed. The main signal observed corresponded to the
modification with the free phosphine even though no precautions were taken to
exclude oxygen. An added advantage of this method was that the excess phosphine
could be readily removed by centrifugation due to the insolubility of the phosphine in
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water. This result showed the first and only very efficient covalent phosphine
modification reaction for the created unique cysteine SCP-2L template so far.
3.3.3.3 Synthesis of phosphine aldehydes
To get further insight into the general applicability of the hydrazone methodology to
synthesise phosphine modified proteins for the development of artificial
metalloenzymes, we synthesised additional phosphinoaldehydes. The synthesis of 3-
diphenylphosphino benzaldehyde P2[38] and 4-diphenylphosphino benzaldehyde P3[39]
was successful using procedures reported in literature outlined in Scheme 10. The
meta substituted diphenylphosphino benzaldehyde was synthesised by selective
monolithiation of one bromide of 1,3-dibromobenzene and quenching with
chlorodiphenylphosphine to introduce the phosphine and reaction with DMF after a
second lithiation to introduce the aldehyde.[38] Both steps proceeded with good yields,
but unfortunately P2 was obtained as a yellow oil which proved hard to handle
because of sensitivity to oxygen. The para substituted diphenylphosphino
benzaldehyde was synthesised through an elegant procedure involving substitution of
2-(4-bromophenyl)-1,3-dioxolane with chlorodiphenylphosphine by lithiation
followed by acid catalysed deprotection of the ketal to the aldehyde.[39] The products
of the first and second steps could be crystallized and were obtained in reasonable
yields. The phosphine P3 was obtained as a white crystalline solid which could be
used and stored under aerobic conditions which make them much easier to handle
compared to P2.
Scheme 10. Synthetic strategy for the synthesis of phosphine aldehydes P2[38]and
P3.[39]
Inspired by the work of Whitesides[40] and others[5a, 6-7] two aldehyde variants P4 and
P5 containing the bis[2-(diphenylphosphino)ethyl]amine motif were synthesised. This
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motif was shown to be very effective as it is very flexible and can easily be influenced
by the protein environment to potentially give good enantio selectivity in asymmetric
catalysis.[4, 6] The two aldehydes containing diphosphine P4 and P5 were synthesised
using the strategies as outlined in Scheme 11.
The diphosphine variant containing the aliphatic aldehyde linker P4 was synthesised
by coupling the protected aldehyde 3-(2-dioxolanyl)propionic acid I1 to the secondary
amine of the bis[2-(diphenylphosphino)ethyl]amine I2 motif which was synthesised
through a literature procedure by the reaction of N,N-bischloroethylamine and
lithiodiphenylphosphine.[40-41] 3-(2-dioxolanyl)propionic acid I1 was also synthesised
through a literature procedure involving quenching of the Grignard of 2-(2-
bromoethyl)-1,3-dioxolane with crushed dry ice. The product was obtained in very
pure form by using a vacuum distillation providing I1 as crystals with a melting point
close to room temperature (see appendix A5.1 for crystal structure). The coupling
reaction using isobutylchloroformate (iBCF) to form protected phosphine aldehyde I3
gave the product in a moderate yield. During column chromatography the main side
product was isolated and found to be the bis[2-(diphenylphosphino)ethyl]amine
modified at the amine with an isobutylformate group (see appendix A6 for NMR
data). It appeared that the low yield is caused either by the similar reactivity of the
two carbonyls in the anhydride intermediate or by incomplete conversion of the I3 to
the anhydride, which caused the isobutylchloroformate to react directly with bis[2-
(diphenylphosphino)ethyl]amine. The use of other reagents for the coupling reaction
like dicyclohexylcarbodiimide (DCC) should circumvent this problem and give higher
product yield. The deprotection of I3 gave the desired phosphine aldehyde P4 in good
yield.
Another diphosphine aldehyde derivative based on bis[2-(diphenylphosphino)ethyl]
amine containing a benzaldehyde linker P5 was synthesised. This compound was also
synthesised via coupling of an acid containing a protected aldehyde to the bis[2-
(diphenylphosphino)ethyl]amine I2 motif followed by removal of the ketal to form
the aldehyde. The protected aldehyde 4-(1,3-dioxolan-2-yl)benzoic acid I3 was
synthesised from 4-formylbenzoic acid by mixing with ethylene glycol in a Dean-
Stark setup according to a literature procedure.[42] A short reaction time and the
saponification before the work-up were found to be essential to get the product pure
and in high yield. For the amide formation reaction with I2 DCC was used to get the
protected diphosphine aldehyde I4 in good yield. Deprotection of the ketal was very
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efficient for this compound providing the aldehyde in quantitative yield. Both
diphosphine aldehydes P2 and P3 were obtained as a white gum which is very oxygen
sensitive and needed to be stored under inert atmosphere.
Scheme 11. Synthesis of aldehyde phosphines P4 and P5.
Nixantphos[43] aldehyde derivative P6 was also synthesised. Wide bite angle xantphos
derivatives are well known and successful phosphine ligands for reactions like
hydroformylation[43-44], allylic substitution[45] and Buchwald Hartwig amination.[46]
This diphosphine ligand motif is very rigid, which means that unlike diphosphine
aldehydes containing bis[2-(diphenylphosphino)ethyl]amine P4 and P5, little
influence of the protein on the native selectivity of P6 in catalytic reactions is
expected. P6 was synthesised by introduction of a protected aliphatic aldehyde
through modification of the secondary amine of commercially available 4,6-
bis(diphenylphosphino)phenoxazine (nixantphos) I6 with commercially available 2-
(3-chloropropyl)-1,3-dioxolane I7 (Scheme 12). The secondary amine of nixantphos
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can not easily be functionalised using carboxylic acids due to the weak nucleophilic
character. However it has been reported that the nitrogen can be substituted by
deprotonation followed by addition to alkylchlorides.[43-44] Deprotonation with sodium
hydride and subsequent reaction with 2-(3-chloropropyl)-1,3-dioxolane I7 was
achieved in excellent yield following this procedure. The deprotection of the ketal I8
(see appendix A5.2 for crystal structure) to the aldehyde diphosphine ligand P6 was
also successful however as for the above ligand containing the aliphatic aldehyde P4
it proved not very high yielding.
Scheme 12. Synthesis of aldehyde containing nixantphos derivative P6.
3.3.3.4 Modification of hydrazide modified proteins using phosphino aldehydes
The successful test reaction between P1 and SCP-2L V83C-M5 was extended to SCP-
2L A100C-M5 and various monophosphine benzaldehydes (Figure 4, Table 3, entries
1 - 10).
Scheme 13. Conjugation of mono- and diphosphino aldehydes to M5 modified protein
templates.
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Table 3. Results of bioconjugation of hydrazide modified proteins (Protein-M5) with
aldehydes P1-P8.[a]
Entry Protein–M5 Phosphine Calculated mass (Da) Observed mass (Da)[b]
1 V83C P1 13830.2 13830.4
2 V83C P2 13830.2 13830.8
3 V83C P3 13830.2 13829.9
4 V83C P7 13898.1 13898.1
5 V83C P8 15890.2 13906.0[c]
6 A100C P1 13858.2 13857.4
7 A100C P2 13858.2 13858.0
8 A100C P3 13858.2 13858.1
9 A100C P7 13926.1 13942.1[c]
10 A100C P8 13918.2 13934.6[c]
11 V83C P4 14065.3 14065.9[d]
12 V83C P5 14114.9 14130.1[c]
13 V83C P6 14161.8 14163.5[d]
14 A100C P4 14093.3 14092.8[d]
15 A100C P5 14142.9 14144.5
16 A100C P6 14189.8 -[e]
[a] 10 equivalents phosphine P1-P8 in 20 mM MES 50 mM NaCl buffer pH 6; full
conversion of Protein-M5 was observed unless stated otherwise [b] Main signal for
modified protein [c] Main signal corresponds to the calculated mass for the protein
containing oxidized phosphine [d] Protein-M5 observed as main signal and only weak
signal for phosphine modified Protein-M5 was found.[e] no protein signal observed.
The modification reactions were performed using a small excess (up to 10
equivalents) of the phosphino aldehydes. A concentrated solution of the phosphino
aldehyde was added to M5-modified protein under inert atmosphere to give a
suspension. Quantitative conversion to the corresponding phosphine modified
proteins was typically observed by LCMS(ES+) analysis of the soluble fraction after
overnight mixing. In addition to the phosphino aldehydes P1-P3, the more electron
rich phosphino aldehyde P7 and electron poor phosphino aldehyde P8 were
successfully coupled to both SCP-2L mutants (Table 3, entries 4, 5, 9, 10). For all
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phosphines the excess of insoluble phosphine aldehyde ligands was easily removed by
centrifugation to allow further use of the phosphine modified protein. Generally the
protein solution was also washed with degassed buffer in a centrifugal concentrator to
remove potential trace amounts of dissolved ligand. The yield of modified protein was
typically around 90% according to analysis of the modification reactions by Bradford
assays. However when a large excess phosphine (over 20 equivalents) is added or if a
protein concentration of over 3 mg/ml is used the yields are typically lower due to
protein precipitation.
Figure 4. Processed mass-spectra (ES+) of SCP-2L V83C (Red), SCP-2L V83C-M5
(Blue) and SCP-2L V83C-M5-P3 (Green) (Copyright Wiley-VCH Verlag GmbH &
Co. KGaA. Reproduced with permission).[47]
An additional signal, which was 16 mass units higher than the modified protein
signals shown in Table 3 was also observed in the mass-spectrum of several
phosphine conjugates (Figure 4). Typically, this signal has an intensity of 20-40%
compared to the signal corresponding to the phosphine modified protein. This signal
corresponds to the mono oxidized protein, which indicates possible phosphine
oxidation. However, a similar signal of +16 mass units is also observed in the spectra
of the unmodified and the hydrazide modified proteins, which indicates that this
signal might not be the result of a significant amount of phosphine oxidation, but most
likely corresponds to methionine oxidation, a phenomenon often observed in mass
spectroscopy of proteins. The phosphine oxide was found to be the most intense
signal for reactions with phosphines P7 and P8. These phosphines were most likely
Chapter 3. Phosphine-protein conjugates
Artificial Metalloenzymes; Modified Proteins as Tuneable Transition Metal Catalysts 116
oxidized by prolonged exposure of the sample for LCMS to air or oxidation in the
ionization chamber.
Figure 5. 31P-{1H}-NMR spectrum of SCP-2L V83C-M5-P3 (red) with the red insert
showing a magnification of the area between 4 and –2 ppm with a comparison to the
31P-{1H}-NMR spectrum of SCP-2L V83C (blue) and the blue insert showing a
magnification of the area between –1 and –9 ppm.
The 31P-NMR spectrum of SCP-2L V83C modified with P3 shows broad signals in
the range of –2 to –8 ppm (Figure 5). These are typical chemical shifts for a free tri-
aryl phosphine, thus confirming that this modified protein contained a phosphine
which was not oxidized. The signals appear to consist of at least two overlapping
broad signals. This set of signals might result from the presence of different
conformations of the conjugates, caused by either the imine bond, the chiral centre
formed by the maleimide-sulfide bond or the conformation of the protein. The
possibility that the different signals originate from phosphine modification of different
amino acid side chains of the protein was ruled out by detailed analysis of trypsin
digests, which showed only modification of the expected peptide fragment containing
the cysteine (Figure 6a). The found mass of this peptide fragment corresponded to the
modification of the peptide with phosphine-oxide analogue of M5-P3. MS-MS
analysis of the peptide sequence of the found signal confirmed that this signal




0.84 ppm 0.29 ppm
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fragments did not provide any indication of any other modified amino acids. In
addition, no protein modification was observed upon LCMS(ES+) analysis of the
reaction between unmodified unique cysteine SCP-2L mutants with the phosphine
aldehydes.
Expected masses for C121H179N26O38PS2
m/z: 2700.21 (100.0%), 2701.21 (83.6%),
2699.21 (74.4%), 2702.22 (29.5%)
Figure 6. a) MALDI-MS spectrum displaying obtained signal for the expected
modified peptide for digested SCP-2L V83C-M5-P3 b) MS-MS of the signal at
2700.23 showing the expected peptide sequence (Cmod stands for cysteine modified
with M5–P3).
The modification procedure shown in Scheme 13 was also performed using
diphosphines P4–P6 (Table 3, entries 11 - 16). Unfortunately, the reactions using
diphosphines P4 and P6 resulted in substantial protein precipitation which is likely
caused by instability of the formed conjugation product. The modification reaction
using diphosphine P5 containing the benzaldehyde did give the desired conjugation
product. Although a small signal corresponding to the hydrazide modified protein was
b)
K G L Cmod V E M F D E D S L I I T T D A A G
a)
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observed the conversions were found to be >95% after correction of the ES+ data for
differences in ionization efficiencies (Table 3, entries 12 and 15). It appeared that the
benzaldehyde containing phosphines were more suitable for conjugation than the
aliphatic aldehydes as the coupling-products were less prone to precipitation. Analysis
of the SCP-2L V83C-M5-P5 by Maldi MS after trypsin digestion showed a signal
corresponding to the expected modified peptide (Figure 7). The found signal
corresponded to the peptide modified with an analogue of M5-P5 containing two
oxidized phosphines. MS-MS of this signal confirmed the expected peptide sequence,
again demonstrating the site selectivity of the modification procedure (appendix A3).
Figure 7. MALDI-MS analysis of trypsin-digested SCP-2L V83C-M5-P5, displaying
obtained signal for the expected modified peptide for (MS-MS of the signal at
2999.32 showing the peptide sequence is depicted in appendix A3).
It was also demonstrated by our group that the hydrazone methodology described
above is applicable to several other unique cysteine containing proteins.[13b, 47] The
used proteins were structurally diverse, containing hydrophobic cavities of different
sizes and shapes for different applications as artificial metalloenzymes in catalytic
reactions. The hydrazone formation procedure proved successful for all these
structurally diverse unique cysteine containing proteins encountering no problems
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C138H197N27O40P2S2:
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truly generally applicable and therefore realises the prospect of the use of virtually
any unique cysteine bearing protein as phosphine containing artificial
metalloenzymes.
3.3.3.5 Structural investigation
The effect of the phosphine modifications using P3 and P5 on the folding of the
protein templates SCP-2L V83C and SCP-2L A100C was investigated by CD
spectroscopy, watergate 1H-NMR and by performing a substrate binding assay. The
near-UV CD-spectra of SCP-2L V83C-M5-P3 and SCP-2L V83C-M5-P5 were
recorded (Figure 8).
















Figure 8. CD spectra of SCP-2L V83C (black), SCP-2L V83C-M5 (red), SCP-2L
V83C-M5-P3 (blue) and SCP-2L V83C-M5-P5 (green).
The CD spectrum of unmodified SCP-2L V83C and SCP-2L V83C-M5 are also
shown for comparison, which allows for the observation of distinct differences
between this spectrum and those obtained for SCP-2L V83C-M5 with P3 and P5.
Each modification seems to affect a different area of the CD spectrum. The
modification with P3 leads to an increase in the signal around 300 nm and 250-270
nm, whereas the modification with P5 leads to a decrease of the signal in the 300 nm
area and a similar but less intense increase of the signal around 250-270 nm.
Interestingly the signal from 275 to 290 nm seems largely unaffected by the
phosphine modification compared to the M5-modification indicating that a large part
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of the structure is retained. The increase in the region from 250 to 270 nm can be
attributed to an increase in the signal due to the introduced aromatic rings being
placed in a chiral environment combined with a distortion in the α helical structures 
present in the protein causing an increase in the strong negative signal between 190-
240 nm. We were unable to perform CD spectroscopy under an inert atmosphere
making phosphine oxidation a likely event. This means that the observed spectra most
likely belong at least partially to the proteins modified with oxidized phosphines,
however oxidation of the ligands is expected to have little effect on the protein
structure.
Figure 9. Watergate 1H-NMR spectra of SCP-2L V83C (blue) and SCP-2L V83C-
M5-P3 (red) ~2 mM in 20 mM MES pH = 6 buffer a) overlay for the region between
11 and 6 ppm b) overlay for the region between 2.3 and –0.5 ppm c) full spectra,
offset for clarity.
The watergate 1H-NMR spectrum of SCP-2L V83C-M5-P3 shows that coupling of
the phosphine mainly results in broadening of the signals, but also induces several
clear changes when compared to the spectrum obtained for unmodified SCP-2L V83C
(Figure 9). Several signals around 0 ppm have shifted significantly indicating some
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changes to aliphatic residues residing in the hydrophobic core of the protein, which is
expected upon the introduction of the hydrophobic ligand.
Both the CD-spectrum and the watergate 1H-NMR spectrum indicate some significant
changes to the fold of SCP-2L V83C-M5 after modification with the phosphines P3
and P5. Changes to the structure of the protein are acceptable as long as the capability
of the protein to bind the substrates for which the protein was selected is not
significantly affected. The substrate binding capability of SCP-2L V83C-M5
modified with P3 and P5 was determined using the fluorescent binding assay
described in section 2.3.3.3. The measured Kd values for binding of Pyr-C12 were
0.24 (±0.06) μM for SCP-2L V83C-M5-P3 and 0.36 (±0.06) μM for the SCP-2L 
V83C-M5-P5. The found values are of the same order of magnitude as the Kd of 0.18
(±0.07) μM found for unmodified SCP-2L V83C. This result shows that although the 
hydrophobic core of the protein is affected by the modification the substrate binding
capability of the protein is not significantly affected by the introduction of the
phosphine-ligands.
A similar but less thorough study was performed for SCP-2L A100C-M5 modified
with phosphines aldehydes P3 or P5. The near UV CD spectra recorded of the SCP-
2L A100C mutant before and after phosphine modification show far more intense
changes to the overall signal compared to those recorded for the SCP-2L V83C
conjugates (Figure 10). Distinct changes over the whole range from 250 to 300 nm
can be observed for both P3 and P5 modifications as well as an increase in the signal
at 287 nm and in the area of 294 to 320 nm. For both modifications there is a smaller
increase at 250 nm compared to the modifications of the SCP-2L V83C mutant, which
can be explained by the fact that the cysteine at position 100 is located on the β-sheet 
structure instead of on the α helix structure (see chapter 2 for more details).This 
means that a smaller effect on the helical structure of the protein can be expected
which causes less distortion to the strong negative signal between 190 and 240 nm.
The change in signal around 260 nm can be assigned to the introduced aromatic rings
of the ligand being located in a chiral environment; however in this case giving rise to
a negative signal as opposed the positive signal observed for the modified V83C
mutant. This effect is more pronounced for ligand P3 than for ligand P5, which
indicates that P3 is located in a different environment or that one diphenylphosphine
moiety of P5 might give a positive signal which cancels out the negative signal. The
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overall signal seems to be more disturbed by the P5 modification indicating more
significant structural changes of the protein.















Figure 10. CD spectra of SCP-2L A100C (black), SCP-2L A100C-M5 (red), SCP-2L-
M5-P3 (blue) and SCP-2L A100C-M5-P5 (green)
Overall, the CD, 1H-NMR and fluorescent binding assay data show that the fold of the
proteins is definitely altered upon modification with the phosphine aldehydes. This
can be expected as the hydrophobic ligand will most likely move inside the protein,
changing the structure of the hydrophobic core of the protein. The CD spectra suggest
that this effect is greater for the A100C mutant compared to the V83C. How this
effects the stability of the protein would be an interesting subject for further research.
3.4 Conclusions and future prospects
This chapter shows a detailed exploration of several procedures for bioconjugation of
functionalised phosphines to the unique cysteine containing templates based on SCP-
2L. The cysteine-selective introduction of phosphines was found challenging due to
the incompatibility of phosphines with standard cysteine selective modification
reactions in combination with the inability to apply protected phosphines because of
ineffectiveness of deprotection procedures with proteins. The additional selectivity
problems of the CDI activated carboxylic acid methodology led to the development of
two-step procedures to circumvent these issues. This was successful by application of
cysteine-selective introduction of a hydrazide using maleimide introduction and
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subsequent modification using phosphine aldehydes. This procedure was shown to be
very selective and efficient. This modification strategy can also be applied to other
unique cysteine bearing templates, as demonstrated by the modification of two
different scaffolds with a variety of different phosphine-ligands. This methodology
can now be applied for the modification of virtually any desired unique cysteine
bearing protein with phosphines.
Further investigation is required into the formation of isomeric structures for SCP-2L
V83C-phosphine conjugates as observed in the form of multiple signals in 31P-NMR.
This is important as these isomeric structures can lead to undesired mixtures of
different catalytic species. Detailed structural investigations by NMR using
isotopically labelled proteins or X-ray crystallography will be required. The results
described in this chapter now allows for the exploration of transition metal complex




Figure 11. Application of Amicon Ultra-15 Centrifugal Filter Unit (left) under inert
atmosphere using a large Schlenk flask
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All reactions involving phosphines and other oxygen sensitive compounds were
performed under an argon atmosphere using degassed solvents and standard Schlenk
techniques. The centrifugation and washings of protein solutions under an argon
atmosphere were performed using a setup involving a large Schlenk flask (Figure 11).
Binding constants of the fluorescent probe Pyr-C12 were determined using the
method outlined in section 2.3.3.3. For processing of the mass-spectra the MaxEnt
algorithm of Masslynx V4.0 (Micromass Ltd) was used. Protein concentrations were
determined using Bradford’s reagent.[48]
3.5.1.2 Equipment
NMR spectra were taken at room temperature with Bruker Avance 300, 400 or 500
NMR spectrometers. Chemical shifts () are given in ppm for high-frequency shifts
relative to a TMS reference (1H and 13C) or 85% H3PO4 (
31P). Watergate 1H-NMR
spectra were recorded on a Bruker Avance 500 spectrometer. LC-MS(ES+) used for
analysis of protein and conjugation-reactions was performed on a Waters Alliance HT
2795 equipped with a Micromass LCT-TOF mass spectrometer, using positive
electrospray ionisation and applying a Waters MASSPREP® On-line Desalting 2.1x
10 mm cartridge using a gradient of 1% formic acid in H2O to 1% formic acid in
acetonitrile. Standard deviations were calculated manually from the raw mass data.
Spin-filter concentrators with a molecular weight cut-off of 10kDa (Amicon Ultra-
15 Centrifugal Filter Units, Millipore®, Carrigtwohill, Co. Cork, Ireland) were used to
concentrate and/or wash protein solutions. CD spectra were recorded using a Jasco J-
810 spectropolarimeter using a 1 mg/ml solution of the protein. Elemental analysis
was performed by Stephen Boyer at the elemental analysis service of the London
Metropolitan University or by Sylvia Williamson at the University of St. Andrews.
HRMS (TOF MS CI+) were recorded on the University of St. Andrews by Caroline
Horsburgh.
3.5.1.3 Materials
Chemicals were purchased in the highest commercially available purity unless stated
otherwise. 3-Maleimidopropionic acid hydrazide hydrochloride M5 and 2-
(diphenylphosphino)benzaldehyde P1 were obtained from Apollo Scientific Ltd and
Aldrich respectively. Dry DMF was purchased from Acros in a sealed bottle
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containing 4Ǻ molecular sieves and was used as received. For dry conditions freshly 
distilled degassed solvents were used. Dichloromethane (DCM) was distilled from
CaH2, triethylamine (Et3N) from lithium aluminium hydride, tetrahydrofuran (THF)
and diethylether (Et2O) were distilled from sodium/benzophenone and ethanol (EtOH)
was distilled from Mg/I2. Thin-layer chromatography (TLC) was performed on silica
(Polygram 0.2 mm silica gel with fluorescent indicator UV254) or alumina (aluminium
oxide 60 neutral with fluorescent indicator UV254) plates purchased from Merck.
Silica gel (60 particle size 0.063-0.2 mm) and aluminium oxide (90 active neutral)
purchased from Merck and Fluka were used for column chromatography. Phosphine
carboxylic acids C1 and C3 were obtained from commercial sources. Compounds
C5–C7 were synthesised by Bianca K. Muñoz and compounds C2 and C8 by René
den Heeten. Maleimide M4[31], T1 and T2 were synthesised by Gregorio Guisado-
Barrios from our group. The phosphine aldehydes 3-
(diphenylphosphino)benzaldehyde P2[39], 4-(diphenylphosphino)benzaldehyde P3[38],
N-(4-azidophenyl)maleimide M2[23] and N-(3-acetylenephenyl)maleimide M3[24] were
synthesised according to literature procedures. Phosphine aldehydes P7 and P8 were
kindly donated Piotr Wawrzyniak of the group of Dr. Matt Clark (University of St.
Andrews).
3.5.2 Modification using CDI activation of carboxylic acid phosphines
3.6.2.1 CDI activation of carboxylic acid phosphines (C1-C8)
This procedure is based on a previously reported procedure [20b] 5-10 Equivalents of
CDI was added as a solid to a 25 mM solution of the corresponding carboxylic acid
phosphine in DMF under an argon atmosphere. The reaction was stirred overnight for
16 h, after which the conversion was determined by 31P-NMR using a D2O locking
insert. The reaction-mixture was used without purification for the bioconjugation to
SCP-2L V83C.
3.5.2.2 Bioconjugation of CDI activated carboxylic acid phosphines (C1-C8) to
SCP-2L V83C
This procedure is based on a procedure reported previously by our group.[20b] A 15
μM solution of SCP-2L V83C in buffer (20 mM HEPES pH 7) was incubated with 5-
20 equivalents of the CDI activated carboxylic acid phosphine added from a 25 mM
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stock solution in DMF. Progress of the reaction was monitored using LCMS (ES+)
analysis of the soluble fraction of the reaction obtained by centrifugation and removal
of the precipitate.
3.5.2.3 Synthesis of methyl 4-(bis(2-(diphenylphosphino)ethyl)amino)-4-
oxobutanoate I9
This procedure is an optimized synthesis based on a
literature procedure.[40] 10.8 g (22.6 mmol) I2
(Synthesised according to a literature procedure)[40-41]
was suspended under argon atmosphere in a flame-
dried flask in 240 ml dichloromethane. 14.2 ml (0.1 mol) triethylamine was added to
this suspension, which resulted after stirring for several minutes in a clear solution. To
this solution was added through a dropping funnel 3.05 ml (25 mmol) methyl 4-
chloro-4-oxybutyrate in 30 ml dichloromethane over 30 minutes. The resulting
brownish solution was stirred for 16 hours at room temperature. The solution was
washe9d two times with a degassed 2 M HCl solution and once with a degassed 0.1 M
NaOH solution. The solvent was removed under reduced pressure and the residue
purified by column chromatography under argon with degassed silica and a degassed
mixture of 2% acetone in dichloromethane. After removal of the solvent 10.06 g
(18.12 mmol, 81%) 35 was obtained as an off white gum. 1H-NMR (300 MHz,
CDCl3), δ 7.37-7.2 (m, 20H, Ar-H), δ 3.60 (s, 3H, CH3), δ 3.39-3.27 (m, 2H, CH2), δ 
3.24-3.14 (m, 2H, CH2), δ 2.48 (t, 
3JHH=6.5 Hz, 2H, CH2), δ 2.26-2.12 (m, 6H, CH2),
31P-{1H}-NMR (121.47 MHz, CDCl3), δ -20.31 (1P, -PPh2), δ -21.77 (1P, -PPh2).
Corresponding to values found before in our group[49].
3.5.2.4 Synthesis of 4-(Bis(2-(diphenylphosphino)ethyl)amino)-4-oxobutanoic
acid C4
This procedure is based literature procedure.[40] Under
argon atmosphere 10.06 g (18.12 mmol) I9 was
dissolved in tetrahydrofuran. 48 ml (38.05 mmol) of a
degassed 0.8 M LiOH solution was added to the
resulting solution and the mixture was stirred at room temperature. After 1 Hour 48
ml of water was added and the tetrahydrofuran was removed under reduced pressure.
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The free acid C4 was precipitated from the solution by addition of 25 ml of a
degassed 2 M HCl solution. The mixture was filtered and dried to obtain 7.07 g (13.07
mmol, 71%) C4 as a white powder. 1H-NMR (300 MHz, CDCl3), δ 7.30-7.11 (m, 
20H, Ar-H), δ 3.29-3.16 (m, 2H, CH2), δ 3.08-2.92 (m, 2H, CH2), δ 2.30-1.80 (m, 8H, 
CH2),
31P-{1H}-NMR (121.47 MHz, CDCl3), δ -20.41 (1P, -PPh2), δ -21.84 (1P, -
PPh2). Corresponding to values found before in our group.
[50]
3.5.3 General procedure for bioconjugation maleimides to unique cysteine
mutants of SCP-2L
A 25-50 μM solution of protein in buffer (20 mM MES 50 mM NaCl pH 6) was 
incubated with 10 equivalents maleimide added from a 50 mM stock solution in the
corresponding buffer or DMF for water insoluble maleimides. Progress of the reaction
was monitored using LCMS (ES+) analysis. Typically no signal for residual free
protein was observed after leaving the reaction for 16 hours at room temperaturet. The
mixture was washed using a centrifugal concentrator with buffer to remove the excess
maleimide.
3.5.4 Procedure for the coupling of tetrazoles T1 and T2 to SCP-2L V83C-
M4
In a quartz cuvette, 200 μM solution tetrazole was added from a 10 mM stock solution 
in PBS to a 10 μM solution of SCP-2L V83C-M4 in 1 ml PBS. The resulting mixture
was placed in a Varian Cary Eclipse fluorescence spectrometer and irradiated at 320
nm with a filter slot width of 20 nm. The reaction was followed in time by measuring
the increase of the emission peak at 450 nm. Only for the reaction with tetrazole T1 a
signal was found in the mass-spectrum belonging to the product (LCMS (ES+),
calculated 13785.64 Da; found 13783.2 Da). Product formation was also analysed by
SDS-PAGE gel (Invitrogen® NuPAGE® Novex® 4-12% Bis-Tris Gell, ran in MES
buffer). After running the gel was analysed under UV-light of ~360 nm to show the
formation of the pyrazoline ring. The gel was than stained with Coomassie Blue to see
if the fluorescent band was in the same position as the protein band.
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3.5.5 General procedure for coupling reactions with Ellman reagent
These experiments are based on a published procedure.[36] A final concentration of 0.6
mM 5,5’dithio-bis(2-nitrobenzoic acid) (Ellman’s reagent/DTNB) was added from a
20 mM stock solution in water to a 13 μM solution of protein in 0.1 ml of buffer 
solution (20 mM MES, 50 mM NaCl, pH 6). The reaction was shaken for an hour at
room temperature before analysis by LCMS (ES+). For the unique cysteine containing
proteins conversion to the DTNB adducts was found (Figure 12), while for the
modified proteins no modification with DTNB was observed (Figure 13).
Figure 12. SCP-2L V83C modified upon reaction with Ellman’s reagent as observed
in the processed mass-spectrum (ES+).
Figure 13. SCP-2L V83C-M5 showing no modification upon reaction with Ellman’s
reagent as observed in the processed mass-spectrum (ES+).
SCP-2L V83C
SCP-2L V83C-M5
SCP-2L V83C +thio-2-nitrobenzoic acid (TNB)
found: 13570.9 Da
expected: 13571.0 Da
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3.5.6 Synthesis of phosphine aldehydes
3.5.6.1 Synthesis of 3-(1,3-dioxolan-2-yl)propionic acid I1
3-(2-dioxolanyl)propionic acid I1 was synthesised following a
literature procedure.[51] The product was purified using
fractional distillation (bp 25ºC/1.5 mbar), providing
crystalline I1 in an 42% overall yield. The 1H-NMR spectrum matched the literature
data:[51] 1H-NMR (400 MHz, CDCl3), δ 5.00 (t,
3JHH=4.1 Hz, 1H, -CH2-CH-(O-)2), δ 
4.05-3.87 (m, 4H, Ketal-CH2’s), δ 2.53 (t,
3JHH=7.4 Hz, 2H, HOOC-CH2-CH2-),
δ 2.07 (td, 3JHH=7.4 Hz,
3JHH=4.1 Hz, 2H, -CH2-CH2-CH-);
13C-{1H}-NMR (75.4
MHz, CDCl3), δ 178.3 (Cq, HOOC-CH2), δ 103.4 (CH,-CH2-CH(-O-)2), δ 65.5 (Ketal-
CH2’s) δ 28.6 (CH2, -CH2-CH2-CH-), δ 28.2 (CH2, HOOC-CH2-CH2-).
3.5.6.2 Synthesis of 3-(1,3-dioxolan-2-yl)-N,N-bis(2-(diphenylphosphino)
ethyl)propanamide I3
This reaction was performed using dry solvents
and glassware. 0.139 g (0.95 mmol) of 3-(2-
dioxolanyl)propionic acid I1 was dissolved in 10
ml of DCM and 0.3 ml (2.2 mmol) of Et3N. The
solution was cooled to -10ºC and 136.7 μl (1.05 mmol) of isobutyl chloroformate was 
added dropwise. The reaction was stirred at -10ºC for 30 minutes after which a cooled
solution of 0.5 g (1.05 mmol) of bis(2-(diphenylphosphino)ethyl)amine hydrochloride
salt I2[40-41] in 4 ml of DCM and 0.3 ml (2.2 mmol) of Et3N was added dropwise. The
reaction mixture was stirred for another hour at -10ºC and for one hour at room
temperature after which TLC (Al2O3, 7:3 PE(40-60ºC):EtOAC) showed complete
conversion of the starting material. The reaction mixture was sequentially washed
three times with 10 ml of H2O (pH 10) and three times with an aqueous HCl solution
(pH 3). The organic layer was concentrated and purified on an Al2O3 packed column
(7:3 PE (40-60ºC):EtOAc), which provided I3 as white gum (300 mg, 0.53 mmol,
55%). Rf 0.45 (Al2O3, 7:3 PE:EtOAc);
1H-NMR (400 MHz, CDCl3), δ 7.3-7.21 (m,
20H, Ar-CH), δ 4.77 (t, 3JHH=4.5 Hz, 1H, -CH2-CH-(O-)2), δ 3.88-3.69 (m, 4H, Ketal-
CH2’s), δ 3.40-3.15 (m, 4H, Ph2P-CH2-CH2-), δ 2.26-2.04 (m, 6H, -CH2-CH2-N-, -
NOC-CH2-CH2-), δ 1.91-1.82 (m, 2H, -CH2-CH2-CH-);
13C-NMR (101 MHz,
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CDCl3), δ 171.6 (Cq, -N-OC-CH2-), δ 137.9 (Cq,
1JCP=12.3 Hz, Ar-C-P-), δ 137.2 (Cq,
1JCP=12.3 Hz, Ar-C-P-), δ 132.7 (CH, JCP=19.1 Hz, Ar-CH), δ 132.6 (CH, JCP=19.0
Hz, Ar-CH), δ 129.0 (CH, Ar-CH), δ 128.7 (CH, Ar-CH), δ 128.7 (CH, Ar-CH), δ 
128.7 (CH, Ar-CH), δ 128.5 (CH, Ar-CH), δ 128.5 (CH, Ar-CH), δ 103.5 (CH,-CH2-
CH(-O-)2), δ 64.9 (Ketal-CH2’s), δ 45.4 (CH2, JCP=26.3 Hz, -P-CH2-CH2- or -CH2-
CH2-N-), δ 43.8 (CH2, JCP=23.9 Hz, -P-CH2-CH2- or -CH2-CH2-N-), δ 29.0 (CH2, -
NOC-CH2-CH2- or -CH2-CH2-CH-), δ 28.0 (CH2, JCP=15.3 Hz, -P-CH2-CH2- or -
CH2-CH2-N-), δ 27.1 (-NOC-CH2-CH2- or -CH2-CH2-CH-), δ 26.5 (CH2, JCP=14.1
Hz, -P-CH2-CH2- or -CH2-CH2-N-);
31P-{1H}-NMR (162 MHz, CDCl3), δ -20.4 (s,
1P, -PPh2), δ -21.8 (s, 1P, -PPh2). Elemental analysis calculated for C34H37NO3P2: C
71.69, H 6.55, N 2.46; found: C 71.55, H 6.37, N 2.27.
3.5.6.3 Synthesis of N,N-bis(2-(diphenylphosphino)ethyl)-4-oxobutanamide P4
3 g (5.3 mmol) of I3 was dissolved in a mixture of
150 ml of THF and 50 ml of H2O. To this mixture
was added 46 mg (0.27 mmol) of p-toluenesulfonic
acid monohydrate. The mixture was heated at 70ºC
for 3 days, after which no further formation of the product was observed on TLC
(Al2O3, 3:2 PE(40-60ºC: EtOAc). The THF was removed in vacuo and 40 ml of DCM
was added. The organic layer was separated and the water layer was extracted twice
with 40 ml of DCM. The organic layers were combined and the DCM was removed in
vacuo. Filtration over a small layer of SiO2 (7:3 EtOAc:PE (40-60ºC)) was performed
to remove oxides yielding 2 g (3.8 mmol, 72%) of P4 as an off-white gum. Rf 0.45
(Al2O3, 3:2 PE(40-60ºC):EtOAc);
1H-NMR (400 MHz, CDCl3), δ 9.70 (s, 1H, HCO-
CH2-), δ 7.36-7.20 (m, 20H, Ar-CH), δ 3.39-3.13 (m, 4H, Ph2P-CH2-CH2-), δ 2.61 (t,
3JHH = 6.4 Hz, 2H, -CH2-CH2-COH), δ 2.25-2.14 (m, 6H, -CH2-CH2-N-, -NOC-CH2-
CH2-);
13C-{1H}-NMR (101 MHz, CDCl3), δ 201.0 (CH, -CHO), δ 170.4 (Cq, -N-OC-
CH2-), δ 137.9 (Cq,
1JCP=12.4 Hz, Ar-C-P-), δ 137.2 (Cq,
1JCP=12.2 Hz, Ar-C-P-), δ 
132.7 (CH, JCP=19.1 Hz, Ar-CH), δ 129.1 (CH, Ar-CH), δ 128.8 (CH, Ar-CH), δ 
128.7 (CH, Ar-CH), δ 128.7 (CH, Ar-CH), δ 128.5 (CH, Ar-CH), δ 128.5 (CH, Ar-
CH),  δ 45.4 (CH2, JCP=26.5 Hz, -P-CH2-CH2- or -CH2-CH2-N-), δ 43.9 (CH2,
JCP=24.3 Hz, -P-CH2-CH2- or -CH2-CH2-N-), δ 38.6 (CH2, -CH2-CH2-COH), δ 28.0
(CH2, JCP=15.4 Hz, -P-CH2-CH2- or -CH2-CH2-N), δ 26.5 (CH2, JCP=14.0 Hz, -P-
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CH2-CH2- or -CH2-CH2-N-) δ 25.6 (-NOC-CH2-CH2-);
31P-{1H}-NMR (162 MHz,
CDCl3), δ -20.2 (s, 1P, -PPh2), δ -21.6 (s, 1P, -PPh2); HRMS (TOF MS CI
+), m/z
calculated for C32H34NO2P2 (M+H
+) 526.2065, found 526.2067.
3.5.6.4 Synthesis of 4-(1,3-dioxolan-2-yl)benzoic acid I4
4-(1,3-dioxolan-2-yl)benzoic acid I4 was synthesised
following a literature procedure.[42] The product was
obtained analytically pure without the need for
recrystallization to give 9.4 g of I4 (48.4 mmol, 74%) as a
white solid. The obtained 1H-NMR spectrum was similar to
literature data.[52] 1H-NMR (300 MHz, CDCl3), δ 8.07 (d,
3JHH=8.3 Hz, 2H, Ar-CH), δ 
7.53 (d, 3JHH=8.3 Hz, 2H, Ar-CH), δ 5.82 (s, 1H, Ar-CH-(O-)2), δ 4.11-3.96 (m, 4H,
Ketal-CH2’s);
13C-{1H}-NMR (75.4 MHz, CDCl3), δ 171.4 (Cq, HOOC-Ar), δ 144.2
(Cq Ar-C), δ 130.7 (CH, Ar-CH), δ 130.3 (Cq Ar-C), δ 127.0 (CH, Ar-CH), δ 103.3
(CH, Ar-CH(-O-)2), δ 65.8 (Ketal-CH2’s).
3.5.6.5 Synthesis of 4-(1,3-dioxolan-2-yl)-N,N-bis(2-(diphenylphosphino)
ethyl)-benzamide I5
This reaction was performed using dry solvents
and glassware. 0.203 g (1.05 mmol) of 4-(1,3-
dioxolan-2-yl)benzoic acid I4, 0.5 g (1.05
mmol) of bis(2-(diphenylphosphino)ethyl)amine
hydrochloride salt I2[40-41] and 153 mg (1.26
mmol) of N,N-dimethylaminopyridine were dissolved in 5 ml of DCM. The solution
was cooled to 0ºC and a solution of 0.216 g (1.05 mmol) dicyclohexylcarbodiimide in
5 ml of DCM was added dropwise over 30 min. The reaction was stirred at 0ºC for 1
hour and for 16 hours at room temperature after which a white solid precipitated. Thin
layer chromatography (SiO2, 4% acetone in DCM) showed complete conversion. The
reaction mixture was filtered over celite and the solvent was removed from the filtrate
en vacuo. The obtained solid was dissolved in methanol and left at -20ºC overnight
after which a white precipitate formed. The white solid was filtered and recrystallized
from methanol to provide I5 as a white crystalline solid (475 mg, 0.74 mmol, 71%).
Rf 0.35 (SiO2, 4% acetone in DCM);
1H-NMR (400 MHz, CDCl3), δ 7.48-7.02 (m,
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24H, Ar-CH), δ 5.76 (s, 1H, Ar-CH-(O-)2), δ 4.10-3.95 (m, 4H, Ketal-CH2’s), δ 3.62-
3.40 (m, 2H, Ph2P-CH2-CH2-), δ 3.31-3.12 (m, 2H, Ph2P-CH2-CH2-), δ 2.45-2.28 (m,
2H, -CH2-CH2-N-), δ 2.10-1.99 (m, 2H, -CH2-CH2-N-);
13C-NMR (101 MHz,
CDCl3), δ 171.2 (Cq, -N-OC-Ar), δ 139.2 (Cq Ar-C), δ 137.8 (Cq,
1JCP=13.4 Hz, Ar-C-
P-), δ 137.2 (Cq Ar-C), δ 136.9 (Cq,
1JCP=13.4 Hz, Ar-C-P-), δ 132.7 (CH, JCP=19.2
Hz, Ar-CH), δ 132.4 (CH, JCP=19.2 Hz, Ar-CH), δ 128.8 (CH, Ar-CH), δ 128.6 (CH,
Ar-CH), δ 128.6 (CH, Ar-CH), δ 126.7 (CH, Ar-CH), δ 126.4 (CH, Ar-CH), δ 103.2
(CH, Ar-CH(-O-)2), δ 65.3 (Ketal-CH2’s), δ 46.9 (CH2, JCP=27.9 Hz, -P-CH2-CH2- or
-CH2-CH2-N-), δ 43.0 (CH2, JCP=25.1 Hz, -P-CH2-CH2- or -CH2-CH2-N-), δ 27.8
(CH2, JCP=16.7 Hz, -P-CH2-CH2- or -CH2-CH2-N-), δ 26.5 (CH2, JCP=12.9 Hz, -P-
CH2-CH2- or -CH2-CH2-N-);
31P-{1H}-NMR (162 MHz, CDCl3), δ -20.6 (s, 1P, -
PPh2), δ -21.7 (s, 1P, -PPh2); Elemental analysis calculated for C38H37NO3P2: C
73.89, H 6.04, N 2.27; found: C 74.04, H 5.97, N 2.18.
3.5.6.6 Synthesis of N,N-bis(2-(diphenylphosphino)ethyl)-4-formylbenzamide
P5
0.4 g (0.65 mmol) of I5 was dissolved in a
mixture of 9 ml of THF and 1 ml of H2O. To this
mixture was added 10 mg (0.05 mmol) of p-
toluenesulfonic acid monohydrate. The mixture
was refluxed overnight, after which full
conversion of the starting material was observed on TLC (SiO2, 5% acetone in DCM).
The THF was removed in vacuo and the residue washed with 10 ml of H2O. The
residue was dried in vacuo to give P5 as a white paste (370 mg, 0.65 mmol, 99%). Rf
0.5 (SiO2, 5% acetone in DCM);
1H-NMR (400 MHz, CDCl3), δ 9.94 (s, 1H, HCO-
CH2-), δ 7.67 (d,
3JHH = 8.3 Hz, 2H, Ar-CH), δ 7.47-7.02 (m, 22H, Ar-CH), δ 3.62-
3.49 (m, 2H, Ph2P-CH2-CH2-), δ 3.25-3.11 (m, 2H, Ph2P-CH2-CH2-), δ 2.45-2.34 (m,
2H, -CH2-CH2-N-), δ 2.02-2.98 (m, 2H, -CH2-CH2-N-);
13C-{1H}-NMR (101 MHz,
CDCl3), δ 191.5 (CH, -CHO), δ 170.2 (Cq, -N-OC-CH2-), δ 142.0 (Cq Ar-C), δ 137.7
(Cq,
1JCP=11.7 Hz, Ar-C-P-), δ 136.7 (Cq,
1JCP=12.7 Hz, Ar-C-P-), δ 136.5 (Cq Ar-C),
δ 132.7 (CH, JCP=18.5 Hz, Ar-CH), δ 132.4 (CH, JCP=19.0 Hz, Ar-CH), δ 129.8 (CH,
Ar-CH), δ 128.9 (CH, Ar-CH), δ 128.9 (CH, Ar-CH), δ 128.7 (CH, Ar-CH), δ 128.6
(CH, Ar-CH), δ 126.9 (CH, Ar-CH), δ 46.8 (CH2, JCP=27.4 Hz, -P-CH2-CH2- or -
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CH2-CH2-N-), δ 43.0 (CH2, JCP=23.5 Hz, -P-CH2-CH2- or -CH2-CH2-N-), δ 27.9
(CH2, JCP=15.3 Hz, -P-CH2-CH2- or -CH2-CH2-N), δ 25.6 (CH2, JCP=14.5 Hz, -P-
CH2-CH2- or -CH2-CH2-N-);
31P-{1H}-NMR (162 MHz, CDCl3), δ -20.9 (s, 1P, -
PPh2), δ -21.8 (s, 1P, -PPh2); Elemental analysis calculated for C36H33NO2P2: C
75.38, H 5.80, N 2.44; found: C 75.29, H 5.74, N 2.36.
3.6.6.7 Synthesis of 10-(3-(1,3-dioxolan-2-yl)propyl)-4,6-bis(diphenyl
phosphino)phenoxazine I8
This reaction was performed using dry solvents and
glassware. 0.88 g (1.56 mmol) of 4,6-
bis(diphenylphosphino)phenoxazine I6[43] was dissolved in
30 ml of THF. To this solution 0.08 g (3.2 mmol) of NaH
was added and the suspension was refluxed for 1h at 70ºC.
The reaction mixture was cooled down to room
temperature and 0.49 g (3.13 mmol) of 2-(3-chloropropyl)-1,3-dioxolane I7 in 10 ml
of THF was added. The reaction was then refluxed until TLC (SiO2, 7:3 PE(40-
60ºC):EtOAc) showed complete conversion (60h). The reaction was quenched by
adding 20 ml of H2O and subsequently most of the THF was removed in vacuo
resulting in a yellow/brown precipitate. The precipitate was filtered off and dried
under reduced pressure. Crystallization from DCM/EtOH provided 933 mg crude I8
(1.4 mmol, 90% yield ~95% purity (1H-NMR)). Crude I8 was used as such in the
following step towards P6. Further purification could be achieved by chromatography
(SiO2, 7:3 PE(40-60ºC):EtOAc). Rf 0.27 (SiO2, 7:3 PE:EtOAc);
1H-NMR (400 MHz,
CDCl3), δ 7.25-7.08 (m, 20H, PPh2(CH’s)), δ 6.58 (t,
3JHH=7.9 Hz, 2H,
Phenoxazin(CH)), δ 6.40 (d, 3JHH=7.9 Hz, 2H, Phenoxazin(CH)), δ 5.92 (d,
3JHH=7.9
Hz, 2H, Phenoxazin(CH)), δ 4.88 (t, 3JHH=3.9 Hz, 1H, -CH2-CH(-O-)2), δ 3.98-3.76
(m, 4H, Ketal-CH2’s), δ 3.48 (t,
3JHH=7.6 Hz, 2H, N-CH2-CH2-), δ 1.81-1.60 (m, 4H, -
CH2-CH2-CH2-CH-);
13C-{1H}-NMR (101 MHz, CDCl3), δ 147.1* (t, J=10.4 Hz,
Cq), δ 136.8* (t, J=4.0 Hz, Cq), δ 133.9* (t, J=10.4 Hz, Phenyl CH), δ 133.0 (Cq), δ 
128.3 (Phenyl CH), δ 128.1* (t, J=3.3 Hz, Phenyl CH), δ 125.2 (Phenoxazin CH), δ 
124.4* (t, J=4.4 Hz, Cq), δ 123.8 (Phenoxazin CH), δ 111.9 (Phenoxazin CH), δ 103.9
(-CH2-CH(-O-)2), δ 65.0 (Ketal-CH2’s), δ 44.5 (N-CH2-CH2-), δ 30.7 (-CH2-CH2-
CH2-CH- or -CH2-CH2-CH2-CH-), δ 18.9 (-CH2-CH2-CH2-CH- or -CH2-CH2-CH2-
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CH-); 31P-{1H}-NMR (162 MHz, CDCl3), δ -18.9 (s); HRMS (TOF MS CI
+), m/z
calculated for C42H38NO3P2 (M+H
+) m/z 666.2327, found m/z 666.2341.
* These 13C signals appear as a triplet with the above coupling constants, but are
actually second order signals resulting from an AA’X spin system.[53]
3.5.6.8 Synthesis of 4-(4,6-bis(diphenylphosphino)-phenoxazin-10-yl)butanal
P6
0.93 g (1.4 mmol) of I8 was dissolved in a mixture of 50 ml
of THF and 15 ml of H2O. To this mixture was added 24 mg
(0.14 mmol) of p-toluenesulfonic acid monohydrate. The
mixture was heated to 70ºC leading to the formation of a
white precipitate. After 2 days no further conversion was
observed on TLC (Al2O3, 3:2 PE(40-60ºC: EtOAc). THF
was removed in vacuo and 40 ml of DCM was added. The water layer was removed
and the organic layer washed twice with 20 ml of H2O. The organic layer was then
concentrated and 15 ml of H2O, 50 ml of THF and 24 mg (0.14 mmol) of p-
toluenesulfonic acid were added and the reaction mixture was heated at 70ºC until full
conversion was achieved according to TLC. Filtration of the reaction mixture afforded
P6 as a white powder (630 mg, 0.95 mmol, 72% yield). Rf 0.37 (Al2O3, 7:3 PE(40-
60ºC):EtOAc); 1H-NMR (300 MHz, CDCl3), δ 9.79 (t, 1H,
3JHH = 0.6 Hz, HCO-CH2-
), δ 7.20-7.06 (m, 20H, PPh2(CH’s)), δ 6.61 (t,
3JHH=7.9 Hz, 2H, Phenoxazin(CH)), δ 
6.48 (dd, 4JHH=1.3 Hz,
3JHH=7.9 Hz, 2H, Phenoxazin(CH)), δ 5.93 (dtd,
4JHH=1.5 Hz,
5JHH=1.9 Hz, 2H,
3JHH=7.9 Hz, Phenoxazin(CH)), δ 3.52-3.40 (m, 2H, N-CH2-CH2-),
δ 2.57 (t, 3JHH=0.6 Hz,
3JHH=6.4 Hz, 2H, -CH2-CH2-COH), δ 1.92 (tt,
3JHH=6.5 Hz,
3JHH=8.0 Hz, 2H, -CH2-CH2-CH2-);
13C-{1H}-NMR (101 MHz, CDCl3), δ 201.0 (-
CHO), δ 147.1* (t, J=10.5 Hz, Cq), δ 136.9* (t, J=6.4 Hz, Cq), δ 133.9* (t, J=10.4 Hz,
Phenyl CH), δ 132.9 (Cq), δ 128.2 (Phenyl CH), δ 128.1* (t, J=3.3 Hz, Phenyl CH), δ 
125.4 (Phenoxazin CH), δ 124.9* (t, J = 9.6 Hz, Cq), δ 123.8 (Phenoxazin CH), δ 
111.8 (Phenoxazin CH), δ 43.5 (N-CH2-CH2-), δ 40.8 (-CH2-CH2-CHO), δ 17.3 (-
CH2-CH2-CH2-);
31P-{1H}-NMR (121.5 MHz, CDCl3), δ -19.0 (s); Elemental analysis
calculated for C40H33NO2P2: C 77.28, H 5.35, N 2.25; found: C 77.28, H 5.35, N 2.25,
found: C 77.28, H 4.98, N 2.47.
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* These 13C signals appear as a triplet with the above coupling constants, but are
actually second order signals resulting from an AA’X spin system.[53]
3.5.7 General procedure for phosphine aldehyde modification of hydrazide
modified proteins
2-10 equivalents of phosphine aldehyde P1-P8 was added to a 25-50 mM solution of
M5-modified protein in buffer (20 mM MES 50 mM NaCl pH 6) from a 50 mM stock
solution in degassed DMF or MeCN under inert atmosphere. The reaction mixture left
overnight after which the excess phosphine was removed by centrifugation. The
remaining protein solution was washed three times with the appropriate buffer in a
centrifugal concentrator. The mass spectra (LCMS, ES+) from the different resulting
solutions provided the results outlined in Table 3. Examples of the processed mass
spectra obtained for the modification using ligands P1, P2, P3 and P4 are shown in
Figure 14, Figure 15, Figure 16 and Figure 17 below.
Figure 14. The processed mass-spectrum (ES+) of SCP-2L V83C-M5-P1.
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Figure 15. The processed mass-spectrum (ES+) of SCP-2L V83C-M5-P2.
Figure 16. The processed mass-spectrum (ES+) of SCP-2L V83C-M5-P3.
Figure 17. The processed mass-spectrum (ES+) of SCP-2L V83C-M5-P4
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3.5.8 General procedure for tryptic digests
The samples (5 μL, 10 pmoles/μL) were dialysed against buffer (50 mM ammonium 
bicarbonate pH 8.0) using a membrane filter (Millipore, Billerica, MA). Trypsin (0.5
μL, 0.1 μg, Promega, Madison, WI) was added to the resulting solutions. The 
solutions were incubated at 37C overnight and the digested solution (0.5 μL). This 
solution together with an α-cyano-4-hydroxycinnamic acid matrix (0.5 μL, 10 mg/mL 
in 50:50 acetonitrile:0.1% TFA) and 0.1% TFA (0.5 μL) was applied to the MALDI 
target, and after being allowed to dry, analyzed by MALDI-MS.
MALDI MS was acquired using a 4800 MALDI TOF/TOF Analyser (Applied
Biosystems, Foster City, CA) equipped with a Nd:YAG 355 nm laser and calibrated
using a mixture of peptides. The samples were initially analysed in positive MS mode
between 800 and 4000 m/z, by averaging 1000 laser shots. The most desired peptides
were selected for MSMS analysis and acquired to a maximum of 3000 laser shots or
until the accumulated spectrum reached a S/N ratio of 35. All MS/MS data were
acquired using 1 keV collision energy.
The combined MS and MSMS data were analysed, using GPS Explorer (Applied
Biosystems) to interface with the Mascot 2.1 search engine (Matrix Science, London,
UK), against the UniProt (Swiss-Prot and TREMBL combined) database (April
2009). No species restriction was applied. The data were searched with tolerances of
100 ppm for the precursor ions and 0.5 Da for the fragment ions, with trypsin as the
cleavage enzyme, assuming up to one missed cleavage, carbamidomethyl
modification of cysteines as a fixed modification and methionine oxidation selected as
a variable modification. Digest results are shown for SCP-2L V83C-M5-P3 in Figure
6 and for SCP-2L V83C-M5-P4 in Figure 7 (MS-MS data can be found in appendix
A2). The depicted peptides were the only peptide found matching phosphine
(oxidized or non oxidized) modification.
In the above experiments an active search was performed for other peptides with the
same modification but no evidence for those was found. In addition, the samples were
analysed by ESI where again no evidence was found for other peptide sequences
containing the modification. For ESI analysis the peptides were acidified with TFA
and then separated using an UltiMate nanoLC (LC Packings, Amsterdam) equipped
with a PepMap C18 trap & column, using a 60 min gradient of increasing acetonitrile
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concentration, containing 0.1 % formic acid (5-35% acetonitrile in 35 min
respectively, 35-50% in a further 20 min, followed by 95% acetonitrile to clean the
column). The eluent was sprayed into a Q-Star XL tandem mass spectrometer
(Applied Biosystems, Foster City, CA) and analysed in Information Dependent
Acquisition (IDA) mode, performing 1 sec of MS followed by 3 sec MSMS analyses
of the 2 most intense signals observed in MS. These masses are then excluded from
analysis for the next 60 sec. MS/MS data for doubly and triply charged precursor ions
were converted to centroid data, without smoothing, using the Analyst QS1.1
mascot.dll data import filter with default settings. The MS/MS data file generated was
analysed using the Mascot 2.1 search engine (Matrix Science, London, UK) against
an internal database containing the protein sequence of interest. The data were
searched with tolerances of 0.2 Da for the precursor and fragment ions, with trypsin as
the cleavage enzyme and allowing for one missed cleavage. Phosphine (free, oxidized
and for 23 double oxidized) modification of cysteine and lysine and methionine
oxidation were selected as variable modifications.
3.5.9 Procedure for recording 31P-{1H}-spectra of proteins
The 31P-{1H}-spectra of SCP-2L V83C and SCP-2L V83C-M5-P3 were recorded on
a Bruker Avance 500 spectrometer over 16 hours at room temperature. The protein
sample was concentrated to ~2 mM and 10% D2O was added for locking. Usually,
small amounts of precipitate formed during the recording period. The 31P-{1H}-
spectrum of SCP-2L V83C before modification is depicted in Figure 5a showing
phosphorous signals at 0-1 ppm. These signals were also observed in the 31P-{1H}-
spectra of SCP-2L V83C-M5-P3 (Figure 5b) which have been subjected to extensive
washing, which gave rise to the hypothesis that they correspond to covalently or very
strongly non covalently bound phosphates.[54]
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Chapter 4. Biphasic rhodium catalysed hydroformylation of 
higher linear alkenes  




This chapter describes studies of transition metal complexation to phosphine modified 
proteins described in the previous chapter and initial results of the application of these 
artificial metalloenzymes in the hydroformylation of alkenes. A phosphine-rhodium 
conjugate was successfully obtained and characterised. The obtained complexes were 
applied in the biphasic rhodium catalysed hydroformylation of linear α-olefins. 
Increased activity was found compared to the traditional Rh/TPPTS catalyst, along 
with good linear selectivity between 75 and 85% depending on the substrate and the 
SCP-2L mutant phosphine rhodium complex used. The results imply a true shape 
selective catalytic system that involves substrate encapsulation by the protein 
template. This work demonstrates for the first time such a system obtained through 
rational design of the appropriate artificial metalloenzyme. In addition, initial results 











The rhodium complex formation procedure has been published in a communication 
article in Angewandte Chemie International Edition: 
P. J. Deuss, G. Popa, C. H. Botting, W. Laan, P. C. J. Kamer, Angew. Chem., Int. Ed. 
2010, 49, 5315. 
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4.2 Introduction 
4.2.1 Hydroformylation 
In the previous chapters the development of phosphine containing artificial 
metalloenzymes based on SCP-2L was described. SCP-2L was specifically chosen for 
its ability to bind linear aliphatic substrates. One of the main opportunities for 
application of this system would be in the rhodium catalysed hydroformylation of 
linear alkenes. This reaction, which is also known as “oxo synthesis”, transforms 
alkenes into aldehyde products using synthesis gas (scheme 1).[1] Catalysts for this 
reaction usually consist of cobalt or rhodium hydrides containing phosphine ligands.[2] 
The importance of the reaction lies in the high added value of the aldehyde products 
compared to the cheap alkene substrates. For example, the products of 
hydroformylation of higher linear α-olefins (C6 and higher) are widely used in the 
detergent and surfactant industry. In the reaction two regioisomers can be formed; the 
linear (L) and branched (B) aldehydes. Selectivity towards one of these products is 
one of the key goals in the catalyst development for this reaction.[3] 
 
Scheme 1. Hydroformylation of alkenes to aldehyde products. 
 
4.2.2 Rhodium catalysed hydroformylation 
The generally accepted catalytic cycle for the rhodium catalysed hydroformylation of 
a monosubstituted alkene towards the linear and branched aldehyde products is 
depicted in Scheme 2.[2, 4] The hydride complex H1, containing three phosphine 
ligands, is the typical catalytic precursor, which is obtained by mixing the phosphine 
with a typical rhodium precursor like [Rh(acac)(CO)2]. Dissociation of a phosphine 
ligand from the hydride complex H1 forms H2, which is considered to be the 
catalytically active species. H2 has so far not been directly observed but indirect 
evidence suggests phosphine dissociation from complex H1 is required for initiation 
of the catalytic cycle.[5] Alkene coordination to H2 gives H3, which undergoes 
migratory insertion of the olefin into the Rh–H bond. For α-olefins, this process can 
give either H4a, which yields the linear aldehyde product via H5a and H6a, or H4b, 
which yields the branched aldehyde product via H5b and H6b. In general, linear-
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selectivity is found for α-olefins using rhodium phosphine complexes due to the steric 
bulk of species H4a, except in special cases were the branched carbon is activated, 
such as vinyl acetate or styrene. Species H2, H6a and H6b can undergo complexation 
of an additional CO molecule to form the resting states H7a, H7b and H8 
respectively, which have been observed in situ by high pressure 31P-NMR and IR 
studies.[5-6] Dicarbonyl species H8 can also form inactive dimers, which can be 
reactivated with hydrogen.[6b, 7]  
 
Scheme 2. Catalytic cycle for the rhodium catalysed hydroformylation. 
 
The electronic parameters of the ligands can play an important role in the activity and 
selectivity. For example, electron withdrawing phosphines decrease Rh-CO π-
backdonation, weakening the Rh–CO bond, thereby positively influencing the 
equilibrium between the dicarbonyl and monocarbonyl species to provide an 
increased catalytic activity. There are several commonly observed pathways that lead 
to undesired side products. Species H4a and H4b can undergo hydrogenolysis to 
afford the hydrogenated alkene. When R is an alkyl chain species H4b can undergo β-
hydride elimination leading to isomerization of the alkene towards more stable 
internal olefins, which are far less reactive towards hydroformylation. Dicarbonyl 
species H8 can lose a phosphine to form monophosphine complex H9, which 
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typically leads to unselective hydroformylation since the complex has only one 
phosphine to control the selectivity. Every substrate brings different demands for the 
catalyst on selectivity and activity, which requires fine tuning of the ligand. Therefore 
ligand development is a crucial aspect of homogeneous rhodium catalysed 
hydroformylation. Not surprisingly, numerous groups are actively involved in ligand 
design and screening using computational and empirical approaches.[3c] 
 
4.2.3. The biphasic rhodium catalysed hydroformylation process 
All aspects of the industrial hydroformylation processes have been well developed, 
like reactor engineering, product separation and catalyst recycling. Especially for 
lower linear α-olefins (C3, propene and C4, 1-butene) sophisticated processes exist 
and the hydroformylation is performed on multi-ton/year scale. The most successful 
process has been developed by Ruhrchemie/Rhône-Poulenc, which involves a highly 
effective biphasic rhodium phosphine catalytic system (Figure 1).  
 
Figure 1. Flow chart showing the hydroformylation process as performed by 
Ruhrchemie/Rhône-Poulenc (Reproduced with kind permission of Springer Science 








No rights for online publication of this figure were obtained. 
 
Please refer to Homogeneous Catalysis: Understanding the Art by P. W. 
N. M. van Leeuwen for this figure.[2] 
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This system uses a water soluble rhodium catalyst by employing triphenylphosphine 
trisulfonic acid trisodium salt (TPPTS) as the phosphine ligand.[8] Rhodium-TPPTS 
complexes are dissolved in the aqueous phase while the organic phase consists of the 
reaction products, mainly linear aldehyde (92%). The substrate and the synthesis gas 
are fed into the reactor through a gas dispersion system for optimal mixing. The most 
important part of this process is the phase separation system where the product is 
separated from the aqueous phase containing the catalyst. After separation the organic 
layer is led to a distillation unit where the linear product is separated from the 
branched product.  
 
4.2.4 Application of the biphasic system for higher alkenes 
The process described above can be applied to higher alkenes. This is however not 
carried out on an industrial scale due to a significant reduction in the turnover 
numbers when the substrate hydrocarbon chain length is increased. A nearly 
exponential decrease in the reaction rate is observed for substrates of increasing chain 
length, which arises from the decreasing water solubility of these substrates (Figure 2) 
Therefore, the industrial hydroformylation of alkenes with a medium chain length 
(C5-C8) is performed using phosphine rhodium catalysts in a single organic phase. 
The reaction products obtained from these reactions can be separated from the catalyst 
solution by distillation.[9] Distillation is less desirable than a phase separation as this 
causes high thermal stress on the catalyst system leading to significant catalyst loss. 
For this reason often cheaper cobalt based catalyst systems are used for these 
processes. Although the use of Rh/TPPTS in a biphasic system is not economically 
viable for these substrates, several studies have been performed to find the optimal 
conditions for hydroformylation of medium chain length alkenes in a biphasic system. 
Selectivity and activity were found to be very sensitive to the equilibrium between H2 
and the less active and selective H8, which is dependent on the CO pressure (Scheme 
2). It was found that the synthesis gas pressure reaches an optimum between 30 and 
80 bar depending on the exact conditions and that selectivity decreases significantly at 
high pressures (270 bar) due to increased formation of H8. Also high ratios of TPPTS 
to rhodium are required to prevent the formation of H9, which also leads to 
unselective catalysis.[6d] The pH of the reaction is optimal between 5.5 and 6.5. It has 
been found that over the course of the reaction the pH can drop by one pH unit due to 
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the formation of CO2 by the water-gas shift reaction.[10] Variation of the counter ions 
to replace sodium showed little effect on both rate and selectivity, although increasing 
the amount of salts leads to a decrease in rate. This “salt-effect” is due to a decreased 
solubility of the alkene in the aqueous phase at increased ionic strength.  
 
Figure 2. Solubility of alkenes in water (■, solid line) and rate constants for the 
Ruhrchemie/ Rhône-Poulenc hydroformylation process (¸, dashed line) as a function 
of substrate chain length (Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 
reproduced with permission).[9] 
 
4.3.5 Solutions for higher alkenes 
For higher alkenes (>C8) it is not possible to separate the aldehyde products by 
distillation due to thermal sensitivity of the aldehydes, making a biphasic system 
highly desirable. However, as described above, the low solubility of higher alkenes in 
water causes very low turnovers in a process similar to that performed by 
Ruhrchemie/Rhône-Poulenc. Several research groups have studied the possibility to 
engineer a suitable biphasic system which is effective for the hydroformylation of 
higher alkenes.[9] To increase mixing, shockwave and ultrasound reactors were 
engineered leading to a rate enhancement by a factor of 1.5-2. Various 
monophosphine and diphosphine analogues of TPPTS were found more effective than 
TPPTS in terms of selectivity and activity.[8-9, 11] The downside is that these phosphine 
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ligands are much more expensive than TPPTS. Addition of other cheap phosphines 
like triphenylphosphine monosulfonate (TPPMS) and triphenylphosphine disulphate 
(TPPDS) or even triphenylphosphine (TPP) to the reaction mixture is very effective at 
increasing the activity but also significantly increases rhodium leaching because of 
the increased solubility of these ligands into the organic layer compared to TPPTS.[9, 
12] Changing the alkali counter ion from Na+ to Li+ or Cs+ proved to have little 
influence on the rate and selectivity and a negative effect was found using Al3+.[9, 13] 
Using additives to enhance phase transfer like cationic detergents,[9, 14] poly(ethylene 
glycol) PEG derivatives,[15] modified cyclodextrins,[16] crown ethers[9] and 
calixarenes[17] was often found to be very effective at increasing the rate, but this is 
accompanied by a decrease in selectivity and complication of the phase separation 
process. The rate can also be enhanced by addition of polar co-solvents. Alcohols and 
methanol in particular proved very effective due to enhancement of the solubility of 
the alkenes into the aqueous layer. The disadvantage is that these solvents also 
increase the solubility of the catalyst in the organic layer increasing catalyst 
leaching.[9] These examples show that improvement of the biphasic system using 
Rh/TPPTS is far from straightforward. 
 
 4.2.6 Bioinspired solutions 
Various proteins are well known to bind hydrophobic organic compounds, including 
important substrates for hydroformylation. Artificial metalloenzymes based on such 
proteins have significant potential as catalysts for the biphasic hydroformylation of 
poorly water-soluble substrates. This is because the protein can bring substrate 
molecules into the water layer, while the insolubility of the protein in the organic 
phase prevents leaching of the catalyst into the organic layer. Moreover, the protein 
may be used to induce selectivity on the reaction. Some studies have been performed 
on protein-based rhodium catalyst systems for hydroformylation. Marchetti et al. 
published two papers on using a system involving a dative adduct of human serum 
albumin (HSA) and [Rh(acac)(CO)2].[18] HSA is known to be a transporting protein 
for various hydrophobic compounds and is also known to bind metal ions. High 
conversion and turnovers were found for several alkene substrates including 1-octene 
in a biphasic system using pentane as the organic phase. However, selectivity was 
poor providing a nearly one to one mixture of branched to linear aldehyde. For 
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substrates which typically afford high branched selectivity the system showed good 
regioselectivity, for example 90% branched selectivity was obtained for styrene. Their 
system was most extensively studied using styrene as substrate. Optimal conditions 
were found to be a reaction temperature of 60 ºC, a high synthesis gas pressure (70-80 
atm), near neutral pH of the water layer and 20 molecules of rhodium per HSA. HSA 
demonstrated high stability under the reaction conditions, showing only minimal 
amounts of grey precipitate after the reaction. The catalyst solution could be reused 
for more than 10 cycles as the rhodium leaching was found to be minimal (8 ppm Rh 
found in the organic layer after the reaction, which corresponds to about 2-3% of total 
rhodium). When papain and egg albumin were used as alternative proteins, far more 
leaching was observed and in case of the latter also total precipitation of the protein. 
Complexation of the rhodium to HSA was analysed by CD spectroscopy giving rise to 
an intense broad positive signal at 350 nm. This signal was attributed to rhodium-
protein adduct. More recent studies showed that the rhodium most likely interacts 
with the sulfur atoms of the cysteines present in HSA and that cysteine-rhodium 
complexes are highly active catalysts.[19] The system was also successfully applied in 
the synthesis of the fragrance Florhydral.[20] 
Another protein based catalyst system was created in the group of Kazlauskas, who 
replaced the zinc in the active site of carbonic anhydrase by rhodium.[21] This catalyst 
system was engineered to selectively bind one rhodium metal in a histidine containing 
active site. This was done by removing other potential binding sites by replacement of 
various amino acids using site directed mutagenesis. Remarkable selectivity was 
observed for the rhodium catalysed hydroformylation of styrene, obtaining linear over 
branched ratios of 8 whereas free rhodium typically gives a ratio of 0.2. This reaction 
was performed under relative mild conditions using room temperature and 20 bar of 
synthesis gas. Good yields are reported but no information is given about the amount 
of substrate used, so the actual activity of this system remains unknown. 
Unfortunately, also no information is provided about the substrate addition process. 
However, the catalyst was also applied in rhodium catalysed hydrogenation of cis and 
trans stilbene[22] and, assuming a similar experimental setup is used for the 
hydroformylation and for their hydrogenation, the substrate is partly dissolved in the 
reaction mixture using acetonitrile. This catalyst system was found less stable 
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compared to the HSA/Rh complexes described above as the protein was reported to 
precipitate after one hour. 
A rhodium hydroformylation catalyst system will be presented in this chapter, which 
is based on SCP-2L phosphine conjugates. This catalyst is developed according to the 
concept shown in Figure 3. A system is envisaged were the protein binds the apolar 
substrate therefore encapsulating it and presenting the covalently bound rhodium 
phosphine system with a selectivity inducing environment. Both bioinspired examples 
outlined above use native dative interactions between amino acid residues of the 
protein to bind the catalytically active metal centre, making them very different from 
the system demonstrated in this thesis. But, although, the concept explained here uses 
phosphine ligands to bind the phosphine metal centre, other amino acid side chains of 
the proteins will have influence on the catalytic reaction. This is important for the 
concept as this allows for optimization of the systems by site directed mutagenesis 
and directed evolution in the future. 
 
Figure 3. Concept for shape selective hydroformylation catalyst. 
 
4.3 Results and discussion 
4.3.1 Rhodium coordination to phosphine containing SCP-2L 
4.3.1.1 Synthesis of rhodium-phosphine proteins adducts 
In the previous chapter the synthesis of phosphine modified SCP-2L ligand is 
described. The formation of rhodium-phosphine complex modified proteins had to be 
studied for successful application of our approach in hydroformylation. Direct 
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modification of M5 modified proteins with preformed rhodium complexes was 
attempted, which would avoid an additional protein modification step (rhodium 
coordination) and the extra set of washings this would require. However, this 
approach was unsuccessful (see appendix A7 for more details). Therefore, we 
explored the coordination of rhodium to phosphine-modified protein. Mixing SCP-2L 
V83C-M5-P3 with 1 equivalent of [Rh(acac)(CO)2] for 16 h, resulted in nearly full 
conversion of the phosphine-modified protein to a mixture of species according to 
LCMS (ES+) analysis, with masses ranging from 13933-14100 Da (hereafter 
collectively referred to as SCP-2L V83C-M5-P3-[Rh]) (Scheme 3, Figure 4). The 
strongest signal within the range of species correlates closely to the calculated mass 
for SCP-2L V83C-M5-P3 modified with a rhodium carbonyl fragment (i.e. SCP-2L 
V83C-M5-P3-RhCO) (Table 1 entry 1). Other signals within the mass range belong 
most likely to rhodium species with other coordinating ligands like water and 
acetonitrile (the latter from the elution solution of the LCMS).  
 
Scheme 3. Complex formation between SCP-2L-V83C-M5-P3 and [Rh(acac)(CO2)]. 
 
Two other signals with m/z 13572 and 13846 Da are assigned to the oxide signal 
(methionine oxidation) of some residual SCP-2L V83C-M5 (calculated 13572.9 Da) 
and oxidized SCP-2L V83C-M5-P3 (calculated 13845.2 Da). These signals are 
observed because of a significantly reduced ionization efficiency of SCP-2L V83C-
M5-P3-[Rh] compared to SCP-2L V83C-M5(-P3), which causes to observation of 
small residual amounts of oxidized SCP-2L V83C-M5 and SCP-2L V83C-M5-P3. 
The reaction between SCP-2L A100C-M5-P3 and [Rh(acac)(CO)2] resulted in a 
similar product distribution,  showing high conversion to SCP-2L A100C-M5-P3-
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RhCO (Table 1 entry 2). Interestingly, LCMS(ES+) analysis of a sample taken 15 
minutes after the start of the reaction showed a completely different product 
distribution. Several species were observed corresponding to the coordination of two 
or three rhodium centres to the SCP-2L A100C-M5-P3. A sample taken after three 
hours reaction time showed the product distribution as observed after 16 hours for 
SCP-2L A100C-M5-P3 upon LCMS(ES+) analysis, with no trace of the rhodium 
species observed after 15 minutes. These results suggest that the rhodium centres 
initially bind to the surface of SCP-2L-A100C-M5-P3 forming statistical mixtures of 
rhodium modified protein before they coordinate to the phosphorous ligand.  
 
Figure 4. Processed mass spectra of SCP-2L V83C-M5-P3 before (red) and after 
modification with [Rh(acac)(CO)2] (blue) (Copyright Wiley-VCH Verlag GmbH & 
Co. KGaA. Reproduced with permission).[23] 
 
Large scale synthesis of rhodium complexes for catalysis experiments allowed for the 
determination of the yield of the rhodium coordination reaction. These experiments 
showed that more than 90% of the protein remains in solution after the reaction and 
subsequent washings and concentration. Moreover, the mass spectrum obtained by 
LCMS (ES+) of the complex after 16 hours is essentially identical to that obtained 
after 3 hours indicating reasonable stability of the formed metalloprotein.  
The reaction between SCP-2L V83C-M5-P5 and [Rh(acac)(CO)2] provided a major 
species corresponding to complexation of RhCO (Table 1 entry 3). The only 
difference compared to the P3 conjugates was that a strong signal corresponding to 
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residual double oxidized SCP-2L V83C-M5-P5 was observed (calculated 14147.5 
Da, observed 14147.6 Da) and a medium signal corresponding to oxidized SCP-2L 
V83C-M5-P5-RhCO (calculated 14262.4, found 14261.9). Similar products were 
observed upon reacting SCP-2L A100C-M5-P5 with [Rh(acac)(CO)2] (Table 1 entry 
4). 
 
Table 1. Most intense signals observed in the mass-spectra obtained after the reaction 
between phosphine modified proteins and [Rh(acac)(CO)2].a  
Entry Phosphine modified protein Calculated mass +RhCO Main signal foundb 
1 SCP-2L V83C-M5-P3 13961.1 13960.1 
2 SCP-2L A100C-M5-P3 13991.0 13991.1 
3 SCP-2L V83C-M5-P5 14246.4 14247.6 
4 SCP-2L A100C-M5-P5 14276.3 14276.3 
a) Reaction conditions: 0.1 mM phosphine modified protein, 1 equivalent 
[Rh(acac)(CO)2] in degassed 20 mM MES 50 mM NaCl pH 6 buffer, 16 h at room 
temperature, and analyzed by mass-spectroscopy b) Most intense signal found by 
analysis of the obtained mass spectrum (ES+). 
 
The reaction between SCP-2L V83C-M5-P3 and [Rh(MeCN)2(cod)]BF4 also yielded 
a range of rhodium adducts. Signals for the addition of rhodium and additional 
corresponding oxidation signals were observed upon LCMS(ES+) analysis as well as 
signals belonging to oxidized SCP-2L V83C-M5-P5. The observation of phosphine 
oxidation of this ligand was not surprising as the significant oxygen sensitivity of this 
ligand was already observed in bioconjugation experiments of P5 to M5 modified 
proteins.  
 
4.3.1.1 Spectroscopic studies of the artificial rhodium-phosphine proteins  
To confirm the formation of a rhodium phosphine complex and to investigate the 
effect of this modification on the protein structures several spectroscopic techniques 
were used. The 31P-NMR spectrum of SCP-2L V83C-M5-P3-[Rh] was recorded 
using the same parameters as for the 31P-NMR spectra obtained for the phosphine 
modified proteins (Figure 5). The spectrum shows signals between 3 and 0 ppm, 
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which have previously been assigned to phosphorylation of the protein, and a broad 
signal between 50 and 30 ppm with sharp signals at 44.8 and 43.8 ppm. The chemical 
shifts of these latter signals are consistent with phosphorus-rhodium complexes. The 
distance between the sharp signals (~200 Hz) is consistent with a phosphorus-
rhodium coupling, however due to the low signal to noise ratio this is hard to confirm. 
The broad signal suggests multiple phosphorus-rhodium species are present, which is 
in line with the observation of a range of different rhodium-adducts by mass-
spectroscopy. The absence of signals between –3 and –7 ppm indicates complete 
conversion of the protein-bound phosphines to rhodium-complexes. CO and the 
phosphine are the only coordinating ligands identified by mass and NMR 
spectroscopic analysis of the obtained complex. These will occupy only two of the 
possible five coordination sites available on rhodium and therefore it is assumed that 
amino acid side chains contribute to rhodium complexation. As there are many 
suitable amino acid side chains present, this could be one of the reasons for the 
observed mixture of rhodium species. 
 
Figure 5. {1H}-31P-NMR spectra of SCP-2L V83C-M5-P3 (red) and SCP-2L V83C-
M5-P3-[Rh] (blue) (Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced 
with permission).[23] 
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A watergate 1H-NMR spectrum was recorded of SCP-2L V83C-M5-P3-[Rh] to study 
the effect of the rhodium coordination on the protein fold (Figure 6). The obtained 
spectrum is similar to the spectrum of SCP-2L V83C-M5-P3 except for some extra 
signals which can be identified as residual DMF (7.70, 2.78 and 2.63 ppm, literature: 
7.92, 3.01 and 2.85 ppm)[24] used as solvent for the addition of [Rh(acac)(CO)2]. Also, 
a slight loss in resolution is observed which could be due to the formation of some 
precipitate during the measurement. Overall the protein structure seems unaffected by 
the addition of [Rh(acac)(CO)2], which is very promising for application in catalysis. 
 
Figure 6. Watergated 1H-NMR spectra of SCP-2L V83C-M5-P3 (red) and SCP-2L 
V83C-M5-P3-[Rh] (blue). 
 
Attempts were made to study the structural integrity of rhodium adducts of the 
phosphine modified proteins by near-UV CD-spectroscopy. However, only an intense 
broad signal with a maximum at 301 nm was observed in the near UV region of SCP-
2L A100C-M5-P3 (Figure 7). This spectrum is very similar to those obtained by 
Marchetti et al. however with a blue-shift of the signal of 50 nm.[18a] Because the 
watergate 1H-NMR spectrum of the SCP-2L V83C-M5-P3-[Rh] complex showed the 
fold of the protein is not significantly changed upon rhodium incorporation, it is 
assumed that the dramatic change in the CD signal corresponds to rhodium-protein 
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interactions or phosphine-rhodium interactions which are known to give UV-
absorptions in this region.[25]  
















Figure 7. Near-UV CD-spectrum of SCP-2L A100C-M5-P3-[Rh]. 
 
4.3.2 Hydroformylation using Rh/TPPTS 
4.3.2.1 Hydroformylation of linear α-olefins 
The conditions for the biphasic hydroformylation of linear α-olefins for using 
rhodium/TPPTS catalyst systems are well established, as shown in the introduction of 
this chapter. However, certain conditions and aspects of the process needed to be 
altered for the application of proteins in these reactions. The rhodium/TPPTS catalyst 
system was selected as model catalytic system to obtain reference data for the protein 
based catalysts under the selected conditions (Scheme 4). Initial experiments using the 
Rh/TPPTS catalyst showed that the complex of TPPTS and [Rh(acac)(CO)2] had to be 
prepared in a separate reaction vessel. This is done to prevent undissolved rhodium to 
accumulate on the glass walls, which subsequently dissolves in the organic layer, 
where it will catalyse unselective hydroformylation. No difference in activity and 
selectivity was observed using degassed water or 20 mM MES 50 mM NaCl pH 6 
buffer. This is important as this indicated that the use of this buffer to stabilize the 
protein and maintain the pH stable during the reaction will not affect the catalysis 
results. 
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Scheme 4. Hydroformylation of linear α-olefins using Rh/TPPTS. 
 
Table 2. Hydroformylation of linear α -olefins using Rh/TPPTS.a 
Entry Catalystb Substratec L1/B1d TONd 
1 [Rh(acac)(CO)2] 1-decene 1.27 369 
2 Rh:TPPTS 1:1 1-hexene 1.29 (±0.02) 615 ±256 
3 Rh:TPPTS 1:1 1-octene 1.26 (±0.01) 427 ±77 
4 Rh:TPPTS 1:1 1-decene 1.27 (±0.02) 667 ±170 
5 Rh:TPPTS 1:1 1-octadecene 1.27 (±0.01) 223 ±65 
6 Rh:TPPTS 1:20 1-hexene 6.31 (±1.71) 16 (±3) 
7 Rh:TPPTS 1:20 1-octene 4.55 (±2.00) ~1 
8 Rh:TPPTS 1:20 1-decene 1.64 (±0.27) <1 
9 Rh:TPPTS 1:20 1-octadecene nd <1 
a) 48 hours, 80 bar CO/H2 = 1:1, 35 ºC, stirred b) Rh (0.3 µmol) as preformed 
complex with the adequate amount of TPPTS in 0.5 ml 20 mM MES 50 mM NaCl pH 
6 c) 0.5 ml substrate added neat containing 9% n-heptane and 1% phenylether as 
internal standards d) determined by GC, turnover numbers (TON) given in [mol 
aldehydes/mol cat]. 
 
Examples of experiments run using the appropriate conditions with different 
phosphine to rhodium ratios can be found in Table 2. These results demonstrate the 
obvious difference in activity and selectivity resulting from the hydroformylation 
catalysed by leached rhodium species and rhodium-TPPTS complexes dissolved in 
the water layer. “Free” rhodium gives a linear over branched ratio (L/B) of ~1.27 and 
high turnover numbers; and similar results are obtained when rhodium and TPPTS are 
used in a 1:1 ratio (Table 2 entries 1-5). Reproducible results were only obtained if an 
excess of 20 equivalents of phosphine was used (Table 2 entries 6 and 7). These 
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experiments also showed the expected selectivity for catalysis by Rh:TPPTS 
indicating complete prevention of leaching of the rhodium to the organic layer. 
Reactions with Rh:TPPTS ratios of 1:5 and 1:10 showed variable results either 
matching the results of Rh:TPPTS 1:1 or Rh:TPPTS 1:20 (data not shown). The 
rhodium content in the organic layer was determined using ICP to verify the levels of 
rhodium leaching. The variable activity was found to be directly related to the amount 
of leached rhodium. The values ranged from 10 to 250 ppm for systems involving 
Rh:TPPTS 1:10 or lower TPPTS content (here 250 ppm = ~ 0.3 μmol = all rhodium 
leached to the organic layer). A rhodium content of less than 0.1 ppm was measured 
for reactions involving rhodium:TPPTS 1:20, indicating that this catalyst system leads 
to true biphasic catalysis. As expected, the turnover numbers are low for the reactions 
that are truly catalysed by Rh/TPPTS in the aqueous layer, due to the very low water 
solubility of the substrates. An effect of the increase in chain length of the alkene 
substrate can be observed going from 1-hexene to higher alkenes for which nearly no 
conversion to aldehydes is found (Table 2 entries 5-9). For 1-decene the reaction rate 
is so low that the traces of rhodium that leach into the organic layer contribute 
significantly to the total conversion, as shown by the decreased selectivity. 
 
4.3.2.2 High pressure NMR experiments 
High pressure NMR experiments were performed to confirm that solubility of the 
substrates is the cause of the observed low activity of the Rh/TPPPTS system. This 
experiment should demonstrate if hydride species such as H1 are formed under the 
conditions used above (Scheme 2). Especially, the low temperature could affect the 
formation of such species. A sample containing Rh/TPPTS was continuously scanned 
under syngas pressure at constant temperature and respective spectra were 
accumulated for 30 minutes. A low Rh:TPPTS ratio of 1:2 was used to make sure that 
the signal of the free phosphine would not suppress the signals belonging to the 
formed complexes. 
A selection of these spectra is shown in Figure 8. The initial formed solution shows 
broad signals at around 32 and 50 ppm, suggesting it contains a mixture of Rh-TPPTS 
species. The sharp signal at 34.5 ppm is assigned to a small fraction of oxidized 
TPPTS, which can be observed in the spectrum of the batch of TPPTS used (Figure 
8a-b). When synthesis gas pressure was applied new species were observed, which 
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could be identified using literature reports of similar and related structures.[6, 7b, 7c] 
After 30 minutes a major species displaying a doublet at 43.3 ppm (1JRh,P = 155 Hz) 
was observed, which was identified as [RhHCO(TPPTS)3], the TPPTS analogue of 
H1 (Figure 8c).  
 
Figure 8. High pressure 31P-NMR experiments using Rh(acac)(CO)2/TPPTS 1:2 under 
40 bar CO/H2 at 35 ºC in 20 mM MES 50 mM NaCl pH 6 containing 10% D2O. 
 
a) TPPTS in 20 mM MES 50 mM NaCl pH 6 containing 10% D2O 
b) Preformed adduct between Rh(acac)(CO)2 and TPPTS 
c)                                                                    40 bar CO/H2 after 30 minutes 
d)                                                                                          after 60 minutes 
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After an hour a new species displaying a doublet (1JRh,P = 136 Hz), at 37.6 ppm was 
observed (Figure 8d) which was identified as [RhH(CO)2(TPPTS)2], whose relative 
concentration slowly increases in time. In addition, a weak signal consisting of two 
broad doublets at 24.8 and 21.8 ppm (1JRh,P = 152 and 156 Hz respectively) with a 2:1 
ratio was observed, whose relative intensity increased over time (Figure 8e). 
According to published data for complexes with the general formula of 
[Rh2(CO)5(phosphine)3] this species was identified as the TPPTS analogues of these 
complexes.[6b, 7b, 7c]  
In addition, a 1H-NMR experiment (with solvent suppression) was run after three 
hours (Figure 9) This spectrum clearly showed two sets of hydride multiplet signals 
between –9.5 and –9.7 ppm and –10.1 and –10.4 ppm with a relative intensity similar 
to the ratio observed by 31P-NMR after this time between [RhHCO(TPPTS)3] and 
[RhH(CO)2(TPPTS)2].These experiment clearly showed the formation of typical 
hydride species that are involved in hydroformylation within 30 minutes at 35ºC and 
40 bar H2/CO. These results confirm that the slow reaction rate found for Rh:TPPTS 
is not due to inefficient formation of catalytically active hydride species. 
 
Figure 9. 1H-NMR spectrum (with solvent suppression) of Rh:TPPTS 1:2 after 300 
min exposure to 40 bar CO/H2 at 35 ºC in 20 mM MES 50 mM NaCl pH 6 containing 
10% D2O. 
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4.3.3 Phosphine rhodium artificial enzyme catalysed reactions 
4.3.3.1 Hydroformylation of linear α-olefins 
Initial hydroformylation experiments were performed using P3 modified proteins. 
These phosphine conjugates were selected because rhodium complexation had been 
tested for these ligands. Initial experiments were performed using a 1:1 modified 
protein to rhodium mixture as the catalyst for the hydroformylation of linear α-olefins, 
under the conditions described above for the Rh/TPPTS system. This catalytic system 
showed very high activity for the hydroformylation of linear alkenes, but low L/B 
ratios and very poor reproducibility. These results were attributed to different amounts 
of rhodium leaching in every run. This was confirmed by determination of the 
rhodium content in the organic layer by ICP, which was performed for several 
reactions involving 1-decene. Values up to 50 ppm were measured, and it was found 
once again that the rhodium content showed a direct relationship with the found 
activity. Differences in rhodium leaching are expected in 1:1 Rh:phosphine mixtures 
in biphasic catalysis if in one experiment a slight excess rhodium might be present 
while in other a slight excess of phosphine modified protein is used. To prevent this, 
we decided to use an excess of ligand. Reproducible catalysis results were obtained 
using a 2:1 ratio of modified protein and rhodium. Following several 
hydroformylation reactions of 1-decene with SCP-2L V83C-M5-P3-[Rh] as catalyst 
the rhodium content in the organic layer was measured. Values lower than 0.5 ppm 
were obtained, confirming very little to no influence of the rhodium leaching on the 
results. An overview of the results of all hydroformylation experiments involving 
protein based catalysts with 2:1 ratio of phosphine modified protein to rhodium is 
given in Table 2. 
Triton-X-100 was added to the reactions involving the protein constructs to prevent 
the formation of large amounts of precipitate. This indeed largely prevented the 
formation of precipitation and thereby simplified the workup of the reaction. The 
addition of Triton-X-100 had no noticeable effect on the selectivity and activity, but 
did make the results slightly more reproducible (compare entries 4 and 6 with 5 and 
7). SCP-2L A100C-M5-P3-[Rh] showed very good conversion and selectivity for 1-
hexene and 1-octene (entries 1 and 3). The activity and selectivity drop when 1-
decene is used as substrate and even more using 1-octadecene (entries 7 and 10). 
SCP-2L V83C-M5-P3-[Rh] appears less selective than SCP-2L A100C-M5-P3-[Rh] 
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for 1-octene and 1-decene (compare entries 2 and 5 with 3 and 7). In general, the 
selectivity of SCP-2L V83C-M5-P3-[Rh] seems to be lower than that found for the 
A100C construct, however SCP-2L V83C-M5-P3-[Rh] seems to retain its selectivity 
better moving to longer alkene substrates (compare entries 9 and 10). Leaching might 
well contribute in various amounts to the obtained selectivity and activity at the low 
turnover numbers found for 1-octadecene. The selectivity is however significantly 
higher than that observed for leached rhodium. Interestingly, also the decrease in 
activity between 1-octene to 1-decene seems more pronounced for SCP-2L A100C-
M5-P3-[Rh] compared to SCP-2L V83C-M5-P3-[Rh]. Most importantly, the overall 
activity was found to be significantly higher when compared to those obtained for 
Rh/TPPTS (compare Table 2 entries 1-4 with Table 3, visualised in Figure 10).  
 
Table 3. Hydroformylation of linear α -olefins using Rh-Protein constructs.a  
Entry SCP-2L-catalystb Substratec L1/B1d TONd 
1 A100C-M5-P3-[Rh] 1-hexene 5.31 (± 1.1) 196 (±71) 
2 V83C-M5-P3-[Rh] 1-octene 3.95 (± 0.20) 57 (±12) 
3 A100C-M5-P3-[Rh] 1-octene 6.72 (± 0.18) 124 (±23) 
4e V83C-M5-P3-[Rh] 1-decene 3.31 (± 0.29) 35 (±11) 
5 V83C-M5-P3-[Rh] 1-decene 3.44 (±0.06) 34 (±11) 
6e A100C-M5-P3-[Rh] 1-decene 3.71 (±0.69) 26 (±9) 
7 A100C-M5-P3-[Rh] 1-decene 4.15 (±0.41) 24 (±8) 
8 PYP-M5-P3-[Rh] 1-decene 1.51 (±0.02) 61 (±10) 
9 V83C-M5-P3-[Rh] 1-octadecene 3.12 (±0.19) 5 (±0.4) 
10 A100C-M5-P3-[Rh] 1-octadecene 2.08 (±0.51) 12 (±8) 
a) 48 hours, 80 bar CO:H2 1:1, 35 ºC stirred b) Protein-P:Rh = 2:1 (0.3:0.15 μmol) in 
0.5 ml 20 mM MES 50 mM NaCl pH 6 containing 0.46 mM Triton-X-100 c) added 
0.5 ml substrate containing 9% n-heptane and 1% phenylether as internal standards d) 
determined by GC, turnover number (TON) given in [mol aldehydes/mol Rh] e) no 
Triton-X-100 was added 
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Figure 10. Comparison of the activity (bars) and selectivity (dots and dashed lines) of 
Rh:TPPTS 1:20 (red), SCP-2L V83C-M5-P3-[Rh] (blue) and SCP-2L A100C-M5-
P3-[Rh] (green) in the biphasic hydroformylation of alkenes. 
 
The catalyst based on the A100C mutant of SCP-2L showed a more than 100 fold 
increased activity for all tested substrates compared to Rh/TPPTS. This high activity 
was accompanied by a high selectivity, which makes these results even more 
outstanding. That the increased activity for higher alkenes is truly the result of shape 
selective biphasic catalysis is so far confirmed by the ICP data for 1-decene and the 
observed selectivity which exclude a significant contribution of hydroformylation 
catalysed by free rhodium. Although these data are very promising, additional proof is 
required to corroborate that the high selectivity and activity are truly caused by the 
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system as we have designed it to work. This means whether or not the substrate is 
bound by the tunnel exposing the terminal carbon of the alkene followed by selective 
linear hydroformylation and product release/replacement with a new molecule of 
substrate should be determined 
The unique cysteine of PYP was also modified with M5, P3 and 0.5 equivalents of 
rhodium using the same methodology as the SCP-2L mutants. This protein only 
contains a small hydrophobic pocket and does not bind linear aliphatic molecules. The 
obtained adduct was applied in the hydroformylation of 1-decene to act as a control 
reaction. When this protein based catalyst was applied also good activity was 
observed, however selectivity was low. This indicated that either rhodium dissociates 
relatively easily from this catalyst giving unselective “free” rhodium catalysis or that 
this catalyst does not induce linear selectivity as SCP-2L does but does still enhances 
the reaction rate. Unfortunately no ICP data were obtained for this reaction to confirm 
the first hypothesis. Either way, this experiment demonstrates the importance of the 
choice of protein template for catalyst development. 
The results for PYP are very similar to those obtained for dative systems by Marchetti 
et al. although the differences in reaction setup and conditions do not allow for direct 
comparison of the results.[18] Various dative Rh-proteins adducts were tested for 
hydroformylation of 1-octene showing different activities but all with low selectivity 
(e.g. L1/B1 = 1-1.3). This indicated that other rhodium-amino acid complexes are 
capable of increasing the activity of 1-octene biphasic hydroformylation catalysis but 
do not lead to increased selectivity. The activity found using SCP-2L A100C-M5-P3-
[Rh] and SCP-2L V83C-M5-P3-[Rh] is high similar to the Rh-HSA catalyst 
developed by Marchetti et al. but also high linear selectivity is observed. This 
observation further underlines the significance of the results obtained using our SCP-
2L based catalysts. 
 
4.3.3.2 The fate of the catalyst 
Some studies were performed to analyse the effect of the catalytic conditions on the 
protein catalysts. The amount of remaining soluble catalyst after the reaction was 
analysed by Bradford assays after separation of the precipitate from the soluble 
protein by centrifugation. The percentage of protein that remained in solution varied 
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significantly when no triton-X-100 was added. When triton-X-100 was added the loss 
of protein could be improved to <50%, but the actual values did still vary.  




















Figure 11. Processed mass-spectra of SCP-2L V83C-M5-P3-[Rh] (protein-P:Rh 2:1) 
a) before and b) after catalysis (both spectra are not calibrated, so mass values have 
shifted slightly) 
 
Interestingly, only a small difference in the reactivity and activity was found between 
reactions with varying amounts of protein precipitate. In general, slightly lower 
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precipitate was observed. The precipitate is not expected to be active, which suggests 
that the precipitate may only be formed near the end of the reaction. However, 
experiments to confirm this will be required. The water layer containing the soluble 
protein after the reaction when no triton-X-100 was used was analysed by 
LCMS(ES+) (Figure 11). Reactions containing triton-X-100 can not be analysed by 
LCMS as the triton-X-100 suppresses the protein signal. Although some of the initial 
rhodium complex was still present, the main product after catalysis was usually found 
to be the protein modified with an oxidized phosphine. However, as the reaction 
work-up and LCMS analysis are not performed under inert atmosphere it is unclear if 
the oxidation occurs during the catalytic runs. The signal to noise ratio of the 
spectrum after catalysis is clearly lower than of the spectrum before catalysis which is 
caused by the loss of a significant amount of protein due to precipitation. This 
explains the slight increase in intensity of the signal belonging to impurities like the 
trace of oxidized SCP-2L V83C-M5. This modified protein appears to be significantly 
more stable compared to the phosphine modified proteins and thus remains in solution 
during the reaction. Overall, phosphine oxidation seems the main decomposition 
pathway for the rhodium-phosphine modified proteins catalysts presented in this 
work. More research is required to determine whether this happens during the reaction 
or during the work-up. It remains unclear what happens to the rhodium after 
phosphine oxidation 
 
4.3.4 Other alkene substrates 
4.3.4.1 Water soluble substrates 
4-Styrenesulfonate and N-allylacetamide were investigated as alternative substrates 
for the hydroformylation using our protein based catalysts (see Scheme 5 and Scheme 
7). These substrates are water soluble and allow for a true homogeneous reaction. 4-
styrenesulfonate was selected because of the high branched selectivity that is usually 
found, which gives the opportunity of asymmetric hydroformylation. The linear 
product of the hydroformylation product of N-allylacetamide is an important 
intermediate in the synthesis of the human sleep regulating hormone melatolin.[26] 
This makes it an interesting substrate for SCP-2L based hydroformylation systems, as 
enhanced linear selectivity is expected by the use of the protein tunnel to induce shape 
selectivity. An added advantage is that because the rhodium precursor 
Chapter 4. Biphasic rhodium catalysed hydroformylation of higher linear alkenes 
Artificial Metalloenzymes; Modified Proteins as Tuneable Transition Metal Catalysts 167
[Rh(acac)(CO)2] is essentially insoluble and thus inactive in water these reactions will 
experience less influence of catalysis by “free” rhodium species in comparison to the 
biphasic systems. Rh/TPPTS was again chosen as model catalyst systems for 
comparison to the protein based catalysts. Lower rhodium to TPPTS ratios can be 
used for these reactions because no problems caused by the leaching of rhodium are 
expected. This is an advantage as lower rhodium:TPPTS ratios generally give higher 
activity due to a positive effect in the equilibrium between H1 and H2 (Scheme 2). 
The reactions were successfully performed using a 5:1 ratio between TPPTS and 
[Rh(acac)(CO)2]. The conditions were chosen to allow the application of the protein 
based catalysts, i.e. buffered solutions (preferably 20 mM MES 50 mM NaCl pH 6) 
and low temperature (35 ºC). The products can be analysed by 1H-NMR using 
previous published NMR data.[26-27] This was done by using suppression of the 
solvent signal from which the aldehyde signals are significantly remote to allow 
accurate peak integration. The aldehyde signal of 2,4-disulphonated benzaldehyde 
was used as internal standard. 
 
4.3.4.2 Hydroformylation of 4-styrenesulfonate 
The hydroformylation of 4-styrenesulfonate using Rh/TPPTS 1:5 in H2O gave full 
conversion in 24 hours (TON <1500 [mol product / mol catalyst]) and the B2/L2 ratio 
was 13 (Scheme 5). The same results were found using 20 mM MES 50 mM NaCl pH 
6, which is promising for the application of phosphine modified SCP-2L rhodium 
catalysts. The selectivity for the aldehyde products was only 31% due the formation 
of large amounts of hydrated aldehyde products. Low aldehyde selectivity for the 
hydroformylation reaction with this substrate and the formation of hydrates has been 
reported before and transformation to the corresponding alcohols during work-up of 
the reaction using sodium borohydride has been described.[27-28] Interestingly, by 
using D2O as solvent product B2 was not observed (Scheme 6), but B2 with a 
deuterium incorporated into the β-carbon was observed instead. No such product was 
observed for L2. These results indicate solvent exchange of the hydrogen at the β-
position of B2 through an enol intermediate. This process is probably catalysed by 
rhodium and eliminates the prospect of obtaining enantioselectivity as this likely 
causes racemization of the chiral centre formed.  
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Scheme 5. Hydroformylation of 4-styrenesulfonate  
 
 
Scheme 6. Hydroformylation of 4-styrenesulfonate in D2O  
 
The hydroformylation of 4-styrenesulfonate catalysed by SCP-2L A100C-M5-P3-
[Rh] resulted in a low yield of aldehyde (~6%). A B3/L3 ratio of 6 was found for the 
small amount of aldehyde product observed, indicating a slightly increased linear 
selectivity compared to the reaction catalysed by Rh/TPPTS. However, the formation 
of large amounts of polymer during the reaction hampered a more detailed product 
analysis. This polymer formation led to formation of a viscous water layer and 
formation of a thick gel. Polymer formation of 4-styrenesulfonate was also observed 
by Anderson et al under hydroformylation conditions using an immobilized rhodium 
phosphine catalyst.[27, 29] They attributed this phenomenon to chain growth 
polymerisation on the alkyl-rhodium intermediate H5 (Scheme 2) of the 
hydroformylation by continuous alkene insertion competing with CO insertion which 
would give hydroformylation products. Control experiments using radical scavengers 
excluded radical polymerization in their system. In our hands the polymerisation was 
also observed to take place under aerobic conditions after the hydroformylation was 
terminated by release of the synthesis gas pressure. In fact, a significant amount of 
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addition polymer was observed after the samples were left overnight. Also, the 
polymerisation reaction was only initially suppressed upon introduction of a radical 
scavenger (hydroquinone). No polymer formation was physically observed (the 
aqueous layer was not viscous) after the reaction was terminated, however the 
reaction mixture did become a viscous solution overnight. These result showed that 
the process more likely does involve radical polymerisation of 4-styrenesulfonate 
instead of the chain growth polymerisation proposed by Anderson et al.[29] 
 
4.3.4.3 Hydroformylation of N-allylacetamide 
The hydroformylation of N-allylacetamide using Rh/TPPTS 1:5 gave 80% conversion 
after 24 hours (Scheme 7). Similar results were again obtained for H2O and 20 mM 
MES 50 mM NaCl pH 6. The selectivity was high (B3/L3 ratio of 7.9), which is 
significantly more selective than the B3/L3 = 1.3 reported for the same catalyst at 
higher temperature (70ºC), lower pressure (10 bar) and a Rh:TPPTS ratio of 1:25.[26, 
30] The aldehyde selectivity was low (25%) which was due to the formation of 
cyclization products, which have previously been reported to be formed under 
hydroformylation conditions.[31]  
 
Scheme 7. Hydroformylation of N-allylacetamide 
 
The initial cyclization product is formed when linear aldehyde reacts intramolecularly 
with the amide to form an alcohol product containing either a four or a five membered 
ring structure. This cyclized structure has been reported to react in the presence of 
rhodium to give several cyclic side products. The formation of these cyclization 
products explains the high B3/L3 ratio found as only the linear product cyclizes. The 
cyclization process was probably also the cause of the low TON of 358 [mol 
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aldehyde/mol catalyst] as this number was only based on the aldehyde products 
found. Correction of this number by including the cyclization products was hampered 
due to the difficult 1H-NMR analysis of the products because of signal overlap. The 
hydroformylation of N-allylacetamide catalysed by SCP-2L A100C-M5-P3-[Rh] 
afforded only trace amounts of aldehyde products. A significant amount of cyclization 
products were observed by 1H-NMR analysis but again peak overlap did not allow for 
quantification. A more detailed study of these reaction products using other analytical 
techniques might provide more insight in the actual activity and selectivity of the 
rhodium based catalysts in this reaction.  
 
4.4 Conclusion and future prospects 
Successful rhodium complex formation using several phosphine modified proteins has 
been described in this chapter. Mass spectrum and 31P-NMR analysis indicated the 
formation of a phosphine-rhodium complex with one coordinating molecule of carbon 
monooxide; however the exact nature of this species and to what extent a mixture of 
species is obtained is still uncertain. 
A 50 to over a 100 fold increase in the TON was found for the hydroformylation of 1-
hexene and 1-octene using the created rhodium containing phosphine modified 
proteins compared to the Rh/TPPTS system. These protein based systems catalysed 
also the hydroformylation of 1-decene and 1-octadecene for which the Rh/TPPTS 
system shows very little to no activity. The obtained linear selectivity was remarkable 
for all systems, with SCP-2L A100C-M5-P3 showing an L/B >5 in the 
hydroformylation of 1-hexene and 1-octene as the most promising results. The 
selectivity is most extraordinary when the results are compared to earlier reported 
dative rhodium-protein complexes in which also increased activity was found but no 
significant selectivity. These initial results did indicate that the catalyst systems truly 
operate trough a mechanism in which the tunnel of SCP-2L facilitates solubility of the 
substrates and enhances selectivity in a shape selective manner.  
Further research will be required to confirm the mechanism of operation of these 
catalysts. The use of inhibitors that strongly bind to the SCP-2L tunnel is one of the 
experiments which can be performed to confirm the role of this tunnel. Other 
interesting experiments will be the use of additional structurally different proteins and 
detailed kinetic studies. Several parameters that could have a significant effect on the 
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catalyst performance like the temperature, pressure, and H2/CO ratio may require 
optimisation and can provide more mechanistic insight. 
The fact that differences in selectivity are observed between the SCP-2L V83C and 
A100C mutants are an indication of how changes to the protein environment can 
influence the selectivity of these reactions. This gives these systems plenty of 
opportunity for optimisation using designed and directed evolution. Opportunities lie 
in the use of different phosphines and maleimide-hydrazide cross-linkers as synthetic 
modification. Also biological tools like site directed mutagenesis can be applied to 
optimise the position of the cysteine inside the protein or the replacement of key 
amino acids. In addition, other protein environments can be selected since the 
developed modification strategy is generally applicable. In conclusion, these 
phosphine based catalytic systems hold great potential for selective hydroformylation 
of higher linear alkenes under biphasic conditions. In addition, this approach has the 





The MaxEnt algorithm of Masslynx V4.0 (Micromass Ltd) was used for processing of 
the mass-spectra. Protein concentrations were determined using Bradford’s reagent.[32] 
Protein solutions were handled under argon atmosphere using the experimental setup 
outlined in section 3.5.1.1. 
 
4.5.1.2 Equipment 
1H and 31P NMR spectra were taken at room temperature with Bruker Avance 300, 
400 or 500 NMR spectrometers. Chemical shifts (δ) are given (in ppm) for high-
frequency shifts relative to a TMS reference (1H and 13C) or 85% H3PO4 (31P). 
Watergate 1H-NMR spectra were recorded on a Bruker Avance 500 spectrometer. 
High pressure NMR experiments were performed on a Bruker 300 MHz machine 
using a 10 mm probe and a quartz-NMR tube suitable for high pressure experiments. 
LC-MS(ES+) used for analysis of protein and protein reactions was performed on a 
Waters Alliance HT 2795 equipped with a Micromass LCT-TOF mass spectrometer, 
using positive electrospray ionisation and applying a Waters MASSPREP® On-line 
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Desalting 2.1x 10 mm cartridge using a gradient of 1% formic acid in H2O to 1% 
formic acid in acetonitrile. Spin-filter concentrators with a molecular weight cut-off 
of 10kDa (Amicon Ultra-15 Centrifugal Filter Units, Millipore®, Carrigtwohill, Co. 
Cork, Ireland) were used to concentrate and/or wash protein solutions. ICP-MS was 
performed using an Agilent 7500 series equipped with a Pt-tip by scanning for 
Rh(103) using free aspiration. Standards were measured using [Rh(acac)(CO)2] 
solution in toluene providing a accurate detection range between 50 and 1000 ppb. 
Each sample was measured 10 times of which an average was taken to give the final 
value. CD spectra were recorded using a Jasco J-810 spectropolarimeter using a 1 
mg/ml solution of the protein. Hydroformylation reactions were carried out in a 
stainless steel autoclave containing up to 8 glass reaction vials (volume of 
approximately 5 ml). The vials were equipped with mini-stirring bars and a septum 
cap, which was pierced with a needle to allow contact with the reaction gases. A CE 




Triphenylphosphine trisulfonic acid trisodium salt (TPPTS) was purchased from 
Fluka containing about 5% of the TPPTS-oxide, Dicarbonyl rhodium acetylacetonate 
[Rh(acac)(CO)2] was purchased from Acros and both were used as received. 
Degassed acetonitrile (MeCN) was obtained by distillation from CaH2. 
 
4.5.2 Procedure for the formation of rhodium complexes of phosphine 
modified proteins 
The appropriate amount of [Rh(acac)(CO)2] in a 12.5 mM stock of degassed MeCN 
was added to a 0.2 mM solution of the phosphine modified protein in 20 mM MES 50 
mM NaCl pH 6 under argon. The pink suspension was stirred for at least three hours 
at room temperature during which it turned into a clear yellow solution. The following 
procedure was used before application in catalysis. The reaction mixture was 
centrifuged and washed under argon with 20 mM MES 50 mM NaCl pH 6 using a 
centrifugal concentrator with the procedure described in chapter 3. Mass spectra were 
recorded of a sample containing 1 μl of the reaction mixture in 50 μl of degassed 
Chapter 4. Biphasic rhodium catalysed hydroformylation of higher linear alkenes 
Artificial Metalloenzymes; Modified Proteins as Tuneable Transition Metal Catalysts 173
water before and/or after the washings. The procedure described in chapter 3 was used 
for the preparation of samples for 31P-NMR. 
 
4.5.3 Hydroformylation experiments 
4.5.3.1 Preparation of Rh/TPPTS for hydroformylation reactions and high 
pressure NMR 
Dicarbonyl rhodium acetylacetonate [Rh(acac)(CO)2] and triphenylphosphine-3,3′,3′′-
trisulfonic acid trisodium salt, (TPPTS) were dissolved in appropriate molar ratio in 
degassed methanol (150 μM based on rhodium) under argon atmosphere and stirred 
for two hours. The methanol was removed in vacuo and the remaining solid 
redissolved in degassed 20 mM MES 50 mM NaCl pH 6 buffer (0.3 mM based on 
rhodium). This solution is directly used in hydroformylation. The same procedure 
was used for the preformation of the complex used for high-pressure NMR using a 
2:1 ratio TPPTS:Rh. The quartz NMR tube was loaded with a solution of this 
complex in degassed 20 mM MES 50 mM NaCl pH 6 buffer (20 mM based on Rh, 
containing 10% degassed D2O) and after recording the first spectrum charged with 40 
bar CO/H2. The 31P-NMR spectra were all recorded at a constant temperature of 35ºC. 
 
4.5.3.2 Biphasic hydroformylation of linear α-olefins  
Experiments were performed in a stainless steel autoclave containing a stainless steel 
insert in which glass vials with stirring bars can be placed. The autoclave was loaded 
with the reactants, pressurized and placed on a stirring plate containing an oil bath. 
This setup allowed for performing up to 10 small volume (≤2 ml) batch reactions 
simultaneously under the same conditions. A pressure of 80 bar of synthesis gas was 
used similar to the work of Marchetti et al.[18b] Lower temperatures are preferred in 
order to minimise denaturation of the protein. A temperature of 35ºC was selected 
which could be maintained using an oil bath. Continuous substrate addition or 
formation of the hydride complex prior to addition of the substrate can not be 
performed due to the small scale and batch-wise manner at which the reactions are 
run. To facilitate analysis a biphasic system was used in which the organic layer 
consisted of substrate (containing GC internal standards) to allow direct analysis of 
the organic phase for formed aldehyde products by gas chromatography. 
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Under argon atmosphere the vials were loaded with the preformed Rh/protein or 
Rh/TPPTS catalyst solutions to a total volume of 500 μL in degassed 20 mM MES 50 
mM NaCl pH 6 buffer (0.3 μmol for Rh/TPPTS and 0.15 μmol for the artificial 
metalloenzymes based on Rh, the artificial metalloenzyme precipitated when more 
concentrated solutions were used). Triton-X-100 was added from a 23 mM stock in 
the same buffer. 500 μL of the corresponding alkene substrate solution containing 9% 
(v/v) heptane and 1% (v/v) diphenyl ether as internal standards was added. This 
substrate solution was prepared by mixing a solution of 10% (v/v) diphenyl ether in 
heptane with an appropriate amount of alkene freshly filtered over a plug of neutral 
alumina. The autoclave was carefully purged three times with 5-10 bar CO/H2 before 
being charged to 80 bars and placed on a stirring plate in an oil bath at 35 ºC. After 
the appropriate time the autoclave was cooled and pressure was very carefully 
released. The organic layer was separated from the water layer and used directly for 
GC and ICP-MS analysis. Soluble protein concentration in the water layer was 
determined by performing a Bradford assay on soluble fraction of the water layer 
after centrifugation (30 min, 16100 g).[32] For LCMS (ES+) analysis, 1 μL of this 
soluble fraction was dissolved in 49 H2O, although this was only possible for reaction 
not containing triton-X-100 as this compound severely interferes with the protein 
mass-spectrum. GC analysis conditions: Restek RTX-1 (general purpose) column 
30m x 0.25 mm x 0.1 μm; injector temperature 250 ºC; 100 kPa constant pressure; 
100:1 splitratio; 1 or 2 μL injection depending on the signal strength; oven method, 
45 ºC isotherm for 5 min, 20 ºC/min to 130 ºC, 130 isotherm for 2 min, 20 ºC/min to 
250 ºC, 250 ºC isotherm for 10 min and 20 ºC/min to 300 ºC; retention times, 1-
hexene 2.1 min, heptane 2.6 min, 1-octene 3.7 min, 2-methylhexanal 4.8 min, n-
heptanal 5.7 min, 1-decene 7.6 min, 2-methyloctanal 8.3 min, n-nonanal 8.7 min, 1-
dodecene 9.7 min, 2-methyldecanal 10.3 min, n-undecanal 10.7 min, phenylether 11.8 
min, 2-methyldodecanal 12.6 min, n-tridecanal 13.0 min, 1-octadecene 15.2 min, 2-
methyloctadecanal 16.6 min, n-nonadecanal 16.6 min. 
 
4.5.3.3 Hydroformylation of water soluble substrates 
The reaction vessels were loaded with the appropriate substrate (1 mmol) and 2,4-
disulphonated benzaldehyde (0.1 mmol) as internal standard. The autoclave was 
degassed and under argon atmosphere the vials were loaded with preformed 
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Rh/protein or Rh/TPPTS (0.15 μmol for the artificial metalloenzymes or 0.3 μmol for 
Rh/TPPTS based on Rh) catalyst solutions to a total volume of 500 μL in degassed 
20mM MES 50 mM NaCl pH 6 buffer. The autoclave was carefully purged three 
times with 5-10 bar CO/H2 before being charged to 80 bars and placed on a stirring 
plate in an oil bath at 35 ºC. After the appropriate time the autoclave was cooled and 
pressure was very carefully released. The samples were loaded in NMR tubes and 1H-
NMR was measures using a 30 second delay time to allow proper quantification. 
Products were identified using reported 1H-NMR data.[26-27] 
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Chapter 5. Artificial copper-enzymes for asymmetric 
reactions 
Modification of SCP-2L templates with nitrogen donor ligands and their 
application in asymmetric copper catalysis  
 
5.1 Abstract 
This chapter describes the development of artificial copper enzymes from SCP-2L for 
the use in asymmetric catalysis. For this purpose, the unique cysteine SCP-2L 
templates described in chapter two were modified with various nitrogen donor 
ligands. Maleimide containing ligands were found most suitable for selective cysteine 
bioconjugation. Fluorescence spectroscopy was used to confirm copper binding to the 
phenanthroline ligand introduced in SCP-2L. Several copper adducts were applied in 
asymmetric Diels-Alder and Michael addition reactions. A clear influence of both the 
protein environment and the introduced ligand was found in the asymmetric Diels-
Alder reaction between azachalcone and cyclopentadiene. A promising 
enantioselectivity of 25% ee was obtained using SCP-2L V83C modified with 
phenanthroline-maleimide N3. This provides a suitable starting point for the 
implementation of various available techniques to optimize the performance of this 
system. Application of these catalyst systems in asymmetric Michael addition 
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5.2.1 Bioinspired copper-nitrogen catalyst systems 
Many groups have reported the use of proteins as chiral scaffold for the development 
of artificial metalloenzymes for asymmetric catalysis. Various approaches have led to 
catalyst systems that induce high enantioselectivity in reactions like, for example, 
asymmetric hydrogenation,[1] asymmetric sulfoxidation.[2] Particularly copper-
nitrogen ligand systems have been widely applied in various bioinspired systems. 
There are various significant advantages of using nitrogen-ligand based catalytic 
systems over the phosphine based systems described in the previous two chapters. 
The main advantage is that nitrogen ligands are not oxygen sensitive, which makes 
the synthesis of the ligands and the synthesis and manipulation of ligand-modified 
proteins much more straightforward. This advantage becomes even more pronounced 
if catalytic systems are going to be used for combinatorial optimisation techniques. 
Also, unlike phosphines, nitrogen donor ligands are in general compatible with 
cysteine selective modification procedures,[3] and the introduction of nitrogen donor 
ligands via covalent modification of biomolecules is well established, particularly 
because of the widespread application of such systems in DNA-cleavage.[4] In 
addition, nitrogen donor ligands, like bipyridine can be introduced as unnatural amino 
acids.[4a]  
Roelfes et al demonstrated how nitrogen copper systems in combination with DNA 
can be used for a wide range of copper catalysed asymmetric reactions (Scheme 1).[5] 
The catalyst was assembled by application of nitrogen donor ligands that can 
intercalate or bind the major groove of DNA. Excellent enantioselectivities were 
obtained for copper catalysed asymmetric Diels-Alder[6], Michael addition[7] and 
Friedel-Crafts alkylation[8] reactions using these nitrogen-copper complexes in 
combination with commercially available salmon testes or calf thymus DNA. 
Recently, this system was also applied in the enantioselective and diastereospecific 
syn hydration of α,β-unsaturated ketones.[9] This reaction is not performed by either 
conventional asymmetric catalysts using transition metals or by DNA/RNAzymes, 
demonstrating how a biomolecule and a transition metal can be combined to form a 
catalyst which opens up new reaction pathways. 
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Scheme 1. Nitrogen donor ligands applied in combination with DNA in various 
copper catalysed asymmetric reactions by Roelfes et al.[6-10] 
 
The group of Reetz has developed various protein based copper nitrogen ligand 
catalysts to obtain enantioselective artificial metalloenzymes.[11] One such system 
consisted of commercially available copper phthalocyanine in combination with 
various serum albumins to create artificial metalloenzymes for copper catalysed 
Diels-Alder reactions (Scheme 2a).[12] These systems proved surprisingly effective 
showing good conversions, high endo selectivities and high enantioselectivity. 
Nevertheless, the lack of an efficient en masse purification system for serum albumin 
hampered application of directed evolution for performance optimization. Very 
recently, Reetz reported the introduction of a copper binding-site in the synthase 
subunit of imidazole glycerol phosphate synthase from Thermotoga maritime (tHisF, 
Scheme 2b). This protein was specifically selected for its thermo-stability which 
allows efficient purification via a simple heat treatment to separate this protein 
directly from the cell extract. The binding site consists of a geometrically 
appropriately introduced histidine-histidine-asparagine motif, which was inspired by 
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natural copper binding sites in proteins. These mutations were introduced using step-
wise site directed mutagenesis. Copper coordination to this motif was confirmed using 
EPR spectroscopy. The obtained artificial metalloenzyme showed good conversion 
and endo-selectivity and more importantly 46% enantioselectivity in the Diels Alder 
reaction between azachalcone and cyclopentadiene. Reetz et al. anticipate that this 
new system will be suitable for application in directed evolution. 
 
Scheme 2. Copper based artificial metalloenzymes applied by Reetz et al. in the 
asymmetric Diels-Alder reaction a) artificial metalloenzymes assembled by 
supramolecular interaction between copper phthalocyanine and serum albumins[12] 
and b) artificial metalloenzymes assembled using the dative interaction between 
copper and an engineered binding site in tHisF.[13] 
 
Scheme 3. Terminal bipyridine modified oligonucleotide used in copper catalysed 
Diels-Alder reactions. 
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Using a different approach Roelfes introduced a bipyridine complex into DNA by 
covalent modification (Scheme 3).[14] The obtained system was applied in the copper 
catalysed Diels-Alder reaction in which the enantioselectivity could be improved from 
22 to 93% by changing the complementary strand. 
 
Scheme 4. Artificial metalloenzyme developed by Distefano et al.[15-16] 
 
Proteins have also been covalently modified with nitrogen donor ligands. The group 
of Distefano developed the first covalently assembled enantioselective artificial 
metalloenzyme, based on copper and a cysteine selectively introduced phenanthroline 
(Scheme 4). The cysteine at position 117 in adipocyte lipid binding protein (ALBP) 
was site selectively modified using 5-iodoacetamide-1,10-phenanthroline. ALBP was 
selected for its large hydrophobic cavity (600 Å3).[15] This cavity is large enough to 
accommodate the covalently introduced phenanthroline and a substrate. Fluorescence 
spectroscopy was used to characterize the copper coordination to the introduced 
nitrogen donor ligand. This was possible owing to quenching of the native 
fluorescence of phenanthroline upon copper coordination. The resulting artificial 
metalloenzyme was applied in amide and enantioselective ester hydrolysis. High 
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conversions were found in both amide and ester hydrolysis and up to 86% ee was 
achieved in the L-specific hydrolysis of the isopropyl ester of alanine. The catalyst 
system could be optimised by variation of the position of the unique cysteine and thus 
the location of the phenanthroline-copper inside the cavity of intestinal fatty acid 
binding protein (IFAP), a structurally related protein.[16] This resulted in an L-specific 
catalytic system that gave 94% ee in the hydrolysis of the isopropyl ester of alanine. 
 
5.2.2 The potential of SCP-2L based copper-nitrogen ligand systems  
SCP-2L and analogous proteins are known to bind a variety of hydrophobic 
molecules.[17] This makes this class of proteins very suitable for the development of 
artificial metalloenzymes for asymmetric reactions involving hydrophobic molecules 
like the typical reactants used in Diels-Alder reactions. The native cavity SCP-2L 
might not have the optimal structure to induce the desired selectivity in a selected 
reaction, but the structure can be optimised for this purpose using directed evolution 
or designed evolution. 
In our approach we wish to introduce our transition metal binding moiety covalently. 
Therefore, an efficient bioconjugation technique is required to make this a viable 
approach for future applications. The conjugation products in the previous chapters 
were analysed by mass-spectroscopy and 31P-NMR. No direct substitute is available 
for the latter to study conjugates containing nitrogen-ligands, however alternative 
analysis techniques like UV-Vis-, fluorescence- and EPR spectroscopy (on 
paramagnetic metal adducts) can be applied instead. Especially EPR spectroscopy 
offers great prospects as this allows for direct analysis of the copper environment. 
Several options for bioconjugation of nitrogen donor ligands to SCP-2L will be 
explored in this chapter along with some initial applications of copper adducts in 
asymmetric catalysis. 
 
5.3 Results and discussion 
5.3.1. Synthesis and bioconjugation of nitrogen donor ligands 
5.3.1.1 Synthesis of nitrogen donor ligands 
Nitrogen ligands do not suffer from the compatibility problems with standard cysteine 
selective bioconjugation methods encountered with phosphorous ligands. Therefore 
single step modification of protein-scaffolds should be straightforward. Distefano et 
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al. already demonstrated the introduction of a phenanthroline moiety site selectively 
to a unique cysteine containing protein using 5-iodoacetamide-1,10-phenanthroline as 
described above.[15] However, it has been reported that this reaction can potentially 
form iodine containing side-products which can influence catalytic results.[18] 
Nevertheless, many other nitrogen donor ligands have been introduced via site 
selective linkage to cysteine in a similar way.[19] 
The synthesis of a dipicolylamine based nitrogen donor ligand N4 for this purpose is 
given below. In addition, nitrogen donor ligands N1[20], N2[14] and N3[21] were used in 
this study, (Figure 1). Several other synthetic routes to novel nitrogen donor ligands 
which were not completed can be found in appendix A9.  
 
Figure 1. Nitrogen donor ligands used for bioconjugation to unique cysteine SCP-2L 
templates in addition to dipicolylamine based ligands. 
 
5.3.1.2 Synthesis of dipicolylamine based ligands 
Nitrogen donor ligands based on the dipicolylamine moiety have not yet been 
explored for copper catalysed reactions. They have however been used in radioactive 
labelling of various macromolecular scaffolds and complex studies involving copper 
and other transition metals.[22]  
 
Scheme 5. Synthesis of dipicolylamine based ligands N4. 
 
Dipicolylamine is commercially available and can be readily modified with 
functionalities for bioconjugation to cysteine. A single step synthetic procedure did 
provide functionalized dipicolylamine based ligand N4 (Scheme 5). Maleimide 
containing N4 was synthesised by an amide bond formation procedure between 
dipicolylamine and 3-maleimidopropionic acid using N,N’-dicyclohexylcarbodiimide 
Chapter 5. Artificial copper-enzymes for asymmetric reactions 
Artificial Metalloenzymes; Modified Proteins as Tuneable Transition Metal Catalysts 
 
184 
(DCC) and hydroxybenzotriazole (HOBT), affording N4 in 95% yield. Other 




Ligand N1 contains a terpyridine motif with a carboxylic acid linker which is suitable 
for bioconjugation via activation of the carboxylic acid.[23] However, activation using 
1,1’-carbodiimidazole (CDI) and subsequent bioconjugation to SCP-2L V83C 
resulted in unselective modification (Table 1, entries 1-3). These results were similar 
to those obtained for carboxylic acid containing phosphine ligands described in 
section 3.3.1.  
 
Table 1. Results of bioconjugation of SCP-2L V83Ca with nitrogen donor ligands N1-
N4.b 
Multiple modification 




(%) 2x (%) 3x (%) 4x (%) 
1c N1 2 63 37 - - - 
2c N1 11 47 50 3 - - 
3c N1 20 22 75 3 - - 
4 N2 1 90 10 - - - 
5 N2 3 74 24 2 - - 
6 N2 5 41 40 16 3 - 
7 N2 10 38 41 18 3 - 
8 N2 20 10 31 35 19 5 
9 N3 10 - 100 - - - 
10 N4 10 - 100 - - - 
a) SCP-2L V83C obtained by the purification procedure without nickel affinity 
chromatography was used for entries 1-3 (see chapter 2 section 2.5.3.3 for more 
details) b) Conditions: 15 µM SCP-2L V83C, 5-20 equivalents of activated CDI 
activated carboxylic acid (from 25 µM stock in DMF) in 20 mM MES 50 mM NaCl 
pH 6 buffer. Product formation (%) determined by peak height ratios in mass 
spectroscopy (ES+). c) 20 mM HEPES pH 7 buffer. 
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The N-hydroxysuccinimide (NHS) activated dipyridine ligand N2 showed the same 
selectivity problems (Table 1, entries 4-6). Therefore, activated carboxylic acid 
bearing ligands proved unsuitable for selective modification of SCP-2L V83C as 
already discussed before in chapter 3.  
In line with the results described before in chapters 2 and 3, maleimide conjugation of 
nitrogen-ligands to SCP-2L V83C proved successful. Maleimide-phenanthroline N3 
was readily introduced site selectively to the cysteine of SCP-2L V83C (Table 1, 
entry 9). Full conversion to the conjugation product was also observed for the 
modification of SCP-2L A100C with N3.  
Maleimide containing ligand N4 was conjugated to SCP-2L V83C giving full 
conversion to the modification product (Table 1, entry 10). The same results were 
obtained using SCP-2L A100C as protein template.  
Thus the two maleimide containing nitrogen donor ligands N3 and N4 were found to 
be the most suitable ligands for cysteine-selective bioconjugation. A disadvantage of 
this modification technique is that a chiral carbon is formed during the reaction which 
gives the possibility of the formation of different stereoisomers. This is highly 
undesirable considering the envisaged application in asymmetric catalysis. However, 
there is a good possibilty that a preference for one of the stereoisomers is induced by 
the chiral protein environment. The selective formation of stereoisomers is difficult to 
determine, therefore a different modification procedure might be required for future 
application. Nevertheless, the modification of SCP-2L V83C and SCP-2L 100C with 
ligands N3 and N4 provided us with a small set of modified proteins, which could be 
used for initial catalytic studies. 
 
5.3.2 Copper complex formation 
5.3.2.1 Synthesis of copper complexes of maleimide-nitrogen ligand N4 
Two approaches can be taken to obtain artificial metalloenzymes of proteins modified 
with the above nitrogen donor ligands. The first is to couple a pre-formed metal 
complex to the protein and the second is to add the transition metal after modification. 
A preformed copper complex was obtained by a reaction of ligand N4 with 
copper(II)chloride, which was tested in the bioconjugation to the unique cysteine of  
the protein (Scheme 6).  
Chapter 5. Artificial copper-enzymes for asymmetric reactions 
Artificial Metalloenzymes; Modified Proteins as Tuneable Transition Metal Catalysts 
 
186 
Crystals suitable for X-ray crystallography were obtained and the resulting structure 
confirmed the formation of a N4-copperdichloride complex with N4 acting as a 
tridentate ligand (Figure 2, see appendix A10 for more information). The structure is 
found as a trigonal bipyramid with the two chloride atoms and the amide nitrogen 
atom in the equatorial plane and the pyridine nitrogen atoms in the axial positions. 
The bond angles show that trigonal bipyramid is distorted with the N1-Cu1-N2 angle 
being lower than 160º, which is most likely caused by the ligand structure. From the 
bond distances it can be concluded that the amide nitrogen forms a weaker nitrogen 
copper bond compared to the two electron rich pyridine nitrogen atoms. The crystal 
structure also confirmed that the double bond of the maleimide, which is essential for 
cysteine conjugation, remained unaffected as a bond distance typical for a C=C bond 
was observed. An EPR spectrum was also recorded of N4CuCl2 (see appendix A10). 
 
Scheme 6. Copper complex formation of N4. 
 
 
Figure 2. Crystal structure of N4CuCl2 and selected bond distances and angles. 
 
Selected bond distances: 
Cu1-N1  1.989 Å 
Cu1-N2  2.014 Å 
Cu1-N3  2.381 Å 
Cu1-Cl2  2.294 Å 
Cu1-Cl3  2.266 Å 
C17-C18  1.437 Å 
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5.3.2.2 Modification using preformed copper complexes 
Modification of SCP-2L V83C with 3-10 equivalents of N4CuCl2 was performed 
using standard condition for maleimide conjugation to cysteine described in earlier 
chapters (Scheme 7).  
 
Scheme 7. Bioconjugation of SCP-2L V83C with N4CuCl2 resulting in a SCP-2L 
V83C dimer. 
 
Disappointingly, analysis of the reaction product by LCMS(ES+) gave only a signal 
corresponding to the dimer of SCP-2L V83C (expected 26751 Da, found 26750 Da) 
which is likely the result of copper catalysed disulfide bridge formation. A small 
fraction of SCP-2L V83C modified with N4 (<5%) was also found but no peaks 
corresponding to copper adducts were detected. Notably, the colour of the protein 
solution remained blue after washing and concentration, similar to the original copper 
complex. This indicated that copper is still present in the protein. Whether this is the 
result of copper coordinating to N4 inside the protein, providing a species which is 
not observed in mass-spectroscopic analysis or of copper complexes formed with 
other amino acid side chains remains unclear from these experiments. The dimer 
formation could be suppressed by addition of the reducing agent tris(2-
carboxyethyl)phosphine (TCEP) in an equimolar ratio to N4CuCl2. Although, this 
experiment led to increased formation of SCP-2L V83C-N4 (75% modified protein, 
25% unmodified protein), still no peaks corresponding to any copper adduct were 
detected. 
 
5.3.2.3 Complex formation by addition of metal salt to nitrogen donor ligand 
modified proteins 
The second approach was to form copper complexes after modification of the unique 
cysteine with nitrogen donor ligands N3 and N4 (Scheme 8). Copper(II)nitrate 
trihydrate was used for this purpose because of its water solubility. Disappointingly, 
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no copper adducts were found upon LCMS(ES+) analysis of the soluble fraction after 
the reaction. The observed signals in the mass-spectrum were identical to those before 
the addition of copper.  
 
Scheme 8. Copper complex formation by addition of Cu(NO3)2 •3 H2O N4 and N5 
modified proteins. 
 
The outcome of the above experiments can be explained in two ways. The first is that 
no copper adducts are formed, which is somewhat unexpected since the introduced 
nitrogen ligands have a high affinity for copper. The second is that the copper adducts 
are not suitable for detection by mass-spectroscopic analysis using the setup and 
conditions used in this research. The second hypothesis is supported by the fact that 
no mass-spectra of copper adducts have been reported in earlier studies using copper 
adducts of proteins.[4a, 12-13, 15-16] Therefore, the complexation was also studied using 
fluorescence spectroscopy. This method was applied by Distefano and co-workers to 
confirm copper complexation to the ALBP-phenanthroline conjugates developed in 
his group.[15-16] They showed that the fluorescence emission peak of the protein-bound 
phenanthroline at 406 nm that occurs upon excitation at 275 nm is quenched upon 
addition of copper(II)sulphate. It was established that this quenching is the result of 
copper coordination to phenanthroline by analysis of the fluorescence spectra of the 
analogous non-conjugated complexes. The fluorescent signal was restored by 
extraction of the copper from the protein by addition of an excess of a copper 
chelating agent like the disodium salt of ethylenediaminetetraacetic acid (EDTA). 
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Figure 3. Fluorescence emission spectra obtained upon excitation at 275 nm of a) 
SCP-2L V83C (black), SCP-2L V83C-N3 (red), + 1 equivalent of copper(II)nitrate 
(green), + 100 equivalents of EDTA (blue) and the difference spectrum of SCP-2L 
SCP-2L V83C-N3 +1 equivalent of copper(II)nitrate and V83C-N3 (yellow) b) SCP-
2L A100C (black), SCP-2L A100C-N3 (red), +1 equivalent of copper(II)nitrate 
(green), + 100 equivalents of EDTA (blue) and the difference spectrum of SCP-2L 
SCP-2L A100C-N3 +1 equivalent of copper(II)nitrate and A100C-N3 (yellow). 
 
The fluorescence emission spectrum of SCP-2L V83C-N3 upon excitation at 275 nm 
shows a peak at 336 nm and a shoulder with a maximum at 402 nm (Figure 3a) This 
shoulder is absent in the spectrum obtained for SCP-2L V83C and is thus assigned to 
a) 
b) 
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the conjugated phenanthroline. The shoulder disappears upon addition of one 
equivalent of copper(II)nitrate, affording a signal that corresponds closely to the 
emission spectrum of unmodified SCP-2L V83C. The addition of 100 equivalents of 
EDTA to the solution containing the copper adduct of SCP-2L V83C-N5 provides a 
spectrum that is similar to that obtained for SCP-2L V83C-N3, indicating removal of 
the copper.  
The fluorescence emission spectrum of SCP-2L A100C-N3 upon excitation at 275 nm 
also shows a similar shoulder compared to that of SCP-2L V83C-N3 (Figure 3b). The 
native fluorescence of SCP-2L A100C is significantly more intense than that of SCP-
2L V83C however the intensity of the shoulder remains the same. This shoulder has a 
maximum of 407 nm. Also this shoulder disappears upon addition of copper and 
reappears upon the subsequent addition of EDTA. 
These results demonstrate the coordination of copper to the phenanthrolines of SCP-
2L V83C-N3 and SCP-2L A100C-N3. Copper binding must be very specific for the 
introduced phenanthrolines as one equivalent of copper already completely quenches 
their signal. Therefore, it can be concluded that LCMS(ES+) is an unsuitable 
technique for analysis of the copper adducts of protein-N3. These results suggest that 
it is likely that copper adducts of protein-N4 conjugates are also formed. The 
application of other analysis procedures, for example EPR, might confirm this in the 
future. 
 
5.3.3 Application of nitrogen donor ligand modified SCP-2L as catalyst in 
copper catalysed reactions 
5.3.3.1 Asymmetric Diels-Alder reaction 
We decided to test our nitrogen ligand modified SCP-2L mutants in the Diels-Alder 
reaction between azachalcone and cyclopentadiene as performed by Roelfes and 
Reetz using their bioinspired catalyst systems (Scheme 9).[6, 10a, 12-13]  
 
Scheme 9. Copper catalysed Diels-Alder reaction using nitrogen donor ligands. 
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The results of the reaction using the modified proteins and a series of control reactions 
are displayed in Table 2. The conversion varied largely depending on the reaction but 
average to good conversions were observed using the artificial metalloenzymes. 
Overall, copper adducts with ligand N3 gave lower conversion than those with N4 
(Table 2, compare entries 1, 3 and 4 with 2, 5 and 6). Higher Endo/Exo ratios were 
found for copper adduct of N4 compared to N3, which demonstrated that also the 
Endo/Exo ratio was dependent on the nitrogen ligand used. Interestingly, 
dipicolylamine ligands have never been used for copper catalysed Diels-Alder 
reactions, but seem to give good conversion and Endo-Exo selectivity.  
 
Table 2. Results of Diels-Alder reactions using nitrogen ligand modified SCP-2L 
mutants.a 
Entry Ligand Conversion (%)b Endo/Exob Ee (%)b 
1 N3 26.9 (±8.5) 5.7 (±0.4) - 
2 N4 85.1 (±4.7) 10.6 (±0.1) - 
3 SCP-2L V83C-N3 19.6 (±9.2) 7.6 (±2.4) 25.1 (±2.0) 
4 SCP-2L A100C-N3 43.4 (±3.0) 11.7 (±2.4) - 
5 SCP-2L V83C-N4 86.8 (±8.7) 14.3 (±2.9) 4.1 (±2.7) 
6 SCP-2L A100C-N4 76.3 (±8.9) 17.6 (±1.3) -5.4 (±3.2) 
7 - 90.3 (±7.1) 14.1 (±0.2) - 
8c - 9.8 (±0.5) 6.0 (±0.5) - 
9 SCP-2L V83C 42.7 (±45.7)d 17.8 (±0.8) -5.9 (±0.7) 
10 SCP-2L A100C 65.7 (±7.4) 8.8 (±2.4) 8.1 (±1.4) 
11e SCP-2L 6.5 (±1.5) 3.4 (±0.6) - 
a) 50 nmol Ligand, 45 nmol Cu(NO3)2, 0.5 µmol azachalcone and 15 µmol 
cyclopentadiene in 20 mM MES 50 mM NaCl pH 6, total volume 0.8 ml, shaken for 
72 hours at 4ºC b) Analysed by HPLC the ee is given for the endo product and a 
negative value corresponds to the (-)-enantiomer and a positive to the (+)-enantiomer, 
standard deviations are given between brackets c) no copper was added d) a large 
deviation in the conversion was observed with either ~90% or ~10% conversion e) 
total volume of 1.2 ml. 
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The reaction catalysed by “free” copper gave the highest conversion and a high 
Endo/Exo ratio (Table 2, entry 7). The non catalysed reaction also proceeds but with 
low conversion and a low Endo/Exo ratio (Table 2, entry 8). Product formation was 
also observed for reactions employing the unique cysteine SCP-2L templates 
themselves as ligands (Table 2, entries 9 and 10). A significant lower conversion was 
observed using native SCP-2L not containing any cysteine, which indicates that the 
free cysteine in SCP-2L V83C and SCP-2L A100C might be involved in copper 
coordination to give an active catalyst (Table 2, entry 11). On average, very low ee 
was found but the reaction using SCP-2L V83C-N3 as catalyst gave a promising ee of 
25%. Interestingly, the ee was found to be dependent on the protein template used 
even when the same nitrogen donor ligand was introduced. SCP-2L A100C-N3 gave 
no ee while SCP-2L V83C-N3 does and SCP-2L V83C-N4 and SCP-2L A100C-N4 
give low ee but of the opposite enantiomer. The ee found for unmodified SCP-2L 
V83C and SCP-2L A100C is also interesting as selectivity for the opposite 
enantiomers was found. In addition, no ee was found for SCP-2L itself once again 
indicating involvement of the cysteine sulfide on the reaction. Overall, the results 
suggest that it may be possible to obtain highly enantioselective copper-catalysts by 
combining SCP-2L and different nitrogen donor ligands. Further optimisation using 
both changes to the protein template as well as the introduction of different nitrogen 
donor ligands might lead to more selective catalysts. Also the transition metal can be 
varied as demonstrated by a ruthenium system developed for Diels-Alder reactions by 
the group of Salmain.[24] 
 
5.3.3.2 Michael addition reaction 
The same catalyst systems as employed for the Diels-Alder reaction were also used 
for a copper catalysed 1,4- addition reaction (also called Michael addition reaction). 
This reaction has been successfully applied by the group of Roelfes for several of 
their copper based catalytic systems involving nitrogen donor ligands.[7] This reaction 
was performed using the same azachalcone substrate as for the Diels-Alder reactions 
with dimethylmalonate as nucleophile (Scheme 10).[10a].  
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Scheme 10. Copper catalysed Michael addition reaction using nitrogen donor ligands. 
 
The reactions using ligands N3 and N4 provided only low conversions, with the 
former performing significantly better than the latter. The N3 and N4 modified 
protein templates performed better as ligands compared to ligands N3 and N4 by 
themselves giving conversions from 36 to 71%. Disappointingly, no ee was found 
using the protein based catalysts. These results show that either the selected protein 
environment or the used nitrogen cofactors make the developed catalyst system 
unsuitable to induce chirality in the reaction above. Further experimentation and 
optimisation are required to indicate the cause of this and to develop effective 
catalysts for this reaction. 
 
Table 3. Result for the Michael addition reactions using nitrogen ligand modified 
SCP-2L mutants.a 
Entry Ligandb Conversion (%)b 
1 N3 24.7 (±4.5) 
2 N4 5.8 (±2.3) 
3 SCP-2L V83C-N3 36.5 (±7.1) 
4 SCP-2L A100C-N3 70.7 (±6.1) 
5 SCP-2L V83C-N4 69.0 (±5.8) 
6 SCP-2L A100C-N4 61.4 (±8.8) 
7 - 31.7 (±10.3) 
8c - - 
a) 50 nmol ligand, 45 nmol Cu(NO3)2, 0.5 µmol azachalcone and 50 µmol 
dimethylmalonate in 20 mM MES 50 mM NaCl pH 6, total volume 0.8 ml, shaken for 
72 hours at 4ºC b) Analysed by HPLC c) no copper was added. 
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5.3.4. Structural characterization of the modified proteins 
SCP-2L V83C-N4 showed the remarkable results in the copper catalysed Diels-Alders 
reaction and was therefore studied by CD and watergate 1H-NMR spectroscopy to get 
some insight in the effect of this modification on the protein fold. The near UV CD-
spectra of SCP-2L V83C modified with nitrogen donor ligand N4 was recorded and 
compared to that of SCP-2L V83C (Figure 4). The main change is the increased 
signal between 260 and 275 nm. This increase can be assigned to the introduced 
pyridine rings of the ligands interacting with the chiral environment of the protein. 
The increase in the signal between 260 and 275 nm is extended to the region between 
250 and 260 nm indicating a change to the helical structure of the protein, which gives 
strong signals in the far UV between 200 and 250 nm. This was also observed for the 
modification of SCP-2L V83C with phosphine ligands (described in chapter 3) and 
can be ascribed to a conformational change in the cysteine-containing helix upon 
modification of this cysteine. The remainder of the spectrum indicated a loss of 
structure similar to that observed for the phosphine modifications, which is most clear 
for the signals at 287, 294 and 300 nm. 
 
Figure 4. Near UV CD-spectra of SCP-2L V83C (red) and SCP-2L V83C-N4 (blue). 
 
The watergate 1H-NMR spectra of SCP-2L V83C-N4 was recorded and compared to 
that of SCP-2L V83C (Figure 5). This spectrum is recorded in phosphate buffer which 
does not have proton signals. Therefore no buffer signals are observed like the ones 
for MES in the spectrum of SCP-2L V83C at 3.61, 2.99 2.76 and 2.54 ppm. The effect 
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of the different buffers on the fold of the proteins is expected to be relatively small. 
The spectrum of SCP-2L V83C-N4 seems only slightly more distorted than that of 
SCP-2L V83C. Some peaks have shifted slightly but overall the structure seems to be 
retained These results indicate some minor changes to the structural integrity of the 
protein. 
The influence of the introduction of the ligand on the substrate binding capacity of the 
protein was assessed by a fluorescent binding study using the procedure described in 
chapter 2. The combined data provided binding constants (Kd) for the fluorescent 
probe Pyr-C12 of 0.25 (+/-0.04) µM for SCP-2L V83C-N4. This Kd value is in the 
same order of magnitude as the Kd of 0.18 (±0.07) µM found for SCP-2L V83C itself. 
This result indicates that the substrate binding capabilities of SCP-2L remain 
effectively the same after the modification with N4. From the results obtained from 
the different spectroscopic techniques it can be concluded that although the structure 
of SCP-2L V83C-N4 is slightly altered compared to that of SCP-2L V83C these 
changes are only minor and do not alter the binding properties of the protein.  
 
Figure 5. Watergate 1H-NMR spectra of SCP-2L V83C (red) and SCP-2L V83C-N4 
(blue) with overlays of the areas between11 and 6 ppm and 2.3 to -0.5 ppm. 
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5.4 Conclusions and future prospects 
The results in this chapter demonstrate how an enantioselective artificial 
metalloenzyme can be created from SCP-2L via the covalent introduction of nitrogen-
ligands. Maleimide containing nitrogen donor ligands were found most suitable for 
cysteine selective introduction into SCP-2L. Unfortunately, the analysis of copper 
conjugates proved troublesome using LCMS(ES+). Copper coordination was 
confirmed by fluorescence spectroscopy; however, this approach is limited to 
phenanthroline and other fluorescent ligands. Other techniques will have to be applied 
to confirm the formation of coordination products with other ligands. One such a 
technique is EPR which already has been shown in literature to be useful for 
characterisation of such systems. Although maleimides have the disadvantage of the 
formation of diastereomers, initial catalytic results showed promising results. The 
selectivity and activity of the Diels-Alder reaction between azachalcone and 
cyclopentadiene proved to be influenced by both the introduced nitrogen donor ligand 
and the protein environment. This makes the system using SCP-2L V83C-N3 that 
gave the highest enantioselectivity of 25% ee a good starting point for further 
optimisation. The results found for the asymmetric Michael addition of 
dimethylmalonate to azachalcone were disappointing. However, more suitable 
catalysts for this reaction might be created by further optimised systems. These 
catalyst systems can be optimised by the introduction of other nitrogen donor ligands 





Where required, reactions were performed under an argon atmosphere using degassed 
solvents and standard Schlenk techniques. For the fluorescent binding study the 
procedure described in section 2.3.3.3 was used. Protein concentrations were 
determined using Bradford’s reagent.[25]  
 
5.5.1.2 Equipment 
NMR spectra were taken at room temperature with Bruker Avance 300, 400 or 500 
NMR spectrometers. Chemical shifts (δ) are given (in ppm) for high-frequency shifts 
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relative to a TMS reference (1H and 13C) or 85% H3PO4 (31P). Watergate 1H-NMR 
spectra were recorded on a Bruker Avance 500 spectrometer. LC-MS(ES+) used for 
analysis of protein and protein reactions was performed on a Waters Alliance HT 
2795 equipped with a Micromass LCT-TOF mass spectrometer, using positive 
electrospray ionisation and applying a Waters MASSPREP® On-line Desalting 2.1x 
10 mm cartridge using a gradient of 1% formic acid in H2O to 1% formic acid in 
acetonitrile. For processing of the mass-spectra the MaxEnt algorithm of Masslynx 
V4.0 (Micromass Ltd) was used. Spin-filter concentrators with a molecular weight 
cut-off of 10kDa (Amicon® Ultra-15 Centrifugal Filter Units, Millipore®, 
Carrigtwohill, Co. Cork, Ireland) were used to concentrate and/or wash protein 
solutions. CD spectra were recorded using a Jasco J-810 spectropolarimeter using a 1 
mg/ml solution of the protein. Elemental analysis was performed by Stephen Boyer at 
the elemental analysis service of the London Metropolitan University. For the 




For dry conditions freshly distilled degassed solvents were used: Dichloromethane 
(DCM) and acetonitrile (MeCN) were distilled from CaH2. Toluene was distilled from 
sodium/benzophenone. Dry DMF was purchased from Acros in a sealed bottle 
containing 4Ǻ molecular sieves and was used as received. Dipicolyl amine and β-
maleoyl propionic acid were obtained from Aldrich. Other reagents were obtained 
from commercial sources in the highest purity. Thin-layer chromatography (TLC) was 
performed on silica (Polygram 0.2mm silica gel with fluorescent indicator UV254). 
Silica gel (60 particle size 0.063-0.2 mm) was used for column chromatography. 
 
5.5.2 Synthesis of dipicolylamine based nitrogen donor ligands 
5.5.2.1 Synthesis of N,N-dipicolyl-N’-maleoyl-3-aminopropanamide N4  
Under an argon atmosphere 138.16 mg (0.75 mmol) dipicolylamine and 138.34 mg 
(0.82 mmol) N-maleoyl-β-analine were dissolved in 10 ml dry DCM. This mixture 
was cooled to 0ºC and 110.8 (0.82 mmol) 1-hydroxybenzotriazole and 169.2 mg (0.82 
mmol) N,N-dicyclohexylcarbodiimide were added. The reaction was stirred 1H at 0ºC 
and than let to heat up to room temperature. Already after 5 minutes white precipitate 
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had formed and the reaction was followed by TLC. Upon completion after 7h the 
white powder was filtered off and the DCM was removed in vacuo from the filtrate. A 
small amount of EtOAc was added to the remaining white solid so that all N4 
dissolved and put in the freezer overnight. The white solid that formed was filtered off 
and the EtOAc was removed from the filtrate by evaporation. The remaining solid 
was purified by flash column chromatography using 150 ml silica and 5% MeOH in 
DCM with a few drops of Et3N. Combination of the fractions and evaporation of the 
solvent resulted in 250 mg (0.714 mmol, 95%) N4 as an off-white oily solid, which 
slowly turned into a hard solid over a few months. 1H-NMR (300 MHz, CDCl3), δ 
8.48 (ddd, 3JHH=4.8 Hz, JHH=1.7 Hz, JHH=0.9 Hz, 1H, Py-H),	  δ 8.43 (ddd, 3JHH=4.9 
Hz, JHH=1.7 Hz, JHH=0.9 Hz, 1H, Py-H), δ 7.62-7.53 (m, 2H, Py-H), δ 7.23 (d, 
3JHH=7.8, 1H, Py-H), δ 7.15-7.06 (m, 3H, Py-H),	  δ 6.60 (s, 2H, Mal-H),	  δ 4.68 (s, 2H, 
Py-CH2-N), δ 5.49 (s, 2H, Py-CH2-N), δ 3.89-3.82 (m, 2H, N-CH2-CH2-CO-N), δ 
2.81-2.76 (m, 2H, N-CO-CH2-CH2-); 13C-NMR (75.47 MHz, CDCl3), δ 170.9 (Cq, 
CH2-CO-N),	  δ 170.5 (Cq, CH-CO-N), δ 157.9 (Cq, PyC-CH2), δ 156.2 (Cq, PyC-CH2),	  
δ 150.0 (CH, PyC-H), δ 150.0 (CH, PyC-H), δ 149.2 (CH, PyC-H), δ 136.9 (CH, 
PyC-H),	  δ 136.8 (CH, PyC-H), δ 134.2 (CH, MalC-H), δ 122.7 (CH, PyC-H), δ 122.6 
(CH, PyC-H), δ 122.4 (CH, PyC-H), δ 121.0 (CH, PyC-H), δ 51.2 (CH2, Py-CH2-N), 
δ 52.9 (CH2, Py-CH2-N), δ 34.2 (CH2, N-CH2-CH2-CO-N), δ 31.4 (CH2, N-CO-CH2-
CH2-); IR-spectrum (PTFE card), 3066.5 cm-1 (w, CH stretch band), 2925.5 cm-1 (w, 
CH stretch band), 1702.9 cm-1 (s, amide CO stretch band), 1642.7 cm-1 (s, amide CO 
stretch band). Elemental analysis calculated for C19H318N4O3: C 65.13, H 5.18, N 
15.99; found: C 65.21, H 5.30, N 15.92. 
 
5.5.3 Bioconjugation 
5.5.3.1 CDI activation of carboxylic acid ligand N1 
This procedure is based on a procedure reported in literature by our group[23b] 5-10 
Equivalents of CDI was added as a solid to a 25 mM solution of the corresponding 
carboxylic acid ligand in dry DMF. The mixture was stirred for 3 or more hours under 
argon atmosphere. The mixture was used as such for the bioconjugation to SCP-2L 
V83C. 
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3.5.3.2 Bioconjugation of activated carboxylic acid phosphines (N1-N2) to 
SCP-2L V83C 
This procedure is based on a procedure reported in literature by our group.[23b] A 15 
µM solution of SCP-2L V83C in buffer (20 mM MES pH 6 or 7) was incubated with 
2-11 equivalents of the activated carboxylic acid ligand added from a 25 mM stock 
solution in DMF. The reaction was stirred for 16 hours and the conversion determined 
by LCMS(ES+). Data obtained by mass-spectroscopy: SCP-2L V83C-N1 (expected 
13565.7 Da, found 13565.8 Da) and SCP-2L V83C-N2 (expected 13558.8 Da, found 
13558.6 Da). 
 
3.5.3.3 General procedure for bioconjugation maleimides to unique cysteine 
mutants of SCP-2L 
A 25-50 µM solution of protein in buffer (20 mM MES 50 mM NaCl pH 6) was 
incubated with 10 equivalents maleimide added from a 50 mM stock solution in the 
corresponding buffer or DMF for water insoluble maleimides. Progress of the reaction 
was monitored using LCMS (ES+) analysis. Typically no residual free protein was 
observed after leaving the reaction overnight. The mixture was washed using a 
centrifugal concentrator with buffer to remove the excess maleimide. Data obtained 
by mass-spectroscopy: SCP-2L V83C-N3 (expected 13651.9 Da, found 13651.6 Da), 
SCP-2L V83C-N4 (expected 13727.0 Da, found 13727.1 Da), SCP-2L A100C-N3 
(expected 13679.9 Da, found 13679.7 Da) and SCP-2L A100C-N4 (expected 13755.0 
Da, found 13755.1 Da). 
 
3.5.4 Fluorescence spectroscopy 
Fluorescence emission spectra were obtained by excitation at 275 nm. A 50 µM 
solution of the protein or modified protein in 20 mM MES 50 mM NaCl pH 6 was 
used for the measurements. 50 µM copper(II)nitrate was added from a 2 mM solution 
in the same buffer. 5 mM EDTA was added from a 1 M stock solution in deionized 
water. The obtained solutions were mixed well after the addition of each solution. 
Equipment settings used: 5 nm excitation and emission slits, PMT of 600 V, scan rate 
50 nm/min, data interval 0.1667 nm, temperature 25 ºC and detection range 300-450 
nm. 
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3.5.5 Catalysis procedures 
3.5.5.1 Diels-Alder reactions 
A solution of 50 nmol ligand and 45 nmol copper(II)nitrate in 794 µL 20 mM MES 50 
mM NaCl pH 6 buffer was mixed for 1 hour prior to the catalytic reactions.. The 
ligands N3 and N5 were added from 50 mM solutions in DMSO while free proteins 
and protein conjugates were added from solution in 20 mM MES 50 mM NaCl pH 6 
buffer of which the concentration was determined before use after removal of formed 
precipitate by centrifugation. 5 µL azachalcone from a 100 mM solution in MeCN and 
1 µL freshly cracked and distilled cyclopentadiene were added to the reaction mixture. 
The obtained solution was shaken for 72 hours in a cold room (4ºC). The obtained 
solutions were extracted three times with about 1 ml diethylether and the combined 
organic layers dried en vacuo. The obtained solid was dissolved in 200 µL 1% IPA in 
hexanes, which was used for HPLC analysis. HPLC analysis was performed using an 
OD-H column with a flow of 1 ml/min of 1% IPA in hexanes (retention times: Exo 
products 13.8 and 15.7 minutes, Endo products 17.5 and 23.1 minutes and 
azachalcone 26.9 minutes). The chromatogram was obtained by UV-analysis at 215, 
230, 254 and 280 nm which all give similar data. The data obtained at 230 nm was 
used for the results displayed in Table 2 as these results gave the smallest standard 
deviation for the obtained ee. Conversion was calculated using a calibration using 
standard samples with different ratios between azachalcone and the product. The 
enantiomers were identified using literature data.[26] 
 
3.5.5.2 Michael Addition reactions 
A solution of 50 nmol ligand and 45 nmol copper(II)nitrate in 794 µL 20 mM MES 50 
mM NaCl pH 6 buffer was mixed for 1 hour prior to the reactions. The ligands N3 
and N5 were added from 50 mM solutions in DMSO while free proteins and protein 
conjugates were added from solution in 20 mM MES 50 mM NaCl pH 6 buffer of 
which the concentration was determined before use after removal of formed 
precipitate by centrifugation. 5 µL azachalcone from a 100 mM solution in MeCN and 
0.5 µL dimethylmalonate were added to the reaction mixture. The obtained solution 
was shaken for 72 hours in a cold room (4 ºC). The obtained solutions were extracted 
with diethylether and the combined organic layers dried en vacuo. The obtained solid 
was dissolved 200 µL 5% IPA in hexanes, which was used for HPLC analysis. HPLC 
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analysis was performed using an OD-H column with a flow of 1 ml/min of 5% IPA in 
hexanes (retention times: azachalcone 16.1 and 19.3 minutes and products 40.9 and 
45.3 minutes). The chromatogram was obtained by UV-analysis at 215, 230, 254 and 
280 nm. The data obtained at 215 nm was used for the results displayed in Table 3 as 
the highest peak intensities were obtained. Conversion was calculated using a 
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Chapter 6. Summary, conclusion and outlook 
 
This thesis describes the design, synthesis and application of artificial 
metalloenzymes for transition metal catalysed reactions not performed by natural 
enzymes (Figure 1). The artificial metalloenzymes were designed to contain a 
hydrophobic cavity for binding selected substrates. The proteins were then modified 
covalently with a transition metal ligand complex which generates catalytic activity. 
The creation of a shape selective catalyst is envisioned by the combination of the 
selective substrate binding of the protein and the strategic position of the transition 
metal centre. The key difference between this approach and several other reported 
successful applications of artificial metalloenzymes lies in the virtual unlimited choice 
of proteins for binding of specific substrates. This freedom of choice is facilitated by 
the application of the covalent modification strategy which is a key factor for the 
successful application of this approach. Additionally, the formed catalysts are 
compatible with the use of both synthetic (e.g. optimisation of ligand structure) and 
biomolecular tools (e.g. optimisation of protein environment) for optimisation, which 
has previously been proven very powerful for the development of artificial 
metalloenzymes.  
 
Figure 1. Concept for the design and creation of shape selective artificial 
metalloenzymes. 
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Chapter 2 describes the design and synthesis of unique cysteine containing protein 
templates. Sterol carrier proteins were selected as the class of proteins of choice for 
the use as protein templates because of their affinity for linear aliphatic substrates. 
One such protein, the protein sterol carrier protein 2 like (SCP-2L) domain of 
multifunctional enzyme (MFE) has the advantage that its reported crystal structure 
clearly reveals the hydrophobic binding site (Figure 2 a and b). Unique cysteines were 
introduced at strategic locations around the binding site in SCP-2L by site directed 
mutagenesis to serve as covalent anchoring sites for the transition metal complex. The 
SCP-2L mutants V83C and A100C were successfully produced at large scale (~60 
and ~30 mg/L bacterial culture respectively) and conveniently purified using nickel 
affinity chromatography (Figure 2c and d). The protein structures of the mutations 
were studied using CD and watergate 1H-NMR spectroscopy and were found nearly 
unchanged compared to wild-type SCP-2L. 
 
Figure 2. Cartoon and surface models of SCP-2L, a) Crystal structure showing part of 
a triton-X-100 molecule (red) in the binding site b) side-view of the crystal structure 
showing, upon removal of the substrate, the hydrophobic tunnel crossing through the 
protein c) unique cysteine containing template SCP-2L V83C d) unique cysteine 
containing template SCP-2L A100C (introduced cysteines for covalent modification 
shown in purple). 
 
Chapter 3 describes the bioconjugation of phosphine ligands to the created unique 
cysteine protein templates. The covalent introduction of phosphine ligands proved 
problematic due to the similarity in nucleophilicity of the phosphines compared to the 
thiol of the cysteine. This led to the development of a two step modification procedure 
(Scheme 1). The unique cysteine is selectively modified in the first step with a 
maleimide-hydrazide to introduce an hydrazide functionality into the protein. This 
hydrazide is modified in the second step using phosphino-aldehydes to give 
phosphine modified proteins. The procedure proved most successful for benzaldehyde 
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containing phosphines and was also used in our group to successfully modify a 
variety of other unique cysteine containing proteins. This is the first and so far only 
general applicable covalent modification method developed for the modification of 
proteins with phosphines. This key discovery opens up new possibilities for the 
application of phosphine modified artificial metalloenzymes in addition to 
overcoming a vital problem in this stage of development of the artificial 
metalloenzymes presented in this thesis. Although, it was shown by CD and watergate 
1H-NMR spectroscopy that the structure of SCP-2L was significantly altered by the 
phosphine modifications the constructs did still possess good substrate binding 
capability for a fatty acid labelled with a fluorescent probe.  
 
 
Scheme 1. Two step modification procedure for the introduction of phosphine ligands 
to unique cysteine containing protein templates. 
 
Chapter 4 describes the formation of rhodium adducts of the phosphine modified 
proteins and application of these systems in the rhodium catalysed hydroformylation 
of α-olefins. Rhodium complexes of several phosphine modified proteins were 
obtained by addition of dicarbonyl rhodium acetylacetonate ([Rh(acac)(CO)2], 
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Scheme 2). Although, rhodium addition to the phosphine of the protein constructs was 
confirmed by 31P-NMR and a peak corresponding to the addition of RhCO to the 
phosphine modified proteins was observed upon LCMS(ES+) analysis, the exact 
nature and composition of the rhodium adducts remains unclear. These studies 
showed that it is likely that a mixture of different rhodium adducts is present. 
 
Scheme 2. Rhodium complexation to phosphine-protein constructs. 
 
The rhodium-phosphine containing artificial metalloenzymes were applied in the 
biphasic hydroformylation of linear alkenes (Scheme 3). The aqueous biphasic 
hydroformylation of linear alkenes (n > 3) using water soluble rhodium catalysts and 
typical hydroformylation conditions suffers from severe activity problems due to the 
limited solubility of these substrates in water. This was reflected by the low activity 
found for this system using triphenylphosphine trisulfonate (TPPTS) as water soluble 
phosphine ligand (Figure 3). This system only showed activity for 1-hexene but for 
higher alkenes (n > 5) the found TON’s were close to 0. Much higher activity was 
found using SCP-2L V83C-M5-P3-[Rh] and SCP-2L A100C-M5-P3-[Rh] were used 
as catalysts and also good selectivities were obtained. Activity was still even observed 
for the hydroformylation of 1-octadecene using these catalysts. The difference in 
activity and selectivity between the two applied phosphine-rhodium based artificial 
metalloenzymes suggests that further optimisation of the location of the cysteine 
might lead to further improved catalysts. The observed activity and selectivity for the 
linear product point towards a true shape selective catalyst system in which the 
protein encapsulates the substrate, thereby solubilizing it in the aqueous phase, and 
creating a preference for the formation of the linear product.  
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Scheme 3. Hydroformylation of linear alkenes using rhodium-phosphine complexes. 
 
Figure 3. Comparison of the activity (bars) and selectivity (dots and dashed lines) of 
Rh:TPPTS 1:20 (red), SCP-2L V83C-M5-P3-[Rh] (blue) and SCP-2L A100C-M5-
P3-[Rh] (green) in the biphasic hydroformylation of alkenes. 
 
The chapters 2-4 demonstrate a unique approach for the design and creation of a 
remarkable shape selective catalyst. If it can be confirmed that the found catalytic 
results truly are the result of substrate encapsulation by the protein scaffold, this 
system represents the first rationally designed artificial metalloenzyme which exploits 
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the shape selectivity of the protein scaffold to direct the outcome of a catalytic 
reaction. This catalytic system has numerous possibilities for optimisation. Several 
more phosphine aldehydes are available as well as different maleimide-hydrazines to 
create different linker structures between the protein and the phosphine. Also, the 
protein scaffold can be further optimised by moving the cysteine to different 
locations. Another possibility is the application of computational modelling in 
combination with catalytic results to identify and replace key amino acids. In addition, 
the protein scaffold itself can be completely substituted for another aliphatic substrate 
binding protein, which has been made possible by the development of the generally 
applicable phosphine modification strategy presented in this work. 
This catalyst system demonstrates numerous new possibilities in artificial 
metalloenzymes. New catalytic systems can be designed based on a specific reaction 
and substrate by selection of the protein host that has binding affinity for the 
substrates of interest. Combined with the general applicable conjugation method for 
the introduction of phosphine ligands this opens many new possibilities for the 
creation of artificial metalloenzymes. 
 
Chapter 5 describes an alternative approach in which SCP-2L is used as chiral 
template for application in asymmetric copper catalysed reactions. Two maleimide 
containing nitrogen donor ligands N3 and N4 were site selectively introduced into 
SCP-2L V83C and SCP-2L A100C (Scheme 4). Fluorescent spectroscopy was used to 
confirm copper complexation to the N3 ligand after modification of the protein 
template. The nitrogen ligand modified proteins were applied in the copper catalysed 
asymmetric Diels-Alder reaction between azachalcone and cyclopentadiene (Scheme 
5). A clear difference was found in the performance between ligands N3 and N4, with 
the latter providing higher endo/exo selectivity and activity. This trend was observed 
for the N3 and N4 modified proteins indicating a clear effect of the nitrogen donor 
ligands on the catalytic performance of the conjugates. Also differences in activity 
and selectivity were observed between the different protein templates. The highlight 
was an enantioselectivity of 25% ee for the Diels-Alder reaction catalysed by SCP-2L 
V83C-N3.  
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Scheme 4. Modification of SCP-2L unique cysteine templates with nitrogen ligands 
 
 
Scheme 5. Copper catalysed Diels-Alder reaction between azachalcone and 
cyclopentadiene 
 
The alternative approach of the use of protein templates as chiral ligands in catalysis 
presented in chapter 5 has already been used by other research groups. However, no 
covalent modified proteins have so far been applied in copper catalysed Diels-Alder 
reactions. The system still has many opportunities for further optimisation using 
different nitrogen donor ligands and by optimisation of the protein structure. The 
covalent introduction of the nitrogen donor ligands also allows for the choice of 
different protein templates that might be more suitable for the induction of selectivity 
in copper catalysed reactions. An example of this would be a protein that can ensure 
proper orientation of the substrate when bound to the catalytic centre. In this way it 
can activate a reaction pathway that leads to the selective formation of one particular 
reaction product. The proper protein structure can be obtained by searching for a 
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protein with a specific active site, shape and dimensions or can designed using 
computational methods starting from a suitable protein host.  
Overall, this thesis demonstrates the development of new artificial metalloenzymes 
based on covalent modification strategies. The freedom of the choice of the protein 
template has been demonstrated to be useful to rationally select a protein that has the 
desired binding properties for a type of substrates of choice. The created shape 
selective hydroformylation catalyst is the first of its kind and might be a milestone for 
the future development of many more interesting artificial metalloenzymes. New 
artificial metalloenzyme catalyst can be designed by utilising the binding properties of 
the protein host for a desired substrate. This provides new opportunities for chemo- 
and stereo- selectivity and substrate specificity for reactions not performed by natural 
enzymes unequalled by traditional synthetic homogeneous catalysts.  
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A1 Peptide sequences 























- Red amino acids show the target sequences of TEV with the “/” indicating the 
cleavage site[2] 
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- Amino acids marked in red are added to the original sequence of SCP-2L 
 




- Red amino acids show the target sequences of TEV with the “/” indicating the 
cleavage site[2] 
- The introduced cysteine is highlighted in purple 
 




- Amino acids marked in red are added to the original sequence of SCP-2L 
- The introduced cysteine is highlighted in purple 
 




- Red amino acids show the target sequence of TEV with the “/” indicating the 
cleavage site[2] 
- The introduced cysteine is highlighted in purple 
 




- Red amino acids show the target sequence of TEV with the “/” indicating the 
cleavage site[2] 
- The introduced cysteine is highlighted in purple 
 
SCP-2L V83C after TEV cleavage 
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- Amino acids marked in red are added to the original sequence of SCP-2L 
- The introduced cysteine is highlighted in purple 
 




- Red amino acids show the target sequences of TEV with the “/” indicating the 
cleavage site[2] 
- The introduced cysteine is highlighted in purple 
 




- Amino acids marked in red are added to the original sequence of SCP-2L 
- The introduced cysteine is highlighted in purple 
 
A1.2 mSCP2 sequences 









- Red amino acids show the target sequences of TEV with the “/” indicating the 
cleavage site[2] 
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- Blue amino acids (including green) shows original mSCP2 sequence[3] 
- Green indicating the native cysteine 
 




- Amino acids marked in red are added to the original sequence of mSCP2 
- Blue amino acids (including green) shows original mSCP2 sequence[3] 
- The native cysteine is highlighted in green 
 









- Red amino acids show the target sequences of TEV with the “/” indicating the 
cleavage site[2] 
- The introduced cysteine is highlighted in purple 
- The location of the replacement of the native cysteine for serine is highlighted in 
orange 
 




- Amino acids marked in red are added to the original sequence of mSCP2 
- The introduced cysteine is highlighted in purple 
- The location of the replacement of the native cysteine for serine is highlighted in 
orange 
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A3 Structural characterization of SCP-2L V83C-P4 
Our group has reported several successful 31P-NMR studies of phosphine modified 
proteins.[4] By application of this method it is possible to confirm whether the 
introduced phosphine is indeed obtained as a free phosphine. An attempt was made to 
perform the modification reaction of SCP-2L V83C with CDI activated C4 at a scale 
that would allow conformation of the presence of the free phosphine by 31P-NMR 
spectroscopy. 
 
Figure 1. 31P{1H} NMR spectrum of SCP-2L V83C-C4.  
 
The 31P{1H} NMR spectrum of SCP-2L V83C-C4 was recorded at 202 MHz using 
30000 scans (Figure 1). The obtained spectrum showed 4 peaks which based on the 
peak intensities appear to be two sets of two relatively broad peaks (set 1: –14.3 ppm, 
–21.0 ppm; set 2: –14.7 ppm and –23.1 ppm). The presence of two sets of signals 
could be the result of modification of the protein in two different positions or the 
ligand being in two different conformations. The large difference between the two 
phosphorus peaks within each apparent set (7-8 ppm compared to 1 ppm in the 
31P{1H} NMR spectrum of the free ligand) are likely to be the result of two entirely 
different environments of the two phosphines.  
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The CD spectrum (Figure 2) and watergate 1H- NMR (Figure 3) spectrum of SCP-2L 
V83C modified with C4 were recorded to investigate the structural integrity of the 
protein upon modification. Although the CD measurement could not be performed 
under oxygen free conditions, the results still yield relevant structural information as 
the structures of the phosphine and phosphine oxide are not expected to differ 
significantly. Watergate 1H-NMR can be performed under oxygen free atmosphere as 
the sample preparation and the measurement are fully compatible with this.  
 
Figure 2. Near UV-CD spectra of SCP-2L V83C (black) and SCP-2L V83C-C4 (red). 
 
The CD spectrum shows significant changes to the signals at 287, 290, 294 and 300 
nm and an increase in the signal at 250 - 275 nm. The latter increase can be assigned 
to the introduced phenyl substituents attached to the phosphines. This result indicates 
that the phosphines are affected by the chiral environment of the protein which is 
promising for application of the conjugate in asymmetric catalytic reactions Another 
effect that can play a role in the increased signal at around 250 nm can be due to 
partial unfolding of α-helices, as intact helices give a strong negative signal in the 
range of 190-240 nm. This is to be expected as C4 is likely partly introduced at 
cysteine at position 83 which is part of the front α helical structure (see section 2.4.3 
of chapter 2). Thus, it seems the structure of the protein is affected by the introduction 
of the ligand. However, the global structure seems retained as the general shape of the 
spectrum between 275 and 320 is retained.  
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Although the phase correction was troublesome the watergate 1H-NMR spectrum 
provides some interesting information. Significant changes can be observed when 
compared to the spectrum obtained from the unmodified protein discussed in chapter 
2 section 2.4.3. In the region above 5 ppm (Figure 3a) all peaks have shifted and are 
broader indicating a more flexible fold. Also in the region around 0 ppm (Figure 3b), 
where signals corresponding to aliphatic residues inside the hydrophobic core of the 
protein are located, significant changes are observed. This can indicate significant 
changes to the cavity structure caused by the incorporation of the hydrophobic ligand. 
The region between 0.5 and 2.5 ppm (Figure 3b) also shows some perturbations but 
also clear similarity indicating that part of the structure is retained. 
 
Figure 3. Watergate 1H-NMR spectra of SCP-2L V83C modified with C4 (red) and 
SCP-2L V83C (blue) 2 mM in 20 mM MES pH = 6 buffer a) overlaid in the region 
between 11 and 6 ppm b) overlaid in the region between 2.3 and -0.5 ppm c) full 
spectra offset for clarity.  
 
A4 Ligand-protein models created using GOLD 
Several models were created of SCP-2L with phosphine modifications to study the 
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were created with GOLD[5] using models of the unique cysteine templates created by 
the SWISS-MODEL online service based on the reported SCP-2L crystal structure 
(1IKT)[6] and structures of the ligands optimised using semi-empirical structure 
optimisations of Spartan Wavefunction (Figure 4).  
 
 
Figure 4. Models of SCP-2L mutant templates of E14C, W36C, V83C and A100C 
with the introduced cysteine shown in red created by SWISS-MODEL online and 
phosphine-hydrazone ligands with Chemdraw and Spartan Wavelength optimized 
structures. 
 
The ligand was covalently docked in the protein structure by overlapping the sulfur 
atoms in both the ligand and the protein structure. Both the S or R conformation of the 
chiral centre created by sulfide-maleimide bond were created and used in the 
optimisation process. Selections of the top ranked structures obtained from 20 
optimisations are shown in Figure 5. Little difference was found between the 
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structures obtained for the maleimide-hydrazone-diphenylphosphine benzaldehyde 
ligands P1-P3 (ortho, meta and para) for each separate protein template (that is why 
only one of each is shown for each template). All the obtained structures for these 
three ligands show that the triphenylphosphine motif has the tendency to be located in 
the wide entrance of the tunnel. This causes the ligand to cap the tunnel for the 
structures obtained for SCP-2L E14C and SCP-2L V83C while the ligand takes up 
almost the entire space of the tunnel for SCP-2L W36C and SCP-2L A100C. The 
structures obtained for the Whitesides based ligand P4 (ws) show that tunnel is only 
large enough to accommodate one of the triphenylphosphine moieties while the other 
triphenylphosphine moiety is located outside of the tunnel. The structures obtained for 
the nixantphos based ligand P6 (nix) demonstrate that this ligand is too large to be 
accommodated by the protein tunnel and therefore is only party located herein. 
Additional models can be found on the CD accompanying this thesis (The program 











Figure 5. Selection of the top ranked results obtained by GOLD of a) SCP-2L E14C 
with from left to right: R-ortho, S-ws and S-nix b) SCP-2L W36C (with R-para, S-
ws and R-nix) c) SCP-2L V83C (with R-meta, R-ws and R-nix) and d) SCP-2L 
A100C (with S-para, S-ws and S-nix) with the cysteine shown in red and R and S 
before the name of the ligand indicating the geometry of the chiral centre of the 
maleimide-sulfide bond. 
 
A5 Crystal structures I1 and I8 
A5.1 Crystallographic data obtained for I1 
Below the crystallographic data is presented for I1 (Figure 6 and Table 1). An 








Figure 6. a) Crystal structure of I1. b) Crystal structure of I1 showing the hydrogen 
bonding between H70 and O6. 
 
Table 1. Crystal data and structure refinement for I1 (St. Andrews reference = pdpk6). 
Identification code  pdpk6 
Empirical formula  C6 H10 O4 
Formula weight  146.14 
Temperature  173(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
a = 5.2617(7) Å α = 90°. 
b = 7.4044(9) Å β = 95.078(4)°. 
Unit cell dimensions 
c = 17.841(2) Å γ = 90°. 
Volume 692.34(15) Å3 
Z 4 
Density (calculated) 1.402 Mg/m3 
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Crystal size 0.150 x 0.150 x 0.030 mm3 
Theta range for data collection 4.98 to 67.46°. 
Index ranges -5<=h<=5, -8<=k<=8, -21<=l<=21 
Reflections collected 5576 
Independent reflections 1074 [R(int) = 0.0523] 
Completeness to theta = 67.00° 86.6 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.9261 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1074 / 1 / 96 
Goodness-of-fit on F2 1.056 
Final R indices [I>2sigma(I)] R1 = 0.0488, wR2 = 0.1359 
R indices (all data) R1 = 0.0493, wR2 = 0.1367 
Extinction coefficient 0.037(7) 
Largest diff. peak and hole 0.282 and -0.264 e.Å-3 
 
A5.2 Crystallographic data obtained for I8 
Below the crystallographic data is presented for I8 (Figure 7 and Table 2). An 
overview of all bond angles and distances can be found on the accompanying CD. 
 
Figure 7. Crystal structure of I8. 
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Table 2. Crystal data and structure refinement for I8 (St. Andrews reference = pdpk7). 
Identification code  pdpk7 
Empirical formula  C42 H37 N O3 P2 
Formula weight  665.67 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
a = 10.340(3) Å α = 71.513(18)°. 
b = 11.455(2) Å β = 89.22(3)°. 
Unit cell dimensions 
c = 15.299(4) Å γ = 78.64(2)°. 
Volume 1682.6(7) Å3 
Z 2 
Density (calculated) 1.314 Mg/m3 
Absorption coefficient 0.172 mm-1 
F(000) 700 
Crystal size 0.2000 x 0.2000 x 0.1000 mm3 
Theta range for data collection 3.04 to 25.29°. 
Index ranges -12<=h<=12, -9<=k<=13, -16<=l<=18 
Reflections collected 10625 
Independent reflections 5912 [R(int) = 0.0517] 
Completeness to theta = 25.00° 97.0 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.6424 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5912 / 0 / 433 
Goodness-of-fit on F2 0.990 
Final R indices [I>2sigma(I)] R1 = 0.0676, wR2 = 0.1556 
R indices (all data) R1 = 0.1144, wR2 = 0.1806 
Largest diff. peak and hole 0.960 and -0.307 e.Å-3 
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A6 1H-NMR spectroscopic data for the side products of the reaction 
between I1 and I2 
Compound I2 was a side-product in the reaction 
described in section 3.5.6.3. It was obtained as a 2:1 
mixture with iso-butylcarbamate of I2 from the alumina 
column described in that section. Rf=0.8 (Al2O3, 7:3 
PE:EtOAc); 1H-NMR (400 MHz, CDCl3), δ 7.40-7.20 (m, 20H, Ar-CH), δ 3.73 (d, 
3JHH=6.7 Hz, 2H, -O-CH2-CH(CH3)2), δ 3.35-3.12 (m, 4H, Ph2P-CH2-CH2-), δ 2.30-
2.08 (m, 4H, -CH2-CH2-N-), δ 1.77 (12tet, 3JHH=6.7 Hz, 1H, -O-CH2-CH(CH3)2) , δ 
0.79 (d, 3JHH=6.7 Hz, 6H, -O-CH2-CH(CH3)2); 31P-{1H}-NMR (162 MHz, CDCl3), δ -
21.0 (s, 2P, -PPh2). 
1H-NMR (400 MHz, CDCl3) δ 4.88 (t, 3JHH=4.3 
Hz, 1H, -CH2-CH-(O-)2), 3.93-3.75 (m, 6H, 
Ketal-CH2’s and -O-CH2-CH(CH3)2), δ 2.38 (t, 
3JHH=7.7 Hz, 2H, OOC-CH2-CH-), δ 1.95 (td, 3JHH=7.7 Hz,3JHH=4.1 Hz, 2H, -CH2-
CH2-CH-), δ 1.86 (12tet, 3JHH=6.6 Hz, 1H, -O-CH2-CH(CH3)2), δ 0.86 (d, 3JHH=6.6 
Hz, 6H, -O-CH2-CH(CH3)2). 
 
A7 Modification of M5 modified proteins with preformed transition 
metal complexes of phosphine aldehydes 
A7.1 Conjugation of preformed rhodium complexes 
The successful bioconjugation of several mono and diphosphines to SCP-2L V83C 
was demonstrated in the chapter 3. Seeking to extend the approach to the synthesis of 
metalloproteins, we explored the use of preformed transition metal complexes 
containing phosphine-aldehyde ligands for the second step in the coupling. This 
method is preferred over metal coordination following the conjugation of the ligand in 
an third conjugation step, as this will be more efficient because it will reduce the 
number of time consuming steps of washing and concentration of the protein. 
However, this requires the synthesis of monophosphine-rhodium complexes, which is 
not straightforward. Indeed, statistical mixtures of mono and bisphosphine rhodium 
complexes were obtained by using readily available [Rh(acac)(CO)2], [Rh(cod)2]BF4, 
[Rh(MeCN)2(cod)]BF4 or [Rh(nbd)2]BF4 as metal precursors and phosphine-aldehyde 
P3. The separation of the different products from the mixtures was unsuccessful. The 
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synthesis of a monophosphine complex of P3 was successful using palladium allyl 
chloride, however problems with the bioconjugation of the complex were encountered 
(see appendix A8). The synthesis of bisphosphine rhodium complexes is more 
straightforward, and although such complexes are unsuitable for artificial 
metalloenzyme-development, bisphosphine complexes might be interesting for future 
crosslinking applications.  
The desired rhodium complexes of the diphosphine-aldehyde ligands C4, P5 and P6 
were obtained without the problems encountered for the monophosphines. The 
complex obtained after the reaction of CDI activated C4 with [Rh(acac)(CO)2] 
provided a complicated second order 31P- NMR spectrum. (Figure 8a). Simulation of 
the spectrum allowed the identification of two sets of signals of almost equal intensity 
(1:0.9, see A7.2 for more details). Following the analysis of the coupling constants, 
the signals were assigned to two different complexes with the phosphines in either 
trans or cis positions, with the former the dominant species. The modification of SCP-
2L V83C with these complexes was unsuccessful, as analysis of the reaction by 
LCMS(ES+) revealed only the presence of unmodified protein and a small fraction of 
protein modified with the oxidized ligand.  
 
Figure 8. Experimental (blue) and simulated (red) spectra of formed complexes of 
[Rh(acac)(CO)2] and phosphines a) CDI activated C4 in DMF. 
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A complex of phosphine aldehyde P5 with [Rh(acac)(CO)2] generated in CDCl3 gave 
a second order 31P NMR spectrum similar to the complex obtained for C4. Also in 
this case analysis of the spectrum using simulation software revealed the presence of 
the trans and cis complexes with a ratio of 1:0.9 (see A7.2 for more details). The 
reaction of SCP-2L V83C-M5 with this complex did not show any modification 
product upon analysis by LCMS(ES+). Only the signal corresponding to unmodified 
SCP-2L V83C-M5 was observed.  
 
Figure 9. Experimental (blue) and simulated (red) spectra of formed complex of 
[Rh(acac)(CO)2] and P5 in CDCl3. 
 
A rhodium-P6 complex was generated with [Rh(MeCN)2(cod)]BF4 in 
dichloromethane. Crystals suitable for X-ray analysis were obtained (see A7.3), 
showing a coordinating MeCN and cod molecule in addition to the diphosphine. The 
reaction of SCP-2L V83C-M5 with this complex did not show any modification 
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A7.2 Experimental data 
A7.2.1 Procedure for in situ complex formation with CDI activated C4 and 
[Rh(acac)(CO)2] 
A 25 mM solution of CDI activated C4 was formed under argon atmosphere using the 
procedure described in chapter 3. 0.9 equivalents of [Rh(acac)(CO)2] were added to 
this solution of CDI activated C4 in DMF and the resulting mixture was mixed for 
about 10 minutes. The {1H}-31P-NMR (162 MHz) was recorded using an inner 
locking tube containing D2O. In addition to the signal of unreacted C4 a second order 
signal was observed between 15.8 and 21.3 ppm. Two species were identified using 
the DAISY second order simulation software of Topspin. The more abundant species, 
which was identified as a trans diphosphine rhodium complex because of the large 
phosphorus-phosphorus coupling constant (2Jp,p=313.5 Hz), contained two phosphorus 
signals at 19.4 and 17.7 ppm with coupling constants of 1JRh,P=127.0 Hz and 
1JRh,P=126.9 Hz. The second species, which was identified as a cis diphosphine 
rhodium complex because no phosphorus-phosphorus coupling was observed, 
contained two phosphorus signal at 18.9 and 18.1 ppm with coupling constants of 
1JRh,P=101.6 Hz and 1JRh,P=101.9 Hz. This solution was used directly for protein 
modification experiments. 
 
A7.2.2 Procedure for complex formation with P5 and [Rh(acac)(CO)2] 
5.6 mg (21.8 µmol) [Rh(acac)(CO)2] were added to a solution of 6.5 mg (21.8 µmol) 
P5 in degassed CDCl3 under argon atmosphere. The obtained solution was mixed for 
10 minutes and the {1H}-31P-NMR (162 MHz) was recorded, which showed a second 
order signal between 16.7 and 22.8 ppm and some unidentified minor impurities at 10, 
30 and 40 ppm. Two species were identified using the DAISY second order 
simulation software of Topspin. The more abundant, which was identified as a trans 
diphosphine rhodium complex because of the large phosphorus-phosphorus complex 
(2Jp,p=354.6 Hz), contained two phosphorus signals at 20.7 and 18.7 ppm with 
coupling constants of 1JRh,P=123.5 Hz and 1JRh,P=122.9 Hz. The second species, which 
was identified as a cis diphosphine rhodium complex because no phosphorus-
phosphorus coupling was observed, contained two phosphorus signal at 20.6 and 19.9 
ppm with coupling constants of 1JRh,P=138.0 Hz and 1JRh,P=138.0 Hz. The solvent was 
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removed and the obtained solid diluted in degassed DMF to be used in coupling 
experiments. 
 
A7.2.3 Synthesis of [RhP6(MeCN)(cod)]BF4 
This procedure was performed using dry glassware and solvents under argon 
atmosphere. 16.67 mg (26.8 µmol) P4 was dissolved in 1 ml dichloromethane. 10.19 
mg (26.8 µmol) [Rh(MeCN)2(cod)]BF4 was dissolved in 2 ml dichloromethane and 
the two solution were mixed and stirred for one hour. The solvent was removed and 
the remaining brown residue washed with 5 x 1 ml ether. Crystals (~1 mg) were 
obtained by slow addition of 10 ml ether to a concentrated solution of the residue in 
dichloromethane. 
 
General procedure for bioconjugation of preformed rhodium phosphine-aldehyde 
complexes with SCP-2L V83C-M5 
A series of parallel reactions were performed using different equivalents of the 
complex (usually 1, 2, 3, 5, 10 and 20 equivalents). This was done by addition of the 
appropriate amount of a 25 mM solution of the complex in MeCN to 3.25 nmol SCP-
2L V83C-M5 in 250 µL of the appropriate buffer (usually 20 mM MES, 50 mM NaCl 
pH 6) in a 1.5 ml or 0.5 ml Eppendorf. The reactions were mixed overnight by slow 
continues inversion on a rotating wheel. The reaction mixtures were then centrifuged 
(16100 g, 10 minutes) to remove formed precipitate and excess complex. The 
solutions were directly used for analysis by LCMS(ES+). 
 
A7.3 Crystallographic data of [RhP6(MeCN)(cod)]BF4 
Below the crystallographic data is presented for [RhP6(MeCN)(cod)]BF4 (Figure 10 
and Table 3). An overview of all bond angles and distances can be found on the 
accompanying CD. 
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Figure 10. Crystal structure of [RhP6(MeCN)(cod)]BF4. 
 
Table 3. Crystal data and structure refinement for [RhP6(MeCN)(cod)]BF4 (St. 
Andrews reference = pdpk10). 
Identification code  pdpk10 
Empirical formula  C50 H48 B F4 N2 O2 P2 Rh 
Formula weight  960.56 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
a = 10.620(5) Å α = 90°. 
b = 32.224(14) Å β = 108.377(8)°. 
Unit cell dimensions 
c = 13.553(6) Å γ = 90°. 
Volume 4402(4) Å3 
Z 4 
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Density (calculated) 1.450 Mg/m3 
Absorption coefficient 0.521 mm-1 
F(000) 1976 
Crystal size 0.20 x 0.10 x 0.03 mm3 
Theta range for data collection 2.03 to 25.43°. 
Index ranges -10<=h<=12, -38<=k<=38, -16<=l<=15 
Reflections collected 44910 
Independent reflections 8101 [R(int) = 0.0688] 
Completeness to theta = 25.00° 99.9 %  
Absorption correction Multiscan 
Max. and min. transmission 1.000 and 0.684 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8101 / 0 / 560 
Goodness-of-fit on F2 1.106 
Final R indices [I>2sigma(I)] R1 = 0.0993, wR2 = 0.2756 
R indices (all data) R1 = 0.1089, wR2 = 0.2844 
Largest diff. peak and hole 1.461 and -0.517 e.Å-3 
 
A8 Palladium-P3 complex formation and protein modification 
A8.1 Results and discussion 
The monophosphine complex shown in Scheme 1 was successfully obtained using 
[Pd(allyl)Cl]2 and phosphine P3 following a literature procedure involving a similar 
phosphine.[8] Several attempts were made for coupling of the complex to hydrazide 
modified SCP-2L V83C (SCP-2L V83C-M5). In each experiment the main product 
found after LCMS(ES+) analysis was the protein modified with an allyl group. When 
a large excess of the complex was used an additional peak was observed 
corresponding to a double allyl modification. A small peak (20% intensity compared 
to the main peak) of the addition of the complex without the chlorine could be found 
in all experiments. The observed competition between modification with the complex 
and allyl addition makes this route ineffective for artificial metalloenzymes formation. 
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Scheme 1. Synthesis of palladium complex with phosphine aldehyde P3 and 
conjugation to SCP-2L V83C-M5. 
 
A8.2 Experimental data 
A8.2.1 Synthesis of the palladium allylchloride complex of P3 
The following method is based on a literature procedure used for 
the synthesis of the triphenylphosphine analogue of this 
complex.[8] 52.14 mg (143 µmol) dimeric palladium allylchloride 
P3 was dissolved in as little as possible warm dry toluene (~ 
2ml, ~ 60ºC). To this yellow solution was slowly added an 
orange/brown solution containing 82.7 mg (285 µmol) p-diphenylphosphine 
benzaldehyde in 0.5 ml warm dry toluene. The solution was stirred for 5 more 
minutes at 80ºC and a white solid precipitated. The reaction mixture was cooled to 
0ºC, the liquid was removed and the solid washed 3 times with 1 ml cold toluene. The 
solid was than dried en vacuo providing P3 as a very light yellow powder. 1H-NMR 
(400 MHz, CDCl3), δ 9.98 (s, 1H, -CHO), δ 7.86-7.79 (m, 2H, Ph-CH), δ 7.74-7.65 
(m, 2H, Ph-CH), δ 7.58-7.47 (m, 4H, Ph-CH), δ 7.46-7.35 (m, 6H, Ph-CH), δ 5.56 (m, 
1H, CH), δ 4.74 (dt, J = 2.1 Hz, J = 7.2 Hz, 1H, CHH), δ 3.73 (dd, J = 9.8 Hz, J = 
13.7 Hz, 1H, CHH), δ 3.10 (d, J = 6.6 Hz, 1H, CHH), δ 2.79 (d, J = 12.3 Hz, 1H, 
CHH); 13C-NMR (101 MHz, CDCl3), δ 191.7 (s, -CHO), δ 140.1 (d, 1JCP = 37 Hz, 
benzaldehyde-p-Cq-P), δ 137.2 (s, benzaldehyde-ipso-Cq), δ 134.4 (d, 2JCP = 12 Hz, 
SCP-2L V83C-M5-allyl (calc 13599.7 Da)  
Found: LCMS (ES+) 13600.0 Da  
P3 
SCP-2L V83C-M5  
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benzaldehyde-m-CH), δ 134.1 (d, 2JCP = 13 Hz, Ph-o-CH), δ 134.1 (d, 2JCP = 13 Hz, 
Ph-o-CH), δ 131.3 (d, 1JCP = 42 Hz, Ph-ipso-Cq-P), δ 131.0 (s, Ph-p-CH), δ 129.3 (d, 
3JCP = 11 Hz, benzaldehyde-o-CH), δ 128.9 (d, 3JCP = 10 Hz, Ph-m-CH), δ 118.3 (d, 
3JCP = 5 Hz, allyl-CH), δ 80.4 (d, 2JCP = 31 Hz, P-trans-allyl-CH2), δ 61.4 (s, , P-cis-
allyl-CH2); 31P-NMR (162 MHz, CDCl3), δ 23.3 (s); Peak assignment based on 
literature data using the triphenylphosphine analogue.[9] 
 
A8.2.2 General procedure for bioconjugation of preformed phosphine aldehyde 
metal complexes with SCP-2L V83C-M5 
A series of parallel reactions were performed using different equivalents of the 
complex (usually 1, 2, 3, 5, 10 and 20 equivalents). This was done by addition of the 
appropriate amount of a 25 mM solution of the complex in MeCN to 3.25 nmol SCP-
2L V83C-X in 250 µL of the appropriate buffer (usually 20 mM MES, 50 mM NaCl 
pH 6) in a 1.5 ml or 0.5 ml Eppendorf. The reactions were mixed overnight by slow 
continues inversion on a rotating wheel. The reaction mixtures were then centrifuged 
(16100 g, 10 minutes) to remove formed precipitate and excess complex. The 
solutions were directly used for analysis by LCMS(ES+). 
 
A9 Nitrogen donor ligand synthesis 
A9.1 Synthesis of N,N-dipicolyl-2-aminoethanethiol N5 
Thiol containing N5 was synthesised to provide a nitrogen ligand that can be 
introduced by disulfide bridge formation. The reaction between dipicolylamine with 
ethylene sulfide gave N5 in quantitative yield (Scheme 2). Surprisingly, the NMR 
data we obtained for N5 did not match that reported in literature.[10] Whereas no 
signals for the thiol proton or coupling constants to this proton by the neighbouring 
CH2’s were reported, in our 1H-NMR spectrum of N5 the signals belonging to the 
thiol proton including coupling constants could clearly be observed. An IR spectrum 
was recorded of N5 to support the correct interpretation of our NMR data. A band at 
2487.0 cm-1 was observed in the obtained IR-spectrum which is typical for a SH 
stretch band. When N5 was left in CDCl3 solution for more than 16 hours and the 1H-
NMR spectrum was recorded a small amount of the compound reported in literature 
appeared. This result demonstrated that N5 does slowly transform into the disulfide 
bridge dimer of N4 most likely by air exposure. 
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Scheme 2. Synthesis of dipicolylamine based ligand N5. 
 
A9.2.Bioconjugation of N5 to SCP-2L V83C 
In contrast to the maleimide conjugation reaction of SCP-2L V83C and A100C with 
N4, the modification reaction between N5 and SCP-2L V83C did only lead to 50% 
formation of the modified protein, even when a large excess of N5 was used (200 eq). 
Full conversion to SCP-2L V83C-N5 could be achieved by addition of ligand N5 as 
the iron(II)chloride adduct (1 equivalent). However, it is unclear whether the iron is 
still present inside the protein or is fully removed by washings. Because the addition 
of oxidative metal salts can give problems for catalytic application this is not a 
preferred modification procedure. Other oxidative additives to catalyse the reaction 
which can be removed efficiently after the reaction by dialysis or centrifugal 
concentration would be more suitable for this approach. 
 
A9.3 Structural investigation into SCP-2L V83C-N5 
Some studies into the effect of modification with N5 on the structure of SCP-2L 
V83C were performed. The CD-spectrum (Figure 11), Watergate 1H-NMR spectrum 
(Figure 12) were recorded. The CD-spectrum shows changes similar to those 
observed for the introduction of dipicolylamine based ligand N4 (section 5.3.4). From 
both the NMR and CD spectra can be observed that the structure of SCP-2L V83C-N5 
seems to be very similar compared to that of SCP-2L V83C. This was confirmed by 
the fluorescent binding assay which gave a Kd of 0.20 (+/-0.05) µM for SCP-2L 
V83C-N5. This Kd value is of the same order of magnitude as the Kd of 0.18 (±0.07) 
µM found for SCP-2L V83C itself. 
Appendixes 




Figure 11. Near UV CD-spectrum of SCP-2L V83C (red) and SCP-2L V83C-N5 
(green). 
 
Figure 12. Watergate 1H-NMR spectra of SCP-2L V83C (red) and SCP-2L V83C-N5 
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A9.4 Synthesis towards mono functionalised tripicolylamine nitrogen 
donor ligands N6 and N7 
Synthetic routes towards additional nitrogen ligands containing tripicolylamine 
motifs for site selective introduction into proteins were also undertaken. The 
strategies outlined in Scheme 3 and Scheme 4 were pursued to introduce a maleimide 
attached in an 3- (N6) and 4- position (N7) on one of the pyridine rings.  
 
Scheme 3. Synthesis towards ligand N6. 
 
The synthetic strategy towards N6 made use of a reported synthesis for E3.[11] The 
target ligand N6 was thought to be accessible through bromination of methyl(6-
methyl)nicotinate followed by nucleophilic substitution using potassium maleimide. 
The reported synthetic route to E3 was performed via E1 through bromination of 
methyl(6-methyl)nicotinate. This bromination was accomplished with NBS and 
tetrachloromethane affording product E1 in 57% yield. However, tetrachloromethane 
is very toxic and therefore we tried to find an alternative method for this first step. 
Bedel et al reported the bromination of similar compounds with NBS in a mixture of 
water and dichloromethane.[12] The mono and dibrominated product ratios reported in 
the article could be reproduced by application of this method; however, the yield was 
very low (15%) due to the formation of what seemed to be insoluble polymeric 
products. E2 was obtained in a 73% yield, which was higher than the reported 
62%.[11b] E3 was reported to be unstable,[11b] which prevented it from being obtained 
in a pure form. Small amounts of unidentified degradation products of E3 were 
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observed even after column chromatography purification. Finally, E3 was obtained 
with traces of impurities in about 75% yield. This mixture was used for the 
bromination step using PBr3 to obtain E4. A mixture of different compounds was 
obtained but none could be identified as E4. Alternatively, N6 should be accessible 
by formation of the tosylate or other compounds which transform the alcohol of E3 
into a good leaving group. 
 
Scheme 4. Synthesis towards ligand N7. 
 
The first step in the synthetic route towards nitrogen ligand N7 was also performed. 
The formation of tripicolylamine structures like E6 can be obtained by a reaction of 
aldehydes similar to E5 with dipicolylamine.[13] These reactions were reported to 
provide the tripicolylamine motif in higher yields compared to the reaction with the 
bromides as used for the synthesis of E2. The most convenient method to obtain 
aldehyde E5 seemed to be by selective oxidation of the substituted picoline using 
selenium dioxide according to a procedure applied by Behforous et al for which 
yields in the range of 40-90% were reported.[14] E5 was obtained in 26% by 
application of this reaction with the corresponding carboxylic acid, the N-oxide and 
polymeric compounds being the main side products. Although the yield was low, it 
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A9.5 Synthesis towards functionalised triazacyclononane nitrogen donor 
ligands N8 and N9 
The synthetic strategy towards triazacyclone nitrogen ligands N8 and N9 is shown in 
Scheme 5.  
 
Scheme 5. Synthesis towards ligands N8 and N9. The value between brackets given 
for E15 shows the obtained yield of the selective synthesis of this compound by a 
procedure reported in literature.[16] 
 
In the first step the tritosylate E9 is prepared by a reported procedure performed by 
various groups with variable yields.[15] In our hands a yield of 65% of E9 was 
obtained. By application of a procedure that was supposed to provide the complete 
detosylation of E9 a mixture of E10 and E15 (3.6:1) was obtained.[15d] The products 
E10 and E15 were easily separated by sequential crystallisation and were identified 
using 1H/13C-NMR and crystallography (see appendices A9.6.7 and A9.7 for further 
information). Alternatively the monotosylate E15 could also be obtained in one step 
using a selective detosylation step developed by Sessler et al in an 87% yield.[16] 
These partially protected triazacyclononane compounds offered several possibilities. 
The ditosylate E10 can be mono functionalised. The functionalization had however 
to be able to withstand the harsh tosylate deprotection conditions. Therefore, E10 
was functionalised with 2-bromoethanol to provide the alcohol E11 in 96% yield. 
From E11, N8 should be accessible via detosylation to E12, methylation to E13 and 
transformation of the alcohol to a leaving group E14 followed by introduction of the 
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maleimide. The monotosylate E15 was methylated with a mixture of formaldehyde 
and formic acid to provide E16 in near-quantitative yield. Deprotection of E16 with 
sulphuric acid gave E17 in 87% yield. Coupling reactions of the maleimide acid 
chloride with n = 1 proved difficult due to troublesome product isolation and 
identification at the small scale at which the reactions were done. Modification with 
3-maleimidopropionic acid (n = 2) using DCC/HOBT was also unsuccessful in the 
first two attempts. 
 
A9.6 experimental data for the synthesis of nitrogen ligands N5-N9 
A9.6.1 Synthesis of N,N-dipicolyl-2-aminoethanethiol N5 
This synthesis was performed according to a literature procedure.[10] Under an argon 
atmosphere 0.33 ml (5.56 mmol) ethylene sulfide was added dropwise to a solution of 
0.65 ml (3.6 mmol) dipicolylamine in 1 ml of toluene. The resulting mixture was 
heated for two days at 65ºC. After this the volatiles were evaporated in vacuo to give 
0.95 g (3.6 mmol) of N5 as a yellow oil. This oil was stored under argon as exposure 
to air seemed to lead to decomposition, most likely in the form of the disulfide 
bridged dimer. 1H-NMR (300 MHz, CDCl3), δ 8.47 (ddd, 3JHH=4.9 Hz, JHH=1.8 Hz, 
JHH=1.0 Hz, 2H, Py-H), δ 7.60 (dt, 3JHH=7.6 Hz, JHH=1.8 Hz, 2H, Py-H), δ 7.47 (td, 
3JHH=7.6, JHH=1.0 2H, Py-H), δ 7.09 (ddd, 3JHH=7.6 Hz, 3JHH=4.9 Hz, JHH=1.0 Hz, 
2H, Py-H),	  δ 3.78 (s, 4H, Py-CH2-N), δ 2.77-2.71 (m, 2H, N-CH2-CH2-SH), δ 2.65-
2.56 (m, 2H, HS-CH2-CH2-),	   δ 1.55 (t, 3JHH=7.3 Hz, 1H, -SH); 13C-NMR (75.47 
MHz, CDCl3), δ 159.3 (Cq, PyC-CH2),	  δ 149.1 (CH, PyC-H), δ 136.5 (CH, PyC-H), δ 
123.1 (CH, PyC-H), δ 122.1 (CH, PyC-H),	  δ 60.2 (CH2, Py-CH2-N), δ 57.1 (CH2, N-
CH2-CH2), δ 22.5 (CH2, CH2-CH2-SH); This NMR data does not completely 
correspond with the data previously reported for this compound, but as no SH signal 
or coupling of the neighbouring CH2’s to the SH-proton is reported, the literature 
data[10] most likely corresponds to the dimer. IR-spectrum (NaCl plate), 3051.0 cm-1 
(m, CH stretch band), 3008.7 cm-1 (m, CH stretch band), 2933.8 cm-1 (m, CH stretch 
band), 2822.2 cm-1 (s, CH stretch band), 2487.0 cm-1 (w, SH stretch band). 
 
A9.6.2 General procedure for bioconjugation of N5 to SCP-2L V83C 
A 25-50 µM solution of protein in buffer (20 mM MES 50 mM NaCl pH 6) was 
incubated with the corresponding amount of equivalents of the N5 added from a 50 
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mM stock solution in DMF. Progress of the reaction was monitored using LCMS 
(ES+) analysis. Typically about 50% conversion to the modified protein was observed 
after 16 hours. Alternatively an iron(II)chloride adduct of the ligand N5 was used 
from a stock solution of the same concentration in water. Full conversion to SCP-2L 
V83C-N5 (expected 13633.9 Da, found 13634.0 Da).was obtained after 16 h after 
analysis by LCMS(ES+).  
 
A9.6.3 Synthesis of methyl(6-bromomethyl)nicotinate E1  
A solution of 3.92 g (25.95 mmol) methyl(6-methyl)nicotinate, 5.08 g (28.55 mmol) 
NBS, 0,43 (2.6 mmol) AIBN in 50 ml water and 50 ml CH2Cl was irradiated by a 300 
W halogen lamp for three hours, while stirring vigorously and refluxing by the heat of 
the lamp. The organic layer was separated and dried with MgSO4. The solvent was 
evaporated and the resulting mixture of starting material, monobrominated E1 and 
dibrominated product was separated by column chromatography with PE:EtOAc 4:1 
over neutralised (with Et3N) silica, yielding 0.85 g (3.7 mmol 15%) E1 as a red solid. 
1H-NMR (400 MHz, CDCl3); δ 9.17 (d, 4JHH = 1.8, 1H, 1-Py-H), δ 8.32 (dd, 3JHH = 
8.1, 4JHH = 1.8, 1H, 3-Py-H), δ 7.55 (d, 3JHH = 8.1, 1H, 4-Py-H), δ 4.60 (s, 2H, Py-
CH2-Br), δ 3.97 (s, 3H, -COOCH3), similar to the data reported in literature.[11b, 17] 
 
A9.6.4 Synthesis of E2  
This synthesis was performed according to a literature procedure.[11b, 17] A mixture of 
0.76 g (3.7 mmol) 2-dipicolylamine, 0.74 g (3.22 mmol) methyl(6-
bromomethyl)nicotinate E1 and 1 ml (6 mmol) diisopropylethylamine in 40 ml THF 
was stirred for 24 hours. The resulting solution was filtered over celite providing a 
dark red solution. The THF was removed in vacuo and the resulting red/brown oil was 
dissolved in ether and again filtered through celite. Several crystallisations from ether 
at -20ºC gave a combined yield of 0.722 g (2.07 mmol, 64%) E2 as a yellow solid. 
1H-NMR (400 MHz, CDCl3); δ 9.1 (d, 4JHH = 1.8, 1H, 1-EPy-H), δ 8.55 (d, 3JHH = 
4.1, 2H, 1-Py-H), δ 8.26 (dd, 3JHH = 8.1, 4JHH = 1.8, 1H, 3-EPy-H), δ 7.75-7.52 (m, 
5H), δ 7.22-7.13 (m, 2H), δ 4.05-3.88 (m, 9H), similar  to literature data.[11b, 17] 
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A9.6.5 Synthesis of E3 
This synthesis was performed according to a literature procedure.[11b] Under argon 
atmosphere, a solution of 0.722 g (2.07 mmol) E2 in dry Et2O was added drop wise to 
a solution of 0.2 g (4.6 mmol) LiAlH4 in dry Et2O cooled to 0ºC. The obtained 
mixture was stirred at room temperature for 18 hours after which TLC showed 
complete conversion. The mixture was again cooled to 0ºC and small quantities of 
water and a 10% NaOH solution were carefully added after which the mixture was 
stirred for an additional 2 hours. The organic layer was separated and the water layer 
extracted with Et2O. The combined organic layers were filtered over celite, dried with 
Na2SO4, filtered and concentrated en vacuo resulting in 0.62 g (1.95 mmol, 95%) 
crude E3 as a brown oil. 1H-NMR (400 MHz, CDCl3); δ 8.62-855 (m, 3H), δ 7.76-
7.56 (m, 6H), δ 7.21-7.16 (m, 2H), δ 4.73 (s, 2H), δ 4.07-3.98 (m, 6H), similar to data 
reported in literature.[11b] 
 
A9.6.6 Synthesis of N,N’,N’’-1.4.7-tritosyl-1,4,7-triazacyclononane E9 
This synthesis was performed according to a literature procedure.[15] Under argon 
atmosphere, 2.13 g (31.3 mmol) sodium etoxide in 20 ml dry EtOH was added to a 
hot slurry of 8.01 g (14.2 mmol) N,N’,N’’-1,4,7-tritosyl-1,4,7-triazaheptane in 20 ml 
dry EtOH . The ethanol was removed en vacuo and the resulting dark brown solid was 
dissolved in 50 ml dry DMF. This dark brown solution and a solution of 4.99 g (13.5 
mmol) ethyleneglycolditosylate were added over 4½ hours to a dry DMF solution at 
110ºC using a syringe pump. The reaction mixture was stirred for 4 more hours at this 
temperature after which it was cooled to room temperature. Water was added 
resulting in the precipitation of the crude product, that could be isolated by filtration 
and washing with water. Purification by column chromatography with PE:EtOAc 3:2 
over alumina resulted in 5.66 g (9,45 mmol, 68%) E9 as a white powder. Rf = 0.21; 
1H-NMR (400 MHz, CDCl3), δ 7.71 (d, 3JHH = 8.1, 6H, Ts-Ar-H), δ 7.33 (d, 3JHH = 
8.1, 6H, Ts-Ar-H), δ 3.43 (s, 12H, N-CH2-CH2-N), δ 2.44 (s, 9H, Ts-CH3), similar to 
data reported in literature.[18] 
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A9.6.7 Synthesis of. N,N’-ditosyl-1,4,7-triazacyclononane monohydrobromide 
salt E10 and N-tosyl-1,4,7-triazacyclononane dihydrobromide salt E15 
This synthesis was performed according to a literature procedure.[16, 19] A yellow 
suspension of 5.22 g (8.22 mmol) N,N’,N’’-1.4.7-tritosyl-1,4,7-triazacyclononane E9, 
60 ml 50% HBr and 30 ml acetic acid  was heated to 100ºC for 24 hours. Addition of 
diethylether and ethanol provided a white precipitate isolated by filtration providing 
2.72 g (5.26 mmol, 64%) E10, which could be recrystallised to needles in a mixture 
of HBr, H2O, EtOH and Et2O (see section A9.7.1 for crystal structure). 1H-NMR (300 
MHz, D6-DMSO), δ 9.07 (broad-s, 2H, -NH2+-), δ 7.72 (d, 3JHH = 8.2, 4H, Ts-Ar-H), 
δ 7.48 (d, 3JHH = 8.2, 4H, Ts-Ar-H), δ 3.47 (s, 8H, N-CH2-CH2-N), δ 3.33 (s, 4H, N-
CH2-CH2-N), δ 2.41 (s, 6H, Ts-CH3); 13C-NMR (300 MHz D6-DMSO), δ 144.5 (Ts-
Ar-Cq), δ 133.9 (Ts-Ar-Cq), δ 130.5 (Ts-Ar-CH), δ 127.6 (Ts-Ar-CH), δ 51.6 (CH2), δ 
47.8 (CH2), δ 45.0 (CH2), δ 21.4 (Ts-CH3). E15 was obtained as glassy crystals from 
the filtrate 0.59 g (1.32 mmol, 18%) by slow solvent evaporation (see section A9.7.2 
for crystal structure). 1H-NMR (300 MHz, D6-DMSO), δ 9.07 (broad-s, 4H, -NH2+-), 
δ 7.74 (d, 3JHH = 8.2, 2H, Ts-Ar-H), δ 7.49 (d, 3JHH = 8.2, 2H, Ts-Ar-H), δ 3.56 (s, 
4H, N-CH2-CH2-N), δ 3.41 (broad-s, 8H, N-CH2-CH2-N), δ 2.20 (s, 3H, Ts-CH3); 
13C-NMR (300 MHz D6-DMSO), δ 144.5 (Ts-Ar-Cq), δ 132.6 (Ts-Ar-Cq), δ 130.2 
(Ts-Ar-CH), δ 127.5 (Ts-Ar-CH), δ 46.8 (CH2), δ 45.1 (CH2), δ 42.8 (CH2), δ 21.0 
(Ts-CH3).  
 
A9.6.8 Selective synthetic procedure to N-tosyl-1,4,7-triazacyclononane 
dihydrobromide salt E15 
This synthesis was performed according to a literature procedure.[16] A reflux setup 
with a magnetic stirrer was connected to a base-trap with a sodium hydroxide 
solution. The flask was charged with 3.29 g (5.56 mmol) N,N’,N’’-1.4.7-tritosyl-
1,4,7-triazacyclononane E9, 3.29 g (41,7 mmol) phenol freshly crystallised from 
petroleum ether 40-60ºC and 50 ml 30% HBr in HOAc. The resulting fuming black 
solution was heated to 90ºC for 36 hours, when a white precipitate had formed. The 
white precipitate was filtered off and washed with diethylether. The off-white powder 
was dried en vacuo resulting in 2.16 g (4.85 mmol, 87%) E15. More product could be 
obtained by crystallisation from the filtrate after addition of diethylether. 1H-NMR 
corresponded to the product of the above reaction from which crystals were obtained. 
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A9.6.9 Synthesis of N-(2-ethoxy)-N’,N’’-ditosyl-1,4,7-triazacyclononane E11 
75.2 mg (0.6 mmol) 2-bromoethanol and a spatula-tip K2CO3 was added to 0.28 g 
(0.55 mmol) E10 in 6 ml of ethanol. The mixture was refluxed under inert atmosphere 
till TLC showed complete conversion (3 days). Dichloromethane was added and 
separated and the organic layer was washed several times with water and dried on 
Na2SO4. The solvent was removed in vacuo yielding the crude product as a pale 
yellow solid. Column chromatography on silica with EtOAc:PE:Et3N 19:1:1.5 
afforded 0.254 g (0.53 mmol 96%) E11 as a pale yellow solid. Rf=0.47; 1H-NMR 
(300 MHz, CDCl3), δ 7.58 (d, 3JHH = 8.3, 4H, Ts-Ar-H), δ 7.24 (d, 3JHH = 8.3, 4H, Ts-
Ar-H), δ 3.53 (t, 3JHH = 4.9, 2H, N-CH2-CH2-OH), δ 3.34 (s, 4H, N-CH2-CH2-N), δ 
3.18 (broad-s, 4H, N-CH2-CH2-N), δ 2.94 (t, JHH = 4.6, 4H, N-CH2-CH2-N), δ 2.36 (s, 
6H, Ts-CH3); 13C-NMR (300 MHz, CDCl3), δ 143.7 (Ts-Ar-Cq), δ 135.1 (Ts-Ar-Cq), 
δ 129.9 (Ts-Ar-CH), δ 127.1 (Ts-Ar-CH), δ 60.4 (CH2), δ 59.6 (CH2), δ 55.2 (CH2), δ 
53.3 (CH2), δ 52.9 (CH2), δ 60.4 (CH2), δ 21.5 (Ts-CH3). 
 
A9.6.10 Synthesis of N-tosyl-N’-N’’-dimethyl-1,4,7-triazacyclononane E16 
This synthesis was performed according to a literature procedure.[20] A clear solution 
of 0.31 g (0.699 mmol) of E15 in 1.5 ml 37% formaldehyde and 3 ml formic acid was 
heated to 90ºC for 20 hours. The solution was cooled to room temperature and HCl 
was added until pH = 1 was reached. All liquid was removed in vacuo followed by the 
addition of more HCl. This process was repeated three times yielding a yellow solid 
being the HCl salt of E16. 0.206 g (6.6 mmol, 96%) free amine of E16 was obtained 
by flash column chromatography on silica with EtOAc:MeOH:Et3N 8:1:1. Rf = 0.21 
in EtOAc:PE:Et3N 19:1:1; 1H-NMR (300 MHz, D3COD), δ 7.58 (d, 3JHH = 8.4, 2H, 
Ts-Ar-H), δ 7.29 (d, 3JHH = 8.4, 2H, Ts-Ar-H), δ 3.15-3.09 (m, 4H, N-CH2-CH2-N), δ 
2.90-2.83 (broad-s, 4H, N-CH2-CH2-N), δ 2.90-2.70 (s, 4H, N-CH2-CH2-N), δ 2.32 (s, 
9H, Ts-CH3 and N-CH3); 13C-NMR (300 MHz D6- D3COD), δ 144.97 (Ts-Ar-Cq), δ 
136.9 (Ts-Ar-Cq), δ 130.9 (Ts-Ar-CH), δ 128.3 (Ts-Ar-CH), δ 56.9 (2x CH2), δ 51.3 
(CH2), δ 45.8 (N-CH3), δ 21.4 (Ts-CH3). 
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A9.6.11 Synthesis of N,N-dimethyl-1,4,7-triazacyclononane E17 
This synthesis was performed according to a literature procedure.[16, 20] A brown 
mixture of 0.55 g (1.76 mmol) N-tosyl-N’-N’’-dimethyl-1,4,7-triazacyclononane E16 
and 5 ml sulphuric acid was heated to 120ºC for 2 days under argon atmosphere. The 
resulting black solution was cooled to 0ºC followed by the addition of a small amount 
of water. This mixture was made basic by careful addition of a concentrated sodium 
hydroxide solution. This mixture was extracted five times with chloroform. The 
combined organic layers where combined and the solvent was removed en vacuo 
providing 0.242 g (1.54 mmol, 87%) E17 as a yellow oil. This yellow oil was stored 
under argon at -4ºC, since it was reported to decompose slowly at room temperature 
in air. This was confirmed by the observation of extra peaks in 1H and 13C and-NMR 
over time. 1H-NMR (400 MHz, D3COD), δ 2.58-2.53 (m, 4H, N-CH2-CH2-N), δ 
2.50-2.45 (m, 4H, N-CH2-CH2-N), δ 2.44 (s, 4H, N-CH2-CH2-N), δ 2.30 (s, 6H, N-
CH3); 13C-NMR (400 MHz, D3COD), δ 54.9 (CH2), δ 53.6 (CH2), δ 46.1 (CH2), δ 
45.4 (N-CH3); MS direct injection (ES+), m/z (relative intensity), 158.16 (M + H+, 
100%), 180.16 (M + Na+, 52%), exact mass calculated for C8H19N3 m/z 157.16, + H+ 
m/z 158.17, + Na m/z 180.15. Also a peak at m/z 170.17 was observed with 85% 
intensity, which could correspond to a decomposition product. 
 
A9.7 Crystallographic data obtained for the crystals of E10 and E15 
A9.7.1 Crystallographic data of E10 
Below the crystallographic data is presented for E10 (Figure 13 and Table 4). An 








Figure 13. a) Crystal structure of E10. b) Crystal packing of E10. 
 
Table 4. Crystal data and structure refinement for E10 (St. Andrews reference = 
pdpk2). 
Identification code  pdpk2 
Empirical formula  C20 H30 Br N3 O5 S2 
Formula weight  536.50 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
a = 5.788(2) Å α = 90°. 
b = 15.674(7) Å β = 92.034(7)°. 
Unit cell dimensions 
c = 25.454(8) Å γ = 90°. 
Volume 2307.8(16) Å3 
Z 4 
Density (calculated) 1.544 Mg/m3 
Absorption coefficient 1.999 mm-1 
F(000) 1112 
Crystal size 0.2000 x 0.0300 x 0.0100 mm3 
Theta range for data collection 1.53 to 25.34°. 
Index ranges -6<=h<=6, -18<=k<=18, -30<=l<=30 
Reflections collected 21254 
b) 
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Independent reflections 4110 [R(int) = 0.0785] 
Completeness to theta = 25.00° 98.1 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.6931 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4110 / 4 / 297 
Goodness-of-fit on F2 1.093 
Final R indices [I>2sigma(I)] R1 = 0.0625, wR2 = 0.1333 
R indices (all data) R1 = 0.0795, wR2 = 0.1434 
Largest diff. peak and hole 0.977 and -0.417 e.Å-3 
 
A9.7.2 Crystallographic data of E15 
Below the crystallographic data is presented for E15 (Figure 14 and Table 5). An 
overview of all bond angles and distances can be found on the accompanying CD. 
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Table 5. Crystal data and structure refinement for E15 (St. Andrews reference = 
pdpk1). 
Identification code  pdpk1 
Empirical formula  C13 H23 Br2 N3 O2 S 
Formula weight  445.22 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
a = 16.947(4) Å α = 90° 
b = 6.3810(14) Å β = 104.277(11)° 
Unit cell dimensions 
c = 15.919(4) Å γ = 90° 
Volume 1668.3(7) Å3 
Z 4 
Density (calculated) 1.773 Mg/m3 
Absorption coefficient 4.992 mm-1 
F(000) 896 
Crystal size 0.100 x 0.100 x 0.010 mm3 
Theta range for data collection 2.48 to 25.35°. 
Index ranges -19<=h<=20, -7<=k<=7, -16<=l<=18 
Reflections collected 8684 
Independent reflections 2773 [R(int) = 0.0662] 
Completeness to theta = 25.00° 91.3 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.5075 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2773 / 4 / 209 
Goodness-of-fit on F2 1.148 
Final R indices [I>2sigma(I)] R1 = 0.0579, wR2 = 0.1148 
R indices (all data) R1 = 0.0700, wR2 = 0.1209 
Extinction coefficient 0.0045(6) 
Largest diff. peak and hole 0.953 and -0.666 e.Å-3 
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A10 N4CuCl2 crystal structure and EPR spectrum 
A10.1 Crystal structure data of N4CuCl2 
Below the crystallographic data is presented for N4CuCl2 (Figure 15 and Table 6). An 
overview of all bond angles and distances can be found on the accompanying CD. 
 
Figure 15. Crystal structure of N4CuCl2. 
 
Table 6. Crystal data and structure refinement for N4CuCl2 (St. Andrews reference = 
pdpk5). 
Identification code  pdpk5 
Empirical formula  C19 H18 Cl2 Cu N4 O3 
Formula weight  484.81 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
a = 17.633(7) Å α = 90°. 
b = 8.433(3) Å β = 99.18(2)°. 
Unit cell dimensions 
c = 13.478(5) Å γ = 90°. 
Volume 1978.4(12) Å3 
Z 4 
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Density (calculated) 1.628 Mg/m3 
Absorption coefficient 1.404 mm-1 
F(000) 988 
Crystal size 0.1000 x 0.0100 x 0.0100 mm3 
Theta range for data collection 2.34 to 25.39°. 
Index ranges -17<=h<=21, -7<=k<=10, -14<=l<=15 
Reflections collected 12110 
Independent reflections 3584 [R(int) = 0.3939] 
Completeness to theta = 25.00° 99.0 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.6759 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3584 / 102 / 262 
Goodness-of-fit on F2 1.277 
Final R indices [I>2sigma(I)] R1 = 0.2570, wR2 = 0.5203 
R indices (all data) R1 = 0.4041, wR2 = 0.5815 
Largest diff. peak and hole 3.529 and -1.825 e.Å-3 
 
A10.2 EPR spectrum N4CuCl2 
An additional advantage of the application of copper(II) complexes is the possibility 
to use EPR for their characterisation. This technique can be used to provide 
information on the surroundings of the metal centre and can also be applied to EPR-
active transition metals in biomolecules.[21] Regarding the conjugation of copper-
nitrogen ligand complexes to proteins, this technique can distinguish coordination of 
the copper to the desired nitrogen donor ligand environment from coordination to 
other potential coordination sites provided by the amino acid side chains. Initial 
experiments for this purpose were performed by recording the continuous wave (CW) 
X-band EPR spectrum of 0.1 mM N4CuCl2 in 20 mM MES buffer pH 6 containing 
20% glycerol. A spectrum was obtained by cooling the sample to 77 K with liquid 
nitrogen and optimisation of the power to 0.1 mW (Figure 16). A typical copper(II) 
spectrum was obtained in which hyperfine splitting for the nitrogen donor atoms can 
be observed in the downwards slope between 3200 and 3300 G. This spectrum could 
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be used as reference spectrum for EPR-spectra obtained for the proteins modified with 
copper-complexes of dipicolylamine based ligands. 
 
Figure 16. CW X-band EPR spectrum of 0.1 mM N4CuCl2 in 20 mM MES buffer pH 
6 containing 20% glycerol at 0.1 mW. 
 
EPR spectra were recorded with the kind help and supervision of Dr. Olav Schiemann 
at the facilities of the University of St. Andrews.  
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